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Ageism and London’s Hospitals: A long-overdue and insufficient remedy 
 
Bryan Young, MD, FRCPC, 
Professor, Division of Neurology, 
Department of Clinical Neurological Sciences, University of Western Ontario 
Member of Active Staff, Neurology and Critical Care, London Health Sciences Centre 
 
 
The term “ageism” was coined in 1969 by 
Robert Butler, who likened it to other forms of 
bigotry such as racism and sexism, defining it as 
a process of systematic stereotyping and 
discrimination against people because they are at 
or beyond a certain age.1 Ageist attitudes are 
perpetuated in many ways. Institutions 
perpetuate ageism and reinforce ageist 
stereotypes by not hiring or promoting older 
workers and through mandatory retirement. 
Ultimately, stereotypes are dehumanizing and 
promote one-dimensional thinking about others. 
Elders are not seen as human beings but as 
depersonalized objects who, therefore, can be 
more easily denied opportunities and rights, 
leading to cruel and inhumane treatment. Ageism, 
as manifested by mandatory retirement, is based 
on fallacious thinking and untenable policies. 
Chronological age is a poor predictor of the 
competence of the older adult.2 Furthermore 
there is far more variation of productivity, ability 
and intelligence within than across age groups.3 
The Ontario Government’s Bill 211, which is 
now in effect,, should force London Health 
Science Centre’s (LHSC) and St. Joseph’s 
Health Centre’s (SJHC) to amend their by-laws 
that gave an absolute cut-off for hospital-based, 
OHIP or LHSC/SJHC-funded remunerative work 
to individuals over 70 years of age. However, the 
plan not to reinstate those recently terminated 
before December 2007/January 2008 will 
unjustly curtail the careers of several capable, 
internationally renowned academic clinicians. 
Thus, this arbitrary decision perpetuates the 
injustice that existed here before Bill 211.  
Why should we persist in discriminating 
against individuals who are otherwise well 
qualified? If we cut off physicians’ livelihood, 
i.e., the ability to be remunerated for clinical 
work, they cannot viably continue their academic 
pursuits, even if the university position remains. 
Mandatory, age-dependent retirement has been 
abolished in most Canadian universities and 
hospitals. The policy is, above all, inhumane: 
“The deprivation of the opportunity to work has 
been the most widespread disadvantage imposed 
on people because of old age.”4 At a time of 
physician shortages, we are losing good people 
who could still make valuable contributions in 
research, teaching and patient care. Within the 
academic medical centre the academic milieu is 
damaged. There are aspects of collegiality, best 
demonstrated in academic rounds and 
collaborative research projects, that would be 
compromised if these individuals were forced to 
retire. 
We need not look far for examples of the 
damaging effects of mandatory retirement. We 
have lost a number of internationally famous 
individuals, who have moved to other 
institutions, e.g., Mayo Clinic, when they could 
no longer work at LHSC and SJHC. In the past 
two years several prominent, active, productive 
faculty members have lost even their outpatient 
privileges and their ability to carry on their 
needed activities in established units at the 
LHSC and SJHC, because of ageist bylaws of 
convenience. This makes no sense if they want to 
work and if they are needed.  
Why must this persist, when LHSC and 
SJHC are otherwise so progressive and 
prominent in research, teaching and patient care? 
Within medical and surgical departments, 
mandatory retirement was a convenient means 
for department heads to be freed from the 
responsibility of passing judgment on the 
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competence of senior departmental members, 
some of whom were the mentors or professors of 
current department heads or service chiefs. It 
also allows the system to eventually free itself of 
incompetent and non-productive members. 
Mandatory retirement is one of the few methods 
by which positions are created to hire new 
departmental members. However, if the senior 
member is still active and capable (often such 
individuals are in their prime at age 65, 70 years 
or beyond), this cannot be justified. Why should 
they be sacrificed? From an ethical perspective it 
is wrong: the ends do not justify the means.5 
Also, at a time of physician shortages in almost 
all branches of medicine, forcing out our most 
productive, competent and prestigious colleagues 
is both wasteful and unwise. 
Reform is the best approach to counteracting 
ageism within institutions. The object is to have 
quality members in the department, regardless of 
age.6 To do this we need a better model. 
Although it will be a challenge to design and 
implement a workable, fair system, it is the right 
thing to do. Departments have Appointments and 
Promotion Committees that have the duty of 
assessing the performance of departmental 
members and recommending their continuation, 
promotion, demotion or discontinuation. Surely 
these committees should function as they were 
intended and allow for yearly, fair, merit-based 
assessments of each Departmental member. The 
committee should be empowered to make 
decisions about appointments, promotion as well 
as the dismissal of individuals based upon 
agreed-upon qualifications and record of 
research, teaching and service in the “stream” 
appropriate for each member. This would take 
the onus off the divisional chairs to make such 
decisions in isolation. Other models for the 
operation of hospital and university departments 
can be formulated that allow continuation of the 
best and hiring of the brightest: the Faculty could 
derive another system for physician assessment 
with appropriate oversight, principles of function, 
accountability and authority with checks and 
balances. Individuals should be maintained on 
our staff while they continue to make meaningful 
contributions to the missions of the university, 
hospital and departments. Mandatory retirement 
from LHSC/SJHC, with respect to admitting, 
consultation and billing privileges should be 
abolished. It is shameful at a time when we need 
capable and knowledgeable academic clinicians 
for them to be effectively dismissed.  
This would be a very good time for LHSC 
and SJHC to abolish mandatory retirement as 
well as the “no re-entry” policy for the unjustly 
retired. We need to develop other models for 
dealing with competence and productivity, so 
that the incompetent and non-productive can be 
jettisoned from and the good retained in 
academic medical centres. 
 
References 
 
1. Butler RN. Age-ism: Another form of bigotry. The 
Gerontologist. 1969; 9: 243-246. 
2. Levine ML. Age discrimination and the mandatory 
retirement controversy.   Baltimore:  Johns Hopkins 
University Press, 1988. p. 108-117. 
3. Kutscher RE, Walker JF. Comparative job 
performance of office workers by age. Monthly Labor 
Reviews. 1960; 83:  39-50. 
4. Norton EH, former Chair, US Equal Opportunities 
Commission. In:  Levine ML, editor. Age 
discrimination and the mandatory retirement 
controversy. Baltimore:  Johns Hopkins University 
Press, 1988. 
5. Kant I. Fundamental Principles of the Metaphysic or 
Morals. Translated by T.K Abbott. Buffalo, NY:  
Prometheus Books, 1987. 
6. Walker A, Taylor P. Ageism versus productive aging.  
In:  Bass SA, Caro FG, Chen Y-P, editors.  Achieving 
a productive aging society. Westport:  Auburn House, 
1993. p 61-80. 
 
 
   UWOMJ 78(1)2008 P3 
 
 
 
A Royal Pain: The Porphyria Disorders 
 
Badrinath Narayan, BSc, Medicine 2009 
Stephen Chihrin, BSc, Medicine 2008 
 
One of the first and most popular examples of historical diagnosis is provided by an examination of King George III 
and the records of his significant illness. Plagued with acute attacks of intense abdominal pain, curiously-coloured 
urine, and a constellation of neuropsychiatric symptoms, historians were at a loss for an explanation for nearly two 
centuries. It is now generally accepted that King George suffered from some form of porphyria, likely acute 
intermittent porphyria (AIP) or variegate porphyria (VP). Porphyria diseases are at their root a variety of disorders of 
heme synthesis. Symptoms are believed to result from the accumulation of biosynthetic intermediates. It is the intent 
of this paper to outline AIP and VP and their association with many influential people from the past. Maintaining a 
high index of suspicion for these entities you will not only undoubtedly impress your senior resident – you may also 
find yourself in royal company for your efforts. 
 
 
Introduction 
One cannot discuss the history of rare diseases 
without mention of King George III. Ruler of the 
British Empire from 1760 to 1820, he presided 
over a considerable time span marked by great 
achievements and questionable decisions alike. 
Britain’s navy had proven itself as the 
undisputed world leader, defeating Napoleonic 
France and strengthening King George’s 
influence across the world. On the other hand, 
mismanagement of the American colonies led to 
the Boston Tea Party, and ultimately, the 
Declaration of Independence. The establishment 
of Australia as a penal colony, also controversial, 
was also conducted during his reign.1 These 
events left somewhat of a shadow over the 
legacy of King George III, “The King Who Lost 
America”.2 Subtle and not-so-subtle indications 
of Parliament’s hesitancy with King George’s 
rule stemmed from his periodic bouts of madness 
– bouts that while well documented would not 
receive a diagnosis for nearly 200 years. 
While evidence suggests minor episodes 
began much earlier, it was in October of 1788 
that King George experienced his most 
prolonged bout of intense, totally debilitating 
madness, leaving England largely without a ruler 
until February of 1789 – a period often now 
referred to as The Regency Crisis.1 Royal 
physicians Dr. Richard Warren and Sir George 
Baker meticulously recorded symptoms of 
tachycardia, fever, periodic jaundice or 
bloodshot eyes, abdominal colic, constipation, 
lower leg cramps, pain, and weakness. They also 
noted bullous eruptions along the arms, 
hoarseness, and port-wine coloured urine, as well 
as a variety of psychiatric manifestations 
including bouts of vivid multi-sensory 
hallucinations, delusions, and rambling which 
often degenerated into incoherent strings of 
obscenities.3 
Initially assumed to be a chiefly psychiatric 
disease, intriguing reports by royal attendants of 
urine that “leaves a pale blue ring upon the glass 
near the upper surface” left historians and 
physicians alike looking for a better answer.4 In 
the 1960’s Ida Macalpine and Richard Hunter 
first proposed that King George III was afflicted 
with acute intermittent porphyria (AIP), and with 
the permission of the royal family collected urine 
samples from his descendants, many of whom 
displayed elevated porphyrin levels.5 The 
subsequent discussion they sparked is perhaps 
unmatched in the field of medical history, and 
the mystery has spawned countless books and 
even an Oscar winning feature film.6 More 
recent proposals have integrated the observation 
of vesicular lesions to suggest instead a 
diagnosis of variegate porphyria (VP)3, though 
VP does not as commonly present with 
psychiatric manifestations, and rarely ever has it 
produced symptomology as severe as observed 
Zebra Files 
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in King George III.7 As this topic remains 
controversial, it is the intent of this article to 
address both AIP and VP. 
 
Epidemiology and Pathogenesis 
AIP results from an autosomal dominant 
mutation in the Porphobilinogen (PBG) 
deaminase gene.8 While mutation rates for this 
gene are relatively high, and more than 400 
mutants have been identified, gene penetrance is 
low resulting in a disease prevalence of 1-2 per 
100,000.9 VP, resulting from an autosomal 
dominant mutation in protoporphyrinogen 
oxidase (PPOX) 8, is just as heterogeneous in its 
mutations, and while one subtype occurs at a 
frequency of 1 per 300 in South Africa, global 
frequency is considerably lower. Furthermore, 
incidence of subtypes displaying associated 
psychiatric disease is rarer still leaving estimates 
as simply “less than AIP”.10 
Both genes are involved in the biochemical 
cascade required for the synthesis of 
protoporphyrin, the integral iron-bound 
component of hemoglobin. Defects in either of 
these two genes results in accumulation of both 
PBG and delta-aminolaevulinic acid (ALA).9 
Interestingly, both of these compounds are 
colourless in the isolated state but develop a 
yellow, red, or purple pigment when left to react 
non-enzymatically in the urine.4 
Under normal circumstances the accumulation of 
biosynthetic intermediates is insufficient to 
produce symptoms of porphyria. However, under 
conditions of hematologic stress, most notably 
infection, blood loss, or Cytochrome P450 
induction resulting from smoking, excess alcohol 
intake, fasting, fever, or pharmacologic 
interactions, porphyrin precursors accumulate to 
dangerous levels.9 While both ALA and PBG are 
implicated in triggering the neuropsychiatric 
aspects of porphyria, research has indicated that 
it is predominantly ALA that is responsible, by 
competitively inhibiting normal GABA receptor 
binding.9 
It has also been proposed that the extreme 
symptoms experienced by King George III may 
have been magnified by accidental, or perhaps 
iatrogenic arsenic exposure.1 It is well 
established that arsenic in its trivalent state can 
disrupt a number of the enzymes responsible for 
hemoglobin synthesis. Analysis of hair samples 
from King George III found arsenic traces 
 
 
Table 1: Signs and Symptoms of Acute Intermittent Porphyria and Variegate Porphyria7,11 
 
Stage Signs and Symptoms 
Early through late 
  (Abdominal) 
Severe colicky abdominal pain (often epigastric lasting days) 
Constipation 
Nausea and vomiting 
 
Mid through late 
  (Psychiatric)* 
Depression common 
Mania 
Psychosis 
 
Late only 
  (Neurologic) 
Areflexia common 
Motor weakness, usually in lower limb 
Diffuse pain, usually in upper limb 
Autonomic neuropathy (hypertension, postural  hypotension,  
  tachycardia are common) 
Delirium, coma, cortical blindness also reported 
 
Skin** Photosensitive lesions, bulla or furrowing (most severe in  
  children) 
Lesions often friable 
Hypertrichosis 
Sclerodermoid changes 
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* Much debate exists as to whether these symptoms have a pathogenic mechanism in VP. Observation 
    of the South African cohort, where roughly 1 in 300 people have the gene for VP, suggests not. 
** Skin manifestations only present in VP. 
throughout the length of each hair, suggesting 
chronic exposure to low dose arsenic. It has been 
proposed that this exposure may have resulted 
from contamination of his antimonial emetic 
tartar, which at one point he was receiving at a 
rate of 120mg q6h. Treatments involving 
elemental compounds were quite popular at the 
time, and Dr. John Willis, head of Dunston 
House, London’s premier asylum of the time, 
was quite found of arsenic therapies. However, 
direct therapy using arsenic is not recorded in the 
logs of King George’s physicians.1 
The observation of a bluish layer 
precipitating to the surface of collected urine has 
also recently been explained.4 It has been 
observed that prolonged constipation can affect 
levels of bacterial sulphatase in the 
gastrointestinal tract, and in the presence of 
excess tryptophan, can lead to excessive 
production of indoxyl sulphate (indican). This 
substance is then processed in the liver and 
excreted via the kidneys. Barely soluble, it falls 
out of solution as urine temperature drops 
outside of the body. While this mechanism is 
largely believed, what is not understood is why 
this phenomenon is observed with greater 
frequency in patients suffering from an acute 
episode of porphyria.4 
 
Diagnosis 
Diagnosis relies on a high index of suspicion 
given the signs and symptoms of both AIP and 
VP (see Table 1).7,11 It should be noted that 
symptom groups generally progress as 
overlapping groups, with initial manifestation 
limited to the abdomen, followed by psychiatric 
symptoms, and finally peripheral neuropathy. 
Ultimately, early morning or 24-hour urine 
collection should be conducted, ideally during an 
acute attack of the disease, and assessed for ALA 
and PBG accumulation.8 While levels will be 
substantially elevated during an acute attack, 
levels of both ALA and PBG, particularly PBG, 
remain elevated, often for years following the 
last acute attack.11 
Urine levels of ALA and PBG may be 
misleading if urine samples are left too long 
before analysis, particularly if exposed to light, 
or if collected from a patient with chronic renal 
failure. In this circumstance measuring direct 
ALA and PBG serum levels is indicated.7 
Measurement of protoporphyrin and 
coproporphyrin in the stool may also assist in 
these circumstances, but is of low sensitivity.5 
Recently, experts have also suggested that 
directly assessing PBG deaminase activity may 
be warranted as it unequivocally detects the 
defect associated with AIP.9 
 
Differential 
The differential diagnosis of acute porphyria is 
potentially enormous, thus diagnosis rests on 
successful identification of hemoglobin 
precursors in the urine, blood, or stool. The 
abdominal symptoms present in AIP are similar 
to many acute GI disorders.7-9,11 
Neuropsychiatric manifestations are most closely 
approximated by heavy metal poisoning. The 
skin lesions observed in cases of VP share 
similarities with a number of dermatological 
conditions, the most important to rule out include 
drug-induced photosensitivity reactions and 
porphyria cutanea tarda.7,9 
 
Management 
Successful management of acute attacks of 
porphyria rest on decreasing heme synthesis, in 
turn decreasing production and accumulation of 
heme precursors.9 Administration of high-dose 
glucose has been observed moderately curtail 
heme synthesis, if given in doses of at least 400g 
per day.11 More severe attacks have been well 
managed with the use of hematin, a heme 
derivative, at a dosing of 4mg/kg/day for at least 
4 days.11 
Just as important as treating acute attacks, 
prevention of further attacks is a critical aspect 
of management, and one that is complicated by 
significant pharmacologic interactions. Well over 
200 drugs have been found to exhibit properties 
that may predispose an individual to more 
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frequent bouts of porphyria.7,11 The classes felt 
to be most harmful include androgens, estrogens, 
progesterones, barbiturates, sulfonamides, 
hydantoins, griseofulvin, as well as ethanol.12 
Due to the sheer volume of potential interactions, 
it is important to consult up to date, 
comprehensive lists when treating patients with 
AIP or any other porphyria. 
Appropriate management must also include 
education and screening of family members. In 
asymptomatic individuals an assay for 
erythrocyte PGB deaminase has been found to be 
most sensitive in families with AIP.11 Similarly, 
assays for protoporphyrinogen oxidase have been 
used in assessing families with VP.7 
 
Conclusion 
The acute porphyria diseases, despite being 
exceeding rare have captured a large portion of 
medical historians’ attention. In fact, it was King 
George and his regency crisis that many cite as 
one of the first and finest examples of ‘historical 
diagnosis’ to be discussed in the literature. Since 
the early papers on this topic a number of other 
historical figures have also been suggested to 
suffer from acute intermittent porphyria. As one 
would expect, many other British Royalty of 
King George’s bloodline have been afflicted, 
including Queen Anne, King James I, Queen 
Mary I of Scotland, and Frederic the Great of 
Germany. Other notable individuals often 
suggested to have had porphyria include Vincent 
van Gogh and King Nebuchadnezzar of Babylon. 
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A Historical Perspective of the Diagnosis of Diabetes 
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Janet Malowany, BHSc (Hons), Meds 2008 
 
Diabetes is a disease whose symptoms have been recorded in the annals of history ever since the earliest reports of 
polyuria in 1500 BC.  However, it was only in the last hundred years that adequate treatment methods have been 
developed, initiated by Banting and Best’s discovery of insulin.  Tracing the historical methods used to diagnose 
diabetes provides a perspective for current diagnostic and treatment strategies.  Diagnostic tests have become 
increasingly quantitative evolving from the earliest diagnostic tests where urine was tasted to modern methods 
assaying the percentage of glycosylated hemoglobin.  The basis of future diagnostic tools for diabetes will most 
certainly be based on past research findings and experiences. 
 
 
The signs and symptoms of diabetes have been 
observed and recorded since the beginnings of 
civilization.  The earliest descriptions were 
limited to changes in urine output and the fatal 
outcome of those inflicted with diabetes. 
Polyuria, as we now know, has many different 
etiologies, thus it is impossible to discern today 
whether the symptoms and treatments were 
correctly directed at diabetes mellitus. However, 
the early recognition of diabetes began with the 
examination of urine. 
While the term “diabetes” was first 
introduced in the 1st or 2nd century BC by 
Demetrius of Apameia,1 descriptions of 
abnormal polyuria were recorded as early as 
1500 BC in the Egyptian Papyrus Ebers, an 
ancient written document of medical 
knowledge.1-3  The term “diabetes” was based 
from the Ionic and Latin terms that meant to pass 
through or to siphon.1 It was coined by Areteus 
of Cappadocia (AD 30-90) “because the fluid 
does not remain in the body but uses the man’s 
body as a ladder whereby to leave it”.3  It was 
the prevailing belief that diabetics had large 
volumes of urine due to large volumes of 
ingested fluids, unchanged as it passes through 
the body, as if the patient was a siphon.1  In 
addition to coining the term diabetes, Areteus is 
credited with the first accurate clinical 
description of diabetes, likening it to “an 
affliction… melting down of the flesh and limbs 
into the urine”.1 
The first test for diabetes was the urine taste 
test.  While the Greek physician Claudius Galen 
(AD 129-200) believed diabetics’ urine was 
“unchanged drink” which may have accounted 
for a different aroma, early Egyptians, Indians, 
and Asians noted the sweet taste of urine.3  
Chang Chung-Ching (AD 229) noted that the 
urine was so sweet that that dogs liked it.3  
Indeed, animals and insects alike were attracted 
to the sweet urine.3,4  The Hindu medical 
textbooks from the 5th century described sweet, 
honey and sugarcane urine amongst 20 varieties 
of diseased flow of urine.1,3  Both Avicenna (AD 
980-1037) and Paracelsus (AD 1493-1541) later 
recommended tasting the urine of diabetics.1,3  
The source, however, of the sweet taste of 
diabetics’ urine remained unknown. Avicenna 
noted a sticky residue as sweet as honey 
remained after urine was left to stand in ambient 
air.1  Theophilos Protospatharios (630 AD) was 
the first to mention applying heat to urine as a 
diagnostic test.3  Paracelsus reported that boiling 
diabetic urine recovered “4 ounces of salt”.3   
However, it was Thomas Willis (1621-1675) that 
first described the saccharine nature of urine, 
describing the sweet taste after evaporation “as if 
imbued with honey (quasi melle) and sugar”.1 
 In 1776, Matthew Dobson performed a 
diagnostics experiment that lead to the belief that 
diabetes was not just a disease of the kidneys, 
but rather a system disorder.1,5  Dobson 
evaporated the urine of diabetic patients to 
Diagnostic Review 
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discover the presence of a substance like brown 
sugar in taste and appearance, he also went on to 
observe that diabetic patients had the sweetish 
taste of sugar  in their blood.1,5  This confirmed 
the relationship between the sugars present in the 
blood and those excreted in the urine.      
John Rollo established the link between the 
food consumed by diabetics and the amount of 
sugar in the urine.6  Rollo recorded the amount 
and kind of food eaten by his diabetic patients, 
and then weighed the "sugar cake" which 
remained after evaporating their urine.6  He 
observed that carbohydrates increased sugar 
levels, and animal product consumption resulted 
in less sugar.1,5,6  He promoted the idea that the 
treatment for diabetes should be a diet low in 
carbohydrates and high in fat and protein. This 
modification of diet became the recommended 
treatment for diabetes until the discovery of 
insulin.7 
The first clinical tests for glycosuria were 
developed in the nineteenth century.  In 1841, 
Karl Trommer, developed a qualitative test for 
sugar which involves treating a urine sample 
with a strong acid  which results in the acid 
hydrolysis of disaccharides into 
monosaccharides.5,6  The solution is then 
neutralized and a solution of copper sulphate is 
added, then excess of alkali, followed by boiling, 
a brick-red cuprous oxide precipitate forms if 
glucose is present.5,6  In 1850, Hermann von 
Fehling developed a quantitative test based on 
Trommer’s work to measure sugar content.6  
Frederick Pavy (1829-1911) established a 
quantitative relationship between the degree of 
hyperglycemia and glycosuria based on 
Fehling’s test.5  Pavy also improved upon the 
Fehling’s test for quantitative sugar urinalysis by 
substituting ammonia for caustic potash and 
thereby facilitating production of the first 
urinalysis tablets.5 
In the twentieth century, easier methods to 
determine urine sugar content and tests for blood 
glucose were developed.  In 1907, Stanley 
Benedict developed a milder test for glycosuria 
using a copper reagent with a carbonate base 
rather than the hydroxide base of Fehling’s test.8   
In 1913, Ivar Bang pioneered a method to test 
blood glucose levels whereby blood proteins 
were fixed to filter paper and the filtrate was 
used to measure glucose using copper sulfate and 
KCl.9  However, the use of glucose-dependent 
copper reagent reduction reactions became 
increasingly analytically problematic as they 
underestimated the amount of glucose present.8  
In 1941, the Ames company introduced the first 
“stick” or “strip” tests (Clinitest) which was still 
based on the old methodology involving copper 
sulfate reduction.10  Shortly thereafter, the Ames 
company produced the far more accurate 
Clinistix which is based on the enzymatic 
reaction of glucose oxidase.10  This enzyme 
generates hydrogen peroxide as it interacts with 
glucose, which in turn reacts with horseradish 
peroxidase to produce oxygen which oxidizes 
orthotoluidine to produce a blue or purple 
colour.10 
In more recent times, the diagnosis of 
diabetes has taken on a more quantified approach.  
The emphasis over that last forty years has been 
on measuring blood glucose levels and response 
to oral glucose challenges.  Debate, however, has 
ensued over the determination of cut-off values 
for diagnosis, and the accepted values have 
changed a number of times, reflecting changes in 
trends and attitudes. 
In 1979, the National Diabetes Data Group 
and the World Health Organization developed 
diagnostic criteria for the diagnosis of diabetes 
that involved measuring glucose tolerance using 
an oral glucose tolerance test (OGTT).11  An 
OGTT involves giving a patient 75 gm of 
glucose by mouth and then measuring their 
blood sugars two hours later.  If a patient’s blood 
sugars are elevated more than they would be in a 
normal individual, then that patient has impaired 
glucose tolerance.  Using this test, the following 
criterion was established for the diagnosis of 
diabetes: fasting blood glucose 7.8 mmol/L or 
higher, or an OGTT two-hour blood glucose 
value of 11.1 mmol/L or higher.11 
These guidelines were updated in 1997 by 
the American Diabetes Association (ADA), and 
then revised in 2003.  The new guidelines require 
meeting one of three criteria in order to diagnose 
diabetes: a) a fasting blood glucose concentration 
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of 7.0 mmol/L or higher with symptoms of 
hyperglycemia, which include polydipsia, 
polyuria, and weight loss; b) a random blood 
glucose of 11.1 mmol/L or higher; c) a two hour 
value in an OGTT of 11.1 mmol/L or higher.12  
The diagnosis must then be confirmed on a 
different day with any of the three criteria.12  The 
ADA cautions use of the OGTT as a tool for 
diagnosis, and stresses the use of fasting blood 
glucose measurements instead, because the 
results of the OGTT are not always reproducible 
and so the test is not reliable.13  
There has been recent interest in using 
hemoglobin A1c values to aid in the diagnosis of 
type 2 diabetes in conjunction with random 
blood glucose levels.14,15  Hemoglobin A1c is the 
glycosylated form of hemoglobin A, the major 
adult hemoglobin type.  The utility in measuring 
hemoglobin A1c comes from the fact that its 
concentration is proportional to blood glucose 
levels.  In non-diabetics, the normal hemoglobin 
A1c level is less than 5% of the total 
hemoglobin.16  In patients with diabetes, 
chronically elevated blood sugars will lead to a 
higher than normal percentage of hemoglobin 
A1c.  It has been proposed that to avoid the 
inconvenience of measuring fasting blood 
glucose as a means of diagnosis, an abnormal 
random blood glucose value (11.1 mmol/L or 
higher) in addition to a hemoglobin A1c value 
greater than 2 standard deviations above normal 
could be used.14,15  Before the incorporation of 
hemoglobin A1c measurements into diagnostic 
criteria, a number of issues need to be addressed 
including erroneous levels due to diseases that 
falsely elevate or depress A1c values.17  Despite 
these potential sources of error, since 1999 Japan 
has been using HbA1c levels over 6.5 % as a 
diagnostic marker for diabetes.18,19  It seems 
clear that there still remains work to be done to 
standardize the diagnostic tools in the 
determination of diabetes.   
From the initial reports of sweet tasting urine 
to the biochemical analysis of glycosylated 
hemoglobin, the tests employed to diagnose 
diabetes have become more sophisticated over 
the past centuries as our knowledge of the 
disease grows.  The future promises to have ever 
more specific tests to diagnose the different 
varieties of diabetes, some of which may enter 
the realm of genetic screening or 
pharmacogenetics. 
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Chasing Hippocrates: Dr. Paul Potter’s Journey through the History of Medicine 
 
Renata Villela, Meds 2009 
 
Dr. Paul Potter received his medical degree from McGill University in 1968 and subsequently completed his graduate 
classical training in Hamilton and in Kiel, Germany.  One year after obtaining his Ph.D. in 1973, Dr. Potter became a 
member of the Faculty of Medicine at the University of Western Ontario.  He currently holds the post of Jason A. 
Hannah Professor and the Chairman of the Department of the History of Medicine.  Dr. Potter provides insight into his 
experiences as a medical historian and the future of the history of medicine. 
 
 
The classical world opened its doors to Dr. Paul 
Potter in Hamilton, Ontario amidst a sumptuous 
chocolate cake and grape juice at a high school 
Greek club meeting.  In spite of its enticing siren 
call, however, Dr. Potter’s love for the classical 
world was counterbalanced by his interest 
in science.  Following his graduation from 
secondary school, he began a seven-year medical 
degree program at McGill University in 1961.  
Fortunately, the program’s structure allowed him 
to pursue a range of subjects, thereby enabling 
him to take several Greek courses in addition to 
his basic science requirements.  By the end of his 
medical degree, Dr. Potter’s fascination with 
languages steered him towards the path of 
devoting himself full-time to the Greek language.  
He returned to Hamilton to complete a Masters 
of Arts degree in Greek at McMaster University 
and next departed for Kiel, Germany.  There, he 
received his Ph.D. in 1973 for a dissertation on 
the Hippocratic text Diseases III.  A subsequent 
sinecure provided him with ample time to study 
medical history.  By 1974, he returned to Canada 
to begin teaching at the University of Western 
Ontario in London.  Dr. Potter currently teaches 
undergraduate and graduate students and is 
cross-appointed between the Classics 
Department and the Faculty of Medicine.   
Dr. Potter’s travels and medical training have 
provided him with a strong foundation for 
understanding the physician within various 
historical contexts.  His research on Greek 
medicine has afforded him the opportunity to 
visit ancient healing temples and hospitals along 
the Mediterranean coasts of Greece, Italy, and 
France.  In addition, his medical degree has 
proven valuable in ways that he had not 
originally foreseen.  For example, several of his 
medical school laboratory sessions involved the 
use of frogs and other animals as subjects for 
physiology experiments.  These experiences 
enabled him to relate to the work of past 
physicians who used animals as models to 
understand better the inner workings of the body.  
Thus, Dr. Potter views himself as an “insider” in 
medicine. 
When not teaching students in the classroom, 
Dr. Potter explores topics in the history of 
medicine through the Osler Society.  The group 
was originally founded in 1922 by Dr. J.W. 
Crane in memory of Sir William Osler, who died 
in 1919.  Although the group began as an honor 
society, its focus moved towards the history of 
medicine after World War II.  By the time Dr. 
Potter arrived at the University of Western 
Ontario, however, the society was barely active.  
In the late 1980s, Dr. Potter was informed of a 
potential removal of funds for the club, which 
served as a catalyst for renewing medical 
students’ interest.  Since then, the club has 
enjoyed a solid membership increase.  Using his 
former Greek club as a model, Dr. Potter offers 
his home as a meeting place for the Osler Society 
each month and serves a delectable selection of 
hors d’oeuvres and desserts.   
Throughout his career, Dr. Potter has noticed 
some interesting developments within the study 
of the history of medicine.  Prior to the 1950s, 
several medical historians were doctors 
interested in exploring the roots of their 
profession.  Between 1950 and 1960, social and 
institutional historians began to enter the field.  
Profiles 
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Their view tended to be more critical of 
medicine than their physician counterparts.  
Whereas the latter focused more on medical 
achievements, the social historians were 
interested in how physicians exerted their power 
and influence in various cultures.   Fortunately, 
these differing perspectives came together to 
form the Canadian Society for the History of 
Medicine.  Dr. Potter foresees that important 
future topics in the history of medicine will 
include the limits of medicine, especially with 
regards to the amount of money society is 
willing to invest in health care and to how 
society will deal with technological advances 
such as genetic engineering.  Ultimately, history 
will provide a template to guide physicians in 
confronting the future challenges of medicine. 
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Light in the Dark Ages 
 
Raza Naqvi, Meds 2009 
Urszula Zurawska, Meds 2008 
 
While the Dark Ages were a time of intellectual and societal stagnation throughout much of Europe, the torch of 
academia continued to burn brightly in the Islamic world. The intellectual progress made during this time includes 
numerous medical breakthroughs which physicians, historians, and students should strive to understand not only for 
academic interest but also to learn and improve medicine today. The use of secular hospitals originated in this era and 
there were significant developments in a variety of medical fields including anesthesia, ophthalmology, pharmacology, 
neurology and psychiatry. A strong emphasis on patient-centered and interdisciplinary care was evident in many of the 
areas of Islamic medicine during the Dark Ages. The achievements of Islamic physicians during the Dark Ages also 
demonstrates the importance of strong communication within the global medical field, as the presence of avenues for 
global academic communication could have eliminated much of the disparity in medical care in different parts of the 
world over subsequent centuries. The need for improved international communication applies to medicine even today. 
 
 
Introduction 
The Dark Ages are known to be a time of 
intellectual and societal stagnation throughout 
much of Europe1 and as learners in the Western 
world we rarely hear about the academic 
achievements during this time. This is clearly 
seen in the medical field where historians often 
move from the work of the Greco-Romans 
before the Dark Ages to the discoveries of the 
Europeans afterwards.2-4 However from the 
seventh to thirteenth centuries the Islamic empire 
spread from Spain to China and was the centre 
for trading of goods, knowledge, and ideas.5-8 
The Islamic civilization was thriving 
intellectually at this time yet many historians 
regard the role of the Muslims during the Dark 
Ages as merely translators and transmitters of the 
Greco-Roman medical knowledge.4   
There are three important stages in the 
development of medicine in Islam.7 The first is 
the compilation and translation of the medical 
works of previous eras which occurred in the 
seventh and eighth centuries. The second stage 
was that of significant and genuine contribution 
by Islamic physicians to the current medical and 
scientific knowledge base. The third stage, 
occurring after the thirteenth century, was that of 
intellectual stagnation and decline within the 
Islamic world.7 
This article will briefly review the above 
described second stage, discussing the unique 
contributions of Islam to medicine during the 
Dark Ages and their relevance to modern- day 
medicine. 
 
Hospitals 
One significant contribution of Islam to medicine 
was the introduction of hospitals as we are 
familiar with them today.7-11 Although hospitals 
had existed prior to the seventh century, it was 
the Islamic era that transformed hospitals into 
secular institutions for the first time in history.9 
All ill individuals were treated irrespective of 
financial status, gender, age, and faith.9,12 Since 
Muslims required clean water to prepare for their 
daily prayers, all hospitals were also supplied 
with ample clean water12 and for the sake of 
modesty between genders separate wards were 
created for male and female patients in which the 
nurses and patients were of the same gender.8,13 
The nature of this hospital care is a clear 
example of making the patient’s needs and 
preferences a priority – a concept towards which 
medicine is returning today. 
The contributions of Islamic medicine to the 
development of hospitals also included allowing 
only qualified physicians to practice medicine7,14, 
originating an extensive teaching system within 
hospitals in which medical students became 
active learners7,9,14-15, the advent of patient 
records for the first time in history7,8, and the use 
of hospitals to care for lepers, the mentally ill, 
History of Medicine 
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and other groups that were ostracized for 
centuries to come in other areas of the world.8,9,16  
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Ophthalmology 
These centuries were also a time of tremendous 
growth in the field of ophthalmology. Not only 
did most medical manuals published during this 
time in the Islamic world include a chapter 
devoted to the eye, but a variety of compendiums 
were also written solely for diseases and 
conditions of the eye.17 Hunain ibn Ishaq’s 
influential “Ten Treatises of the Eye” was a 
work that demonstrated significant advancement 
from the previous knowledge of the Greco-
Romans,17-18 while al-Haytham’s “Optical 
Thesaurus” inspired the theories of future 
notables including Roger Bacon, Leonardo da 
Vinci, and Johannes Kepler.8,19 
Furthermore, it was Al-Razi (Rhazes) who 
discovered the light-reaction of the pupil, Ibn 
Sina (Avicenna) who first described the six 
intrinsic muscles of the eye, and Ammar bin Ali 
who was the first to describe cataract extraction 
using suction.8 This again reinforces the idea that 
the Islamic era was not merely one of translation 
but rather one of medical breakthroughs. 
 
Anesthesia 
Ali ibn Isa was the first in history to propose the 
use of anesthesia.20 The soporific sponge, which 
was a sponge soaked with aromatics and 
narcotics and then held to the patient’s nostrils, 
was also invented by Islamic physicians.4,7-8,21 
This implementation of anesthesia was one of 
the causes of the “rise of Arab surgery to the 
level of an honorable specialty” while it 
remained a less cultivated profession in Europe 
until the formula for the soporific sponge was 
received from Muslim sources in the thirteenth 
century.22 In 1886, Burton reiterated the 
precedence of Islamic physicians in the field of 
anesthesia by stating that “anesthetics have been 
used in surgery throughout the East for centuries 
before ether and chloroform became the fashion 
in the civilized West”23 thereby reminding that 
communication of medical research and 
discovery is integral to global health and well-
being. 
In addition, it was Avicenna who introduced 
the concept of oral anesthetics.7-8 He described 
numerous recipes for anesthetics and analgesics 
in his Canon of Medicine and was the first to 
propose the pharmacological effects of opium as 
well as various other drugs.7-8,24 Avicenna was 
also the first to describe the effect of pain on 
one’s ability to ventilate.24-25  
 
Pharmacology 
The field of pharmacology saw tremendous 
growth during the Dark Ages within the Islamic 
world. Indeed it was during this era that 
pharmacology was first established as a separate 
discipline from alchemy and medicine. For the 
first time, licensing for pharmacists was 
introduced.8 These changes were also 
accompanied by refinement of the methods of 
drug production as drug preparation and 
extraction became a high art.8,26 Furthermore, 
pharmacies were introduced adjacent to 
numerous hospitals for the first time in history7 – 
this is yet another example of the precociously 
progressive approach of early Islamic medicine 
towards multi-disciplinary care.  
Islamic physicians of the time also 
introduced a variety of new drugs, including 
camphor, musk, and senna.8,26 The use of alcohol 
as a pharmaceutical, anesthetic, and anti-septic 
also originated during this era.22 
The various medical texts published during 
this time consistently included chapters devoted 
solely to pharmacology26 and it was Ibn al-
Baytar whose compendium described more than 
five hundred drugs discovered by Islamic 
scientists in addition to over one thousand 
classical drugs derived from previous 
knowledge.27  
 
Neurology and Psychiatry 
Several significant developments occurred in the 
field of neurology and psychiatry in the Islamic 
world as well. Contrary to the common practices 
in Europe, Islamic medicine attributed 
psychological problems to neurological deficits 
and not to demonic possession or supernatural 
forces.15 The importance of sharing knowledge 
globally is evident as this could have prevented 
much of the social stigmatization that 
accompanied psychiatric disorders throughout 
the world in subsequent centuries. 
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Some modern-day history-taking techniques 
were also evident during this time. For example, 
in his 11th century practice, Ibn Ridwan would 
ask questions to determine a patient’s state of 
mind and note both their responses and 
behaviour. He also noted whether the affliction 
was of recent or long-term origin and treated 
accordingly. Ibn Ridwan’s exam tested the acuity 
of vision and hearing and articulation of speech. 
Furthermore, he evaluated muscle strength by 
asking patients to lift weights and grasp objects. 
He also recommended that physicians observe a 
patient’s gait both forwards and backwards 
during their clinical assessments.29 Physicians 
such as Ibn Ridwan exemplify the truly advanced 
state of medical sciences in the Islamic world 
over one millennium ago.  
Physicians in the Islamic world at this time 
were also responsible for discovering 
hydrocephalus and various brain tumours, as 
well as differentiating between delirium, 
meningitis, and meningismus.22 They were also 
the first to describe post-traumatic epilepsy and 
the notion of epilepsy as a manifestation of brain 
disease.22 
Numerous other developments in neurology 
were made, including Rhazes’ description of the 
pupillary light reaction and his original 
description of the laryngeal branch of the 
recurrent laryngeal nerve.4 Avicenna elucidated 
the differences between vertigo and epilepsy30 
and also gave the first account of a trigeminal 
neuralgia.31 This era also brought the first 
description of a brain abscess following otitis32 
as well as the association between headaches and 
temporal arteritis.33 
 
Other Contributions 
Islamic physicians made numerous other notable 
contributions to medicine during this era. One of 
the most significant was the first description of 
the pulmonary circulation by Ibn el Nifas in the 
thirteenth century.8 Furthermore, it was Rhazes 
who distinguished measles from smallpox 8, 
Avicenna who introduced the use of catgut for 
surgery34, Halle Abbas who first proposed that 
childbirth was caused by uterine contractions21, 
and Ibn al-Quff who presented novel works on 
embryology.35 
 
Conclusion 
The era between the seventh and thirteenth 
centuries was one of tremendous development 
and growth in the Islamic world, playing host to 
many physicians who made profound 
contributions to the world of medicine. Their 
compendiums and texts were commonly used 
throughout Europe during the subsequent 
centuries, illustrating that throughout time, the 
torch of knowledge was passed from one 
civilization to the next. It is important for 
physicians, students, researchers and historians 
today to realize that this torch continued to burn 
brightly even during the Dark Ages. 
It is also important that we apply the lessons 
learnt from early Islamic physicians, such as the 
value of interdisciplinary and patient-centered 
care, as well as recognize that global sharing of 
information in medical care today is essential to 
ensure the success of medical care tomorrow. 
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Medicine’s Role in Decoding Ancient Egypt 
 
Raza Naqvi, Meds 2009 
 
Recent medical investigations have worked to decode some of the great mysteries surrounding the life of various 
Ancient Egyptians. The research has sparked debate over this mysterious civilization; debates that range from the 
genetic makeup of the Pharaohs to whether or not they were murdered. The scientific and historical knowledge gained 
from such research has opened the doors for medicine to unravel some of the great mysteries of Ancient Egypt and 
other past civilizations. Tutankhamun, better known as King Tut, became Pharaoh at the tender age of nine and died 
after ten years of reign when he was only nineteen. It had long been suspected that he had been murdered, as 
evidenced by X-ray images from the late 1960s indicating a blow to the lower base of his skull.  However, a series of 
CT scans in 2005 have shown no evidence of this suspected blow but do implicate a large fracture in the Pharaoh’s left 
femur as the cause of death. Thus the most recent theory is that this Ancient Egyptian ruler was not murdered for his 
throne, but rather likely died due to an infection secondary to his broken leg. 
 
 
Ancient Egypt – Mummification and Beyond 
For over three millennia, ancient Egyptian 
civilizations have awed society with their 
unparalleled development and innovation. From 
the complex hieroglyphics found etched 
intricately into stone walls, the fine art of 
mummification, and the mysteries that remain 
regarding pyramid development and architecture, 
this era was replete with scientific and historical 
masterpieces.   
 
With the infamous discovery of Tutankhamun’s 
tomb in 1922 by English archaeologist Howard 
Carter, the first tomb to be discovered 
completely intact, came rejuvenated excitement 
in academic circles as to the potential that these 
relics had in deciphering many mysteries from 
the Egyptian era.1 The discovery provided new 
insight into the process of mummification, the 
lives of the pharaohs of the 18th Dynasty, artistic 
practices of the time, and many other areas of 
history. It turns out that medicine has played an 
enormous role in deciphering this complex story. 
 
Tutankhamun – King Tut 
The ancient boy king Tutankhamun has 
captivated the interest of the entire world since 
the discovery of his intact tomb by Howard 
Carter in 1922.2 Ascending the thrown as a mere 
nine year old boy in 1334 BC, Tutankhamun is 
possibly a son of the heretical Akhenaten and has 
been given credit for the reversion of Egypt back 
to its ancient polytheistic beliefs and traditions. 
His reign lasted just over nine years as 
Tutankhamun died as a young nineteen year old 
in1325 BC.3 His premature death as a nineteen 
year-old has led many Egyptologists to speculate 
as to the cause and numerous theories involve a 
murder in their explanation. 
 
Tutankhamun rests in piece(s) 
Carter and his staff, which included Derry and 
Saleh, two forensic specialists, began their 
investigations of Tutankhamun’s body in 
November of 1925.4 The mummy had been stuck 
to the inside of the coffin by the unguent that had 
been used to preserve Tutankhamun’s body. His 
body adhered to the base of the coffin and his 
skull remained fitted inside a golden helmet.4 
Carter’s team removed Tutankhamun from his 
coffin in pieces. They chose to cut the head off at 
the neck, used heated knives to remove the skull 
from the mask, detached the arms and legs, 
separated the pelvis and trunk, and effectively 
dismembered the body to facilitate their analysis. 
Derry and Saleh predicted an age of death 
between 18 to 22 based on Tutankhamun’s bony 
epiphyses and partially erupted molars. 
 
X-ray Vision 
Tutankhamun’s body was left untouched until 
1968 when a team led by anatomy professor R.G. 
Harrison of the University of Liverpool began 
their investigations. The first thing that was 
History of Medicine 
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discovered was that rather than leaving 
Tutankhamun to rest in peace, Carter and his 
team had left him resting in pieces, a fact that 
was omitted from Carter’s report and 
documentation. Harrison’s goal was to image the 
body of Tutankhamun but they found it to be in 
poor and fragile condition. The team did manage 
to perform X-rays on the skull of Tutankhamun. 
Their analysis showed two thick deposits of 
opaque material, later determined to be solidified 
embalming fluid, in the skull as well as a 
fragment of bone near the occiput. Several 
historians and Egyptologists have since 
suggested that the bone chip is concrete evidence 
in favour of the theory that Tutankhamun was 
murdered by a deadly physical injury to his 
head.5 
The 1968 X-ray series also demonstrated that 
the sternum and some of Tutankhamun’s frontal 
ribs were missing6 which then led to various 
medical and historical theories. Egyptologist 
Dennis Forbes theorized that perhaps 
Tutankhamun died in a chariot accident that 
crushed his sternal area7 and the sternum and ribs 
were subsequently removed by embalmers in 
order to facilitate the embalming. Others claim 
that Tutankhamun may have been pigeon-
chested, a birth defect, and note that his spine 
shows pronounced scoliosis to support this 
theory.8 
 
Astounding Discoveries 
The latest medical investigation of Tutankhamun 
was followed closely by many historians and 
gave rise to a strong sense of anticipation. World 
renowned Egyptologist Zahi Hawass performed 
a full-body CT scan of Tutankhamun on January 
5, 2005.  With a team of radiologists, anatomists, 
and forensic specialists from the Faculty of 
Medicine at Cairo University, Hawass and his 
team spent the next two months analyzing the 
1,700 images that were taken on that historical 
night. Upon reaching their conclusions, the team 
confirmed their results with a variety of foreign 
consultants including paleopathologists and 
radiologists from several European countries. In 
March of 2005, the stunning results were 
published to an anxiously awaiting community 
of historians and Egyptologists. 
 
Through a more detailed examination of 
Tutankhamun’s epiphyses and partially erupted 
third molars, Hawass and his team fixed the 
king’s age of death at nineteen years. They 
confirmed his height of 170cm and noted that 
Tutankhamun showed no signs of malnutrition or 
chronic disease. The team confirmed the 
elongated nature Tutankhamun’s skull, as had 
been noted previously6, but added that there was 
no premature fusion of the cranial sutures, thus 
confirming that the elongated skull was not a 
developmental abnormality but rather a normal 
anthropological variation. 
The detailed analysis also indicates that 
Tutankhamun did not suffer from scoliosis as 
previously claimed by some historians.2 The 
vertebra did not display any rotation or 
deformation and thus the medical team 
concluded that the curvature of the spine was 
likely a result of the manner in which the 
embalmers placed the body, and not scoliosis. 
Another extraordinary finding involves the 
suspicious missing ribs and sternum. The CT 
scans reveal that the ends of the ribs have been 
cut with a sharp instrument.  Hawass and his 
team believe that the removal may have been by 
the embalmers, however evidence fails to show 
any signs of serious chest trauma as has been 
suggested by some historians7 as the vertebrae 
remain undamaged. One cannot rule out a minor 
chest injury, although there is an alternate theory 
that is favoured by many. It seems difficult to 
conceive that Derry and Saleh, the two forensic 
pathologists who made detailed notes on their 
observations in the 1925 uncovering of 
Tutankhamun’s body, would fail to mention the 
obvious missing ribs and sternum – and fail to 
mention it they did. It would also make sense 
that the ribs, if removed by embalmers, would 
have been wrapped and kept within the 
sarcophagus of Tutankhamun, as was the 
Egyptian custom2. This indicates that the frontal 
ribs and sternum may have been removed by 
Carter’s team and simply never replaced. These 
missing items would be in addition to the right 
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thumb and other body parts which were reported 
missing by Harrison’s team in 1968 but are 
evident in images taken by Carter’s team in the 
1925 investigations.6 
The most striking conclusion that has 
resulted from the CT scans involves the cause of 
death of Tutankhamun. It turns out that the team 
of investigators has been able to conclude that 
Tutankhamum did not die from a blow to the 
head, as previously theorized. The loose pieces 
of cranium could not have come from an injury 
prior to death as they remain outside of the 
solidified embalming fluid. The team is 
unanimous in their agreement that the cranial 
injuries constitute postmortem damage however 
there is some debate as to whether the injuries 
were due to the embalmers over three millennia 
ago or Carter’s team in the early twentieth 
century.2 
A fracture of the lower left femur, at 
approximately the level of the epiphyseal plate, 
was also found in the full-body CT results. 
Although there are many fractures in the body 
caused by the (mis)handling of Carter’s team, 
this one is unique in several respects. Firstly, one 
of Carter’s forensic specialists, Derry, actually 
recorded this fracture in his notes as an 
observation, something which is not seen for the 
various additional fractures caused by the 
handling at the time.9 As well, the break has 
ragged, rather than sharp, edges and also has two 
thin layers of embalming fluid that have entered 
the injury site2. Furthermore, Derry had also 
reported a loose left kneecap which may be used 
as additional evidence for an injury to the left 
lower limb.9 
The theory that Hawass has proposed based 
on these findings is that Tutankhamun died not 
of a malicious attack to dethrone him but rather 
due to a severe fracture in his left femur. A 
fracture of this size could have easily led to 
infection and even caused gangrene, thus 
resulting in an infectious death secondary to the 
injury.2 Critics argue that although the blow to 
the head may not have been the cause of death, 
this still does not rule out the possibility of 
Tutankhamun’s murder by poisoning or other, 
less conspicuous, methods of murder.10 
 
Medicine in the future of Ancient Egypt 
We can thus see how medicine has played a 
variety of roles in the uncovering and decoding 
of some of history’s great mysteries. Traditional 
medical analyses may be used to analyze the life 
and death of historical figures from a variety of 
eras and medical technology may be used to 
objectively analyze the physical remains of these 
historical figures. Ancient Egypt lends itself 
perfectly to this type of analysis due to the 
unparalleled preservation of bodies attained due 
to the process of mummification. The benefits 
that the history of Ancient Egypt has already 
seen due to medicine’s contribution will soon 
carry over into various other ancient civilizations 
as the investigative power of medicine continues 
to expand. Advances in DNA analysis and 
recovery, fields that are still in their infancy, as 
well as the potential of future imaging techniques 
as computers continue to improve, expand, and 
surpass all previous expectations, will all 
continue to demonstrate the unlimited potential 
of the medicine to solve many of history’s great 
mysteries. 
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Patient privacy is one of the fundamental tenants of the practice of medicine. Mutual trust and confidentiality form the 
basis of the physician-patient relationship and have been recognized as sacred from the beginning of the medical 
profession. In Canada, healthcare falls under the jurisdiction of the provinces, which are able to assess and 
accommodate their own unique healthcare needs. Today, privacy of personal information is a top priority of 
governments, as personal information gains more significance in the applications it can have. Health records are no 
exception to this; information such as family history of congenital disorders, psychiatric conditions and financial 
information are being included in patient records and the drive to protect this from being shared with undesirable 
parties is escalating. This drive however must be balanced by the needs of healthcare professionals who require the 
information to properly treat patients. After many recommendations and failed attempts to provide a comprehensive 
legislation, on November 1, 2004, Ontario passed the Personal Health Information Privacy Act [PHIPA]. The 
effectiveness of PHIPA will not be readily apparent for some time given its recent enactment, however the struggle to 
provide the adequate balance between the protection of personal information and allowing healthcare professionals 
ease of access to facilitate patient care will ultimately determine the effectiveness of this new Act. 
 
 
Introduction 
Patient privacy is one of the fundamental tenants 
of the practice of medicine. Mutual trust and 
confidentiality form the basis of the physician-
patient relationship and have been recognized as 
sacred from the beginning of the medical 
profession.1 The Hippocratic Oath addresses the 
importance of protecting the health information 
of patients: “What I may see or hear in the 
course of the treatment or even outside of the 
treatment in regard to the life of men, which on 
no account one must spread abroad, I will keep 
to myself, holding such things shameful to be 
spoken about.”2 
 In Canada, healthcare falls under the 
jurisdiction of the provinces, which are able to 
assess and accommodate their own unique 
healthcare needs. Today, privacy of personal 
information is a top priority of governments, as 
personal information gains more significance in 
the applications it can have.3 Health records are 
no exception to this; information such as family 
history of congenital disorders, psychiatric 
conditions and financial information are being 
included in patient records and the drive to 
protect this from being shared with undesirable 
parties is escalating. This drive however must be 
balanced by the needs of healthcare professionals 
who require the information to properly treat 
patients. 
Who owns medical records? 
The ability of physicians to share medical 
records hinges upon the ownership of the 
records.  This question was addressed in the 
1992 landmark Supreme Court decision of 
McInerey v. MacDonald.4 The principle behind 
this case is that the information contained within 
the health record belongs to the patient, but the 
record itself is property of the medical 
institution.4 As such, legislation must then 
provide a framework establishing the rights of 
both the patient and healthcare professionals in 
regards to the use, collection and distribution of 
healthcare information. 
 
The Development of Health Information 
Privacy in Ontario  
In 1977, the Royal Commission of Inquiry, lead 
by Mr. Justice Krever was established to 
investigate and make recommendations on the 
privacy of health information.5  This commission 
was created in response to allegations of police 
access to patient records in OHIP and healthcare 
facilities without obtaining prior consent.5 At 
this time, no overarching legislation for the 
protection of privacy and health information had 
Medicine and the Law 
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been established and each healthcare facility was 
subject to their own practices. After reviewing 
the seventy-seven statutes and numerous 
regulations that were in place, it concluded that 
many aspects of health information were not 
clearly covered under any legislation.6 The 
Krever Report identified for the first time the 
discrepancies in the practices of healthcare 
institutions, healthcare professionals and the 
ambiguity in the legislation governing privacy 
and health information. It also recognized that 
the implementation of legislation to provide a 
universal provincial framework for privacy and 
health information should not be so cumbersome 
to impede the effective and timely delivery of 
healthcare. 
 With these suggestions, the Ontario 
government attempted to update and clarify the 
existing legislation to provide clearer guidelines 
for healthcare institutions and healthcare 
professionals and reflected the growing role of 
patient autonomy and privacy. However, no one 
piece of legislation provided a comprehensive 
approach. The Krever Report, recognized that 
the many pieces of legislation were not sufficient 
to encompass all the aspects of privacy and 
health information, since each Act dealt with 
separate issues, targeted to specific populations 
and sectors of society.6 Many gaps in how 
patient health information was handled 
remained. 
 
Two Failed Attempts 
The Ontario Ministry of Health attempted to 
create guidelines in June 1996 with the paper, A 
Legal Framework for Health Information.7 If 
this initiative was successful, Ontario would be 
the only province to implement comprehensive 
rules for personal health information. In 
November of 1997, the Ministry of Health 
created the Personal Health Information Protect 
Act, 1997.8  The ambitious draft provided clear 
guidelines on the collection, use and disclosure 
of health information, the rights of patients to 
access their information, the procedure for the 
correction of health records. The scope of this 
draft was large and encompassed territory that 
had not been covered in previous legislation. 
Therefore, much debate was generated and in the 
end, the legislation was not made law.5 
 In the wake of the failed attempt of the 
Personal Health Information Protection Act, 
1997, Bill 159, An Act respecting personal 
health information and related matters9 was 
introduced to the legislature on December 7, 
2000. The bill was not well received and found 
to be lacking the adequate balance sought by 
healthcare professionals and patients.  
 
Federal Legislation and the Romanow Report 
The provincial governments have the authority to 
regulate the delivery of healthcare but must do so 
in accordance with the Canadian Charter of 
Rights and Freedoms.10 The Charter does not 
explicitly protect privacy, but the Supreme Court 
of Canada has established that privacy is a 
constitutionally protected right.11 
 In 2001, The Committee of the Canada Privy 
Council appointed the Honourable Roy 
Romanow, Q.C, as Commissioner to review and 
enquire to the future of Canada’s healthcare 
system.12 The results of the review, released in 
2002 and popularly referred to as the Romanow 
Report, made many recommendations in regards 
to health information privacy that were similar to 
the Krever Report. Issues raised were the rights 
of patients’ access to medical records, concern 
over the misuse of information found in these 
records, the critical needs for patients to have 
access to their own information, and the need for 
health information to provide adequate 
treatment. Unlike the Krever Report, which 
made recommendations for the province, the 
Romanow Report called for clear and consistent 
privacy rules across Canada. 
 In April 2000, the federal government passed 
the Personal Information Protection and 
Electronic Documents Act (PIPEDA),13 which 
was limited to entities under federal jurisdiction, 
such as banks. However, if by January 2004, a 
province did not have its own privacy act that 
was substantially similar, PIPEDA would apply 
to all organizations within the province that 
collect, use or disclose personal information, 
including personal health information. PIPEDA 
was intended for commercial activities, and its 
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application to the health sector neither reflected 
the needs of the healthcare system nor provided a 
detailed framework for heath professionals to 
use.5 This would be the catalyst for the 
provincial government to draft comprehensive 
privacy legislation for health information that 
would better suit both the patients’ and 
healthcare professionals’ requirements in 
Ontario. 
 In December 2002, the Ministry of 
Consumer and Business Services and Ministry of 
Health and Long-Term Care, released a draft 
called Privacy of Personal Information Act, 2002 
(POPIA).14 The purpose of this legislation was to 
meet the criteria of being substantially close to 
PEPIDA and relieve the pressure of Ontario 
health organizations from having to comply with 
the federal legislation. Unfortunately, POPIA 
was far from ideal; it contained two separate sets 
of rules, one pertaining to personal health 
information, and the other that regulated personal 
information in the private sector.5 Although the 
pressure to introduce POPIA was strong, with 
the 2004 deadline of the PIPEDA approaching, 
the bill failed. 
 
Privacy Legislation Introduced at Last! 
On November 1, 2004, Ontario passed the 
Personal Health Information Privacy Act 
(PHIPA).15 This legislation would provide an all 
encompassing framework for the protection of 
personal health information.  
 PHIPA creates a set of rights and obligations 
relating to the collection, use, and disclosure of 
personal health information within Ontario.16 
One of the overarching goals of PHIPA is to 
strike an appropriate balance between (a) 
protecting privacy rights and (b) facilitating the 
effective delivery of healthcare services. Other 
objectives include providing individuals with the 
right to: access health records and correct 
erroneous information, request and independent 
review and resolution of complaints relating to 
the handling of health information, and obtain 
remedies for contraventions of the Act. 
 PHIPA applies primarily to ‘health 
information custodians’ (HICs), which include 
professionals and organizations usually involved 
with the provision of healthcare services. One of 
the most salient features of PHIPA is its 
treatment of an individual’s consent to the use of 
disclosure of health information. A patient’s 
consent can either be express or implied. 
Typically, consent will be implied when a health 
care provider discloses health information to 
another party within the patient’s ‘circle of care’. 
Express consent is necessary however when the 
provider discloses information to a party not 
classified as an HIC including, for example, a 
personal trainer.17 It is important to note that a 
request to hold health information confidential 
nullifies any implied consent which was 
presumed in the past. 
 
Conclusion 
The development of legislation to protect health 
information privacy in Ontario has been a long 
process, influenced by the federal and provincial 
governments and many healthcare and patient 
advocates.  The effectiveness of PHIPA will not 
be readily apparent for some time given its 
recent enactment; however the struggle to 
provide the adequate balance between the 
protection of personal information and allowing 
healthcare professionals ease of access to 
facilitate patient care will ultimately determine 
the effectiveness of this new Act. 
 
(The website of the Information and Privacy 
Commissioner includes basic information, 
developments, and orders relating to the 
interpretation of the Act and serves as an 
invaluable resource to practitioners and 
administrators concerned with health privacy. 
For more information visit www.ipc.on.ca) 
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The Medical Oath: Honorable Tradition or Ancient Ritual? 
 
Justin Morgenstern 
 
 
When asked to contribute a commentary on 
ethics in the history of medicine, it demonstrates 
a distinct lack of imagination to write about the 
Hippocratic Oath. While it may not be 
imaginative, the Oath’s enduring role in modern 
medicine makes it a topic of fundamental 
importance. The Hippocratic Oath, or some 
derivative thereof, plays a central role in the 
graduation ceremony of nearly every medical 
school in North America.1 However, whether 
this is symbolic of one’s entrance into the 
medical profession, a tribute to the great tradition 
of medicine, or a solemn ethical commitment is 
rarely indicated. What exactly is an oath and 
what are its implications for the practice of 
medicine? What impact should it have? Why the 
Hippocratic Oath in particular? Why any oath at 
all? 
These questions have concerned me since I 
first read the Oath, upon matriculation at medical 
school. Since, I have repeatedly reviewed the 
Oath, both in its original form and the “updated” 
form we used on the first day of class. I searched 
for meaning in the document I had always 
believed to epitomize the grandeur of medicine, 
but instead became incredulous that the archaic 
text was still read at all. 
Perhaps it is understandable that the original 
oath, written in an era far removed from our own, 
would conflict with our understanding of ethics 
today. The Oath strictly prohibits abortion and 
euthanasia, takes a vague stance against all 
surgery, and indicates that medicine is strictly 
the domain of men.2,3 These positions so 
blatantly conflict with modern thought that the 
common, and convenient, solution is to simply 
omit the difficult passages. (The document I first 
read made no reference to these ideals.) Of 
course, ignoring the original tenets of the Oath 
does a great injustice to the field of medical 
ethics. If we truly believe that the positions 
articulated in the oath are in error, we must 
acknowledge and justify an alternate position. It 
is only through such acknowledgement that we 
can fully understand our ethical obligations. 
While revising outdated positions may be 
seen by some as trivial, there is a more 
compelling reason why the Hippocratic Oath 
should no longer be sworn. There is a single 
theme that underlies the Oath – the so called 
“Hippocratic Principle.”4 By stating that all 
treatment will be applied “… for the good of my 
patients according to my ability and my 
judgement…,”3 the Oath is both paternalistic and 
individualistic. The Oath’s focus on the 
individual patient is at odds with the modern 
practice of medicine, where scarcity and 
rationing are common. We now understand the 
physician to fulfill multiple roles – with 
responsibilities to society as well as to individual 
patients. A Hippocratic understanding of 
medicine cannot recognize these divergent 
objectives, and is therefore a poor ethical guide 
for modern medicine. Furthermore, the emphasis 
that the Oath places on the physician’s “abilities 
and judgement” is incompatible with the modern 
understanding of the doctor-patient relationship. 
The Hippocratic ethic assumes that a vulnerable 
patient will place himself at the physician’s 
mercy and defer to the physician’s ‘better 
judgement.’4 The doctor-patient relationship as 
described in the Hippocratic Oath is the 
antithesis of modern medical thought, which 
embraces the concept of patient autonomy. 
Therefore, the time has come to abandon the 
practise of swearing the oath. 
However, if we abandon the Hippocratic 
Oath what, if anything, should fill the void? 
There are three related properties of oaths that 
must be considered to answer this question. 
Oaths, like promises, are properly described as 
‘performative utterances’. That is, once sworn, 
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an oath does not simply describe the world – it 
changes the world.5 The motives, goals, and 
actions of the professor are fundamentally 
altered by the words of the oath. Consequently, 
an oath is also a serious moral commitment. “To 
make or go back on a promise [or oath] is a very 
solemn matter precisely because a promise [or 
oath] is world altering.”6  Finally, an oath is a 
lifelong commitment. Unlike a promise, an oath 
contains no qualifications as to time or place, and 
so the professor is declaring a principle that he 
will always uphold.7  
The significance and permanence of an oath 
might suggest that it has no place in medicine, 
where it is a simple fact that ethical thought can 
and has changed. While these changes are 
relatively easy to accommodate within 
professional codes of ethics – and even medical 
practice – it is far more difficult for physicians to 
learn that the solemn oath they have sworn, and 
that has changed their lives, is no longer relevant.  
Furthermore, the assumption that ethics 
could be reduced to a set of rules is particularly 
troubling. The swearing of an oath – particularly 
an oath formulated like the Hippocratic Oath - 
implies that in simply doing this and not doing 
that, one is acting ethically. It is a thoroughly 
robotic and thoughtless process. Ethics requires 
more than this. In order to truly act ethically, one 
must understand the grounds for one’s actions. 
One must intend to act morally.6 Pragmatically, 
doctors must understand and be able to apply 
ethical principles, not just rules, because every 
circumstance is unique and no single set of rules 
could cover every scenario. Furthermore, with 
new technologies and redefined professional 
relationships, an oath cannot remain truly 
inclusive. Thus, as a set of ethical rules, the 
permanence of an oath makes it ineffectual and 
undesirable. 
Yet, perhaps these arguments against oath 
taking can be resolved by examining the 
distinction between an oath and a code of ethics. 
It has been observed that “the Oath of 
Hippocrates, while primarily an oath, also 
contains elements of a code. While primarily a 
commitment to become a certain kind of person, 
working for the benefit of one’s patients, it also 
contains a specific list of do’s and don’ts. [sic]”7 
Such rules are properly established in a code of 
ethics. Unlike oaths, there is little difficulty in 
arguing, changing, or augmenting ethical codes. 
Thus, the distinction between oath and code, if 
observed, can resolve the perceived difficulties 
with oath taking. 
However, if an oath does not outline a 
specific set of moral rules, does it perform any 
function within the medical profession? Some 
might suggest that the Hippocratic Oath, as a 
medical oath, is a relic of an earlier time and 
should be abandoned.3,4,8  I believe there in 
another, more appropriate option. Although 
medical ethics has been increasingly viewed as a 
simple subsection of universal ethics, such an 
approach is likely over simplistic. While medical 
professionals certainly must adhere to all the 
directives of general ethics, the obligations of a 
physician may not be fully described by such 
ethics. For example, it would be very difficult, if 
not impossible, to describe the basis of medical 
beneficence in the language of universal ethics. 
Beneficence, as an ethical obligation, simply 
does not seem to apply to other professions or to 
society in general. While the ethical codes of 
lawyers, engineers, and even politicians employ 
the principles of justice and non-maleficence, 
they certainly do not demand the altruistic 
dedication obliged by beneficence. If 
beneficence is not a consequence of normal 
ethical responsibilities, how does it become an 
obligation in medical ethics? 
The answer, as I see it, is that the medical 
oath has played a very important role all along. 
As a performative utterance, an oath has the 
power to alter the world, both for its professor 
and for the public who bear witness. Just as one 
who makes a promise creates a new ethical 
obligation for himself that is not generally 
applicable (to keep that promise), the medical 
community has established the ethical principle 
of beneficence through the solemn promise of its 
oath. Importantly, the specifics that caused such 
difficulty for the Hippocratic Oath – those 
statements that are more correctly delineated in a 
code – are not necessary to establish this general 
ideal. If the specifics are omitted, an oath can 
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easily accommodate new technologies and 
ethical theories. General principles, such as 
beneficence, can be applied in various ways 
without altering the underlying ideal. Therefore, 
a properly formulated medical oath could be both 
essential and enduring. 
The time has come for the medical profession 
to do away with the tradition of swearing the 
Hippocratic Oath at graduation ceremonies – and 
to learn from its many short-comings. However, 
a medical oath is very important in establishing 
the altruistic ethic that is so central to medicine. 
The distinction between an oath and a code of 
ethics is important and must be recognised in 
order to preserve the validity of any medical oath. 
Professional codes of ethics are required to 
outline the individual rules that govern the 
practise of medicine, but these rules are too 
specific to preserve the permanence and 
incorruptibility necessary of an oath. Thus, 
although I presently offer no substitute for the 
Hippocratic Oath, I suggest that one be 
developed that focuses exclusively on the 
essential principles of medicine, including the 
physician’s altruistic dedication to his patients. 
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The Mediterranean Diet 
 
Jennifer Clara Tang 
Luke Harris 
 
“Let thy food be thy medicine, and thy medicine be thy food” 
-Hippocrates (460-377 B.C.) 1 
 
 
Since the ancient times, nutrition has always 
played an integral part in the pursuit of human 
health.  Early physicians and philosophers like 
Hippocrates, Plato, and Galen recognized the 
importance of diet in health and wrote 
extensively on the subject.  Ironically, while our 
ancient predecessors fell prey to famine and the 
plague2, North Americans are dying from 
obesity-related diseases.  For most North 
Americans, the 21st century has been an age of 
decadence, where, to paraphrase Christopher 
Marlowe, “quod me nutrit me destruit” 3,  what 
nourishes us is destroying us.  
In the last 50 years, the public has been 
bombarded with promises of good health from 
myriad popular diets.  Unlike many of the other 
fad diets, the Mediterranean diet is rooted in 
ancient tradition.  “Mediterranean diet” is a 
general term used to describe the dietary style of 
ancient Crete and the majority of Greece.4  This 
diet (fig 1) is characterized by copious 
consumption of fruits, vegetables, whole-grains, 
olive oil, cheese and yogurt.  Consumption of 
fish, poultry, red wine and eggs is moderate, 
while consumption of meat is occasional.4  The 
possible health benefits of the Mediterranean diet 
came to public attention with the “Seven 
Countries” study led by Ancel Keys.  Keys et al. 
demonstrated a correlation between dietary 
patterns in 1960s Crete and low rates of coronary 
heart disease.4  This article seeks to examine the 
origins of the Mediterranean diet and discuss the 
efficacy of the diet with respect to health 
protectiveness.                       
 Though the Mediterranean diet focuses on 
the habits of ancient Greeks and Cretans, it 
should be noted that the Mediterranean region is 
comprised of more than 15 countries, including 
Greece, Italy, Cyprus and Turkey.  War and 
political acquisitions helped to blend dietary 
culture.  For example, in 8th century B.C., 
southern Italy was colonized by Greeks and is 
known as “Magna Graecia”. 5  Diet played a key 
role in classical Greek society (500-323 B.C.) as 
evidenced by numerous references to food and 
nutrition in Plato’s Republic (360 B.C.).  So 
famed were the Greeks for their plant-based diet, 
the satirical poet Antiphanes (407-343 B.C.) 
dubbed them the “leaf chewers”.  Olive oil was 
commonly used for lighting, cooking and as a 
therapeutic balm.6  Cereals played a central role 
in Greek diet, so much so that the Greek goddess 
of the Earth, Demeter played a central role in 
classical culture.  Wheat was commonly  
fashioned into cakes and eaten with olive oil.  
Legumes were often boiled into soups and their 
laxative properties were championed by 
Pythagorus.7  Figs, pears, apples pomegranates, 
sorb-apples, bulbs, onions, greens, acorns and 
myrtle berries were also popularly consumed.6  
Meat was rarely consumed, as it was expensive 
and also considered unfit to eat in certain 
regions.7  In classical Athens, fish (mackerel, 
tuna, mullet, anchovy, octopus, sole, eels, 
mussels and oysters) was more popular than 
meat.6  When it was consumed, meat was boiled 
with spices and salt or roasted.  Milk was rarely 
consumed, but cheese was a staple of classical 
Greek diet.  Red wine was very popular and was 
often diluted for consumption.  Honey was used 
as a primary sweetener. 
 Moderation and balance were key parts of the 
Mediterranean diet as evidenced by Hippocrates’ 
comment on diets:  “a regimen carried to the 
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extreme of restriction is perilous; and in fact 
repletion too, carried to extremes is perilous” .6  
Hippocrates also recognized the dangers of 
obesity:  “those who are constitutionally very fat 
are more apt to die quickly than those who are 
thin” .8  Perhaps there is something to be learned 
from these two gems of ancient wisdom in our 
time. 
 It is important to note that although the 
Mediterranean diet has ancient beginnings, it can 
serve as a healthy dietary template for present 
day people – and adherence to the diet is easy.  
The diet’s staple foods, namely olive oil, fish, 
fruits, legumes, and vegetables, are widely 
available at grocery stores.  These foods, while 
offering protection against cardiovascular 
disease and cancer 8, are also inexpensive.  The 
majority of health benefits of the Mediterranean 
diet stem from its rich content of healthy fatty 
acids and antioxidants.8  Recently, the diet has 
emerged as a solution to the triad of 
cardiovascular disease, diabetes, and cancer; 
these diseases account for the majority of 
morbidity and mortality in the Western world.  
In fact, a close inspection of the Harvard School 
of Public Health’s “Healthy Eating Pyramid” 
reveals that the majority of the pyramid’s food 
choices consist of Mediterranean staples.9  The 
food pyramids of the Mayo Clinic and the 
University of Michigan are also inspired by the 
Mediterranean diet. 
 Virgin olive oil, a staple of the 
Mediterranean diet, is comprised mostly of 
monounsaturated fatty acids (MUFAs).  These 
fats have been shown to lower blood pressure 10, 
protect arterial endothelium, and decrease post-
prandial plasma glucose levels.  The latter effect 
is likely related to the substitution of simple and 
complex carbohydrate consumption with MUFA 
consumption.8  Fish, another vital component of 
the Mediterranean diet, is rich in n-3 
polyunsaturated fatty acids (n-3 PUFAs).  This 
group of fatty acids exerts anti-inflammatory and 
anti-thrombotic effects.  Eicosapentanoic acid 
(EPA), a type of n-3 PUFA, is known to inhibit 
the synthesis of thromboxane A2, a platelet 
aggregator and vasoconstrictor.8  EPA also 
enhances the vasodilator effect of nitrous oxide, 
and reduces leukocyte adhesion to the 
endothelium.11  Fish consumption is associated 
with a decreased incidence of cardiovascular 
diseases12, and weekly fish intake has been 
shown to reduce the risk of sudden cardiac death 
by half.13 
Olive oil, while contributing beneficial fatty 
acids, is also a potent source of phenols.  These 
compounds have strong anti-oxidant effects, and 
are known to be protective against 
cardiovascular disease, colon cancer, and 
prostate cancer.  Virgin olive oil, which has an 
even greater concentration of phenols than 
regular olive oil, is a source of 30 phenolic 
compounds.8  Vegetables are another important 
source of phenols.  Vegetables that are especially 
high in these antioxidants include artichokes, 
cabbage, broccoli, garlic, and red chicory 
lettuce.14  Wine is also especially high in these 
antioxidants, and is another key part of the 
Mediterranean diet. 
As our knowledge of cardiovascular disease 
and cancer pathophysiology evolves, modern 
evidence increasingly supports the ancient menu 
of the Greeks and Cretans.  One of the greatest 
challenges in public health today is trying to help 
Canadians improve their diets.  This is perhaps 
more easily accomplished by providing them 
with a template from which to select foods.  The 
Mediterranean diet provides such a template, and 
is pleasing to the palate.  By encouraging the 
North American consumer to substitute 
“Mediterranean for McDonald’s”, physicians can 
arm patients with a health protective diet that is 
easy to adhere to and ascribes to the Hippocratic 
notion “Let thy medicine be thy food”. 
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The Robots Are Coming: 
The History – and Future Prospects – of Telerobotic Surgery 
 
Samuel Krausz, Meds 2009 
Joanna Zurawska, Meds 2008 
 
Telerobotic surgery has come a long way in its brief history. While teleconsultation continues to be used today, the 
advent of high speed communications and increased computational power is  making long distance remote control of 
operating instruments, termed telepresence surgery, a reality. Based on laparoscopic technology, telerobotic surgery 
was tested first on animals and, more recently, on humans with success. The technology offers several advantages, 
including improved accuracy and the ability to bring difficult procedures to rural and remote locations where trained 
surgeons are not available. While various technical difficulties and ethical issues must still be worked out, the 
advantages of remote surgery ensure that this technology will continue to be developed for widespread implementation 
in the years to come.   
 
 
Surgery, which is arguably as much art as 
science, has evolved from the early crude days of 
trepanation and battlefield amputations to 
modern procedures such as complex 
neurosurgeries and minimally invasive 
laparoscopic interventions. Just as the artist can 
do little without his brushes, however, the 
surgeon is virtually useless without his tools, and 
it is perhaps the development of these tools, 
which has directly driven the evolution of 
surgery. While various tools such as scalpels, 
loops, stitches, anesthesia and antiseptics have 
each expanded the range of possibilities for 
procedures, some of the newest tools to enter the 
surgical arena are computers and robotic 
instrumentation. 
 
Teleconsultation and the dawn of remote 
surgery 
While the advantages of computer and robotic 
assistance in surgery, in terms of enhanced 
accuracy and control may seem obvious, one of 
the most interesting and useful applications of 
this technology is to perform surgeries remotely. 
Patients in rural and remote locations often do 
not have access to advanced surgical care due to 
a lack of qualified personnel.1 This is not only 
the case in both wartime battlefields and third 
world countries,2 but is, unfortunately, a problem 
in many remote areas of Canada as well. Surgical 
care in these locations is either impossible or 
requires transportation to an urban center over 
long distances. 
The first attempts at remote care were really 
what would be termed teleconsultation. The 
1960’s saw the beginning of electronic 
transmission of radiological films, while the 
1970’s brought the ability for practitioners to 
consult with experts remotely over  
video-conference systems.3  In a surgical 
implementation of teleconsultation, a remote 
videoconferencing system was set up in the 
operating room and was linked to an expert 
physician at an urban center.2 This ‘remote’ 
surgeon did not actively participate in the 
procedure, but rather offered advice or guidance 
to the attending surgeon at critical points. At best, 
electronic remote control of the video camera 
was available, but little else. While definite 
benefits in terms of transmitting expertise and 
training inexperienced surgeons could be 
realized with this setup, true remote surgical 
control was impossible. 
 
Laparoscopic surgery: a catalyst for 
advancement of telerobotic surgery 
This changed with the advent of a robotic system 
aimed at assisting in laparoscopic procedures. 
Laparoscopic surgery utilizes a miniature camera 
(i.e., laparoscope) and small surgical tools which 
are inserted into the body via tiny incisions and 
controlled via external manipulators. Minimally 
Medicine and the Internet 
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invasive surgery performed using laparoscopy 
provided several advantages to the patient: less 
pain, a shorter hospital stay, better cosmetic 
outcome and faster recovery.4 Unfortunately, this 
surgical technique, in its original conception, had 
several shortcomings. The laparoscope produced 
only a 2-dimensional view of the surgical area, 
and hand-eye coordination was difficult due to 
the need to look at a monitor instead of one’s 
hands. Furthermore, the laparoscope was held by 
an assistant, and therefore direct was taken out of 
the hands of the surgeon. Perhaps most 
importantly however, laparoscopy, by its very 
nature, introduced amplification of tremor, loss 
of degrees of freedom in manipulation, and the 
brought the requirement for making non-intuitive 
motions when performing a procedure.4 
In an attempt to overcome the inherent 
limitations of laparoscopic surgery, research 
supported by the United States Defense 
Department’s Star Wars program was undertaken 
in the early 1990s at the Stanford Research 
Institute to develop a ‘master-slave 
telemanipulator’ – a system wherein a computer 
and robotic instrumentation intervened between 
the surgeon and the patient.4 Ironically, the 
original goal of this technology was to enable 
actual manipulation of surgical instruments by 
remote surgeons,5 a concept termed telepresence 
surgery. It was hoped that this technology would 
be useful in performing remote trauma surgeries 
on the battlefield or outer space, where surgeons 
could not venture.5 Unfortunately, while a 
system was developed, it lacked the required 
degrees of freedom necessary for efficient 
surgery, and its large size precluded widespread 
use. When this research program ended in 1994, 
the patents were sold to a private company, 
which continued development to produce what is 
now called the da Vinci robot system. This 
robotic system builds on traditional laparoscopic 
technology, rectifying some of its flaws while 
introducing the capacity for remote manipulation. 
The first refinement is that the camera platform 
is stable, and can be controlled by the surgeon’s 
feet or voice commands, eliminating the need for 
an assistant. Second, visualization is greatly 
enhanced with a 3-dimensional magnified 
system to simulate natural vision, or alternately 
2-dimensional displays positioned near the hand 
controls.6 Moreover, since physical manipulation 
of the controls is processed by a computer, 
tremors can be digitally filtered out preventing 
undue error. Finally, the use of motion scaling, 
which reduces large movements to fine ones, 
allows surgeons to perform actions which were 
previously impossible due to their delicacy.6 
 
Telerobotic surgery matures 
Early telepresence surgery research was 
extremely limited, and being hampered by 
technical limitations, was carried out only on 
animal models. Advanced manipulation 
techniques were not possible due to lack of 
adequate computational power and 
communication bandwidth. An early ‘procedure’ 
was performed in 1993 by issuing keyboard and 
mouse commands to manipulate an echographic 
probe, biopsy needle and scalpel over a 
transatlantic fiber optic telephone link to remove 
a cyst from a pig’s liver. Unfortunately, transfer 
of real-time video over the wired network was 
technologically impossible at the time due to 
bandwidth constraints; consequently, relatively 
expensive satellite links were required.2 
One of the leading difficulties in developing 
clinically viable telerobotic surgery has been the 
requirement of minimal time lag between the 
issuing of commands, actual surgical action, and 
reception of visual confirmation on the screen. 
This lag is influenced by multiple factors 
including time required for converting video and 
movements into the appropriate signals and the 
inherent delay in the communication network 
itself. Experiments have determined that the 
acceptable limit for safe surgery is 330 
milliseconds.7 Even with the satellite video link 
in early experiments, overall delays of 
approximately 2 seconds2 were inherent in the 
technology – obviously far from acceptable for a 
real-time surgical procedure. Accordingly, it was 
estimated that feasible distances for remote 
surgery could not exceed several hundred 
kilometers.8 This was, however, disproved in 
subsequent years. 
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The first successful telerobotic procedure on 
a human was performed in 1995 by Dr. Alberto 
Rovetta in Italy -- a prostate biopsy was obtained 
from a patient 5km away via a robotic 
telemanipulator.9 While this experiment was 
promising, the original dream of a true long-
distance fully controlled remote surgery was not 
realized until several years later when suitable 
high speed, high bandwidth communications and 
adequate computational power were available. 
On September 7th 2001, the world’s first trans-
Atlantic complete operation, termed the 
“Lindberg operation”, took place. In this case, a 
patient in Strasbourg underwent a 
cholecystectomy with the controlling surgeons 
located in New York.7 This surgery was 
completed using a second commercially 
available robotic surgery system, called ZeusT, 
which featured a robotic endoscope positioning 
system called AESOP (Automated Endoscope 
System for Optimal Positioning). With a time 
delay of 155 milliseconds, the surgery was 
deemed safe, and no post-operative 
complications were noted.7 While telerobotic 
surgery is still far from mainstream, several 
surgeries have already been successfully 
completed including fundoplications, sigmoid 
resections, hemicolectomies, inguinar hernia 
repairs, colectomies, radical prostatectomies and 
nephrectomies.6,7 Other surgeries, including the 
first Canadian remote coronary bypass (1999) 
and mitral valve replacements were performed at 
London Health Sciences Center.13 
 
 
Image 1: Robotic preclinical testing and training lab. Courtesy of CSTAR. 
 
 
The challenges ahead 
While remote surgery seems promising, several 
issues remain to be worked out. For one, current 
systems lack tactile feedback, although this is 
actively being developed. Without the ability to 
feel resistance in tissues, the surgeon must 
carefully review visual information to avoid 
making an accidental tear.10 Another problem 
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stems from the compliance of certain tissues; for 
instance, the robotic manipulators have difficulty 
in grasping slippery surfaces11. However, these 
obstacles will likely be surmounted in future 
versions of the technology, and a testament to 
the incredible functionality already achieved by 
these robots can be made by observing the 
actions of the surgeons . Almost without fail, 
surgeons using the telepresence system 
unwittingly find themselves removing their 
hands from the manipulators to retract a piece of 
tissue, the advanced technology making them 
forget for a moment that they are not really at the 
surgical site.12 
While telepresence surgery holds much 
potential for fulfilling many of today’s remote 
surgery requirements, it also brings with it a 
variety of unique challenges. First, the cost of 
equipment and communication links is high. 
Training surgeons with the technology is time-
consuming, as is setting up the equipment. 
Second, it is essential that an adequately trained 
surgical team be present at the surgical site, 
ready for emergency intervention in case the 
equipment malfunctions, or the communications 
line is severed. This ties down surgeons who 
might otherwise be performing their own 
operation elsewhere. Similarly, significant time 
is required to switch surgical instruments on the 
machine between operations.9 Finally, there are 
many legal and ethical questions that must be 
answered before remote surgery can be widely 
adopted. Medical licensing over provincial and 
international borders is unclear, at best. Perhaps 
more importantly, however, the traditional 
patient-clinician relationship will have to be 
redefined, as the patient may never meet his 
surgeon face to face.10 
 
 
Image 2: Hybrid operating room/angiosuite. Courtesy of CSTAR. 
 
 
The prospects for telesurgery are exciting. 
From remote surgeries in space to mobile 
hospitals in war zones or developing countries, 
the possibilities are endless. While we have 
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already come a long way from the early surgeries 
performed with nothing more than a blade, the 
continuous evolution of computers, 
communications systems and mechanical 
surgical equipment ensures that many exciting 
developments in the field of telesurgery will take 
place in the years to come. 
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A Brief History of Physician Remuneration 
 
Tom Warren 
 
In the general prologue of The Canterbury Tales, Geoffrey Chaucer describes physicians as having a “special love for 
gold.”  Since well before Chaucer’s time, the issue of physician remuneration has been discussed, with the debate 
continuing today.  The earliest evidence of this issue is in the Code of Hammurabi from around 1750 BC.  Hippocrates, 
Plato, and Galen discussed remuneration, and it was an issue in Jewish and Islamic culture too.  During the last few 
centuries, issues around physician remuneration have continued to be discussed.  Examples from Australia, the United 
States and Canada show how remuneration was handled in these nations. 
 
 
In the general prologue of the Canterbury Tales, 
Geoffrey Chaucer describes physicians as having 
a “special love for gold”.1  Rightly or wrongly, 
physicians have been accused of extorting higher 
than deserved fees for the services that they 
provide and in this article I will briefly review 
how physicians have been remunerated 
throughout the history of medicine. 
Probably the oldest extant primary source of 
medical fees is the code of Hammurabi.  Written 
about 2000 B.C., the code is a set of laws 
decreed by King Hammurabi of Babylon.  There 
are several references to physicians, including 
how they should be paid for their services.  For 
example, sections 215-217 of the code read: 
 
If a physician has treated a man with a 
metal knife for a severe wound, and has 
cured the man, or has opened a man’s 
tumour with a metal knife, and cured a 
man’s eye; then he shall receive ten 
shekels of silver.  If the son of a 
plebeian, he shall receive five shekels of 
silver.  If a man’s slave, the owner of the 
slave shall give two shekels of silver to 
the physician.2 
 
Ancient authors such as Hippocrates, 
Aristophanes, Sophocles, Plato, Aristotle and 
Galen debated whether physicians should be paid 
at all.  There was disagreement as to whether 
medicine was an art or a “techne” (skill or craft).  
If medicine was a craft like carpentry then 
physicians should be paid similarly, for all 
craftsmen practiced their craft for money to earn 
a living.  However, if medicine was a liberal art 
such as philosophy, mathematics or poetry, then 
a man would do it for the sake of virtue and 
collecting fees would “be regarded as doing 
something typical of a hireling or slave” 
according to Aristotle.3  The Hippocratic 
writings often refer to medicine as an art, and 
mention fees in some places but in others advise 
to practice medicine without payment.   
Aristophanes says that medicine was an art and 
not a mere skill or craft, while Sophocles called 
physicians “craftsmen of medicine”.4  In Plato’s 
Republic, Socrates discusses the question of 
whether a physician is a “money-maker or 
someone who treats the sick”.5  Galen believed 
that physicians practiced medicine either because 
they love humanity, or because they love honour, 
or because they love glory, or because they love 
money.6  According to Galen, it was preferable 
to practice medicine because of the love of 
humanity but those that practice because of other 
reasons were not inferior physicians but inferior 
philosophers.  Galen says he never requested 
payment but would accept it if offered, which he 
believed was an important difference.4  
Practically, there were many physicians in the 
ancient world who did not come from wealthy 
and noble families like Hippocrates and Galen, 
so there were many poor physicians who did 
request and even sued for payment.4 
There are examples from medieval Islamic 
writings of physicians who worked in other 
businesses on the side or received a patronage 
from wealthy individuals such as a caliph or 
sultan, so they had the opportunity to provide 
their services free of charge.  Ishaq b. ‘Ali al-
Ruhawi, a ninth-century Islamic writer says that 
Feature Article 
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because health is the prerequisite for the 
performance of all other human activities, 
medicine occupies the highest position of all 
professions.7  Therefore, society should meet the 
physician’s financial demands in order that he 
does not have to do other work to support 
himself and that “the rich should pay the 
physician more than enough, because he cannot 
charge the poor towards whom he must extend 
his charity.”7 
According to the Hebrew scriptures, human 
physicians could practice medicine but 
ultimately, healing came from God.  The Talmud 
quotes an adage “A physician for nothing is 
worth nothing”, and includes the fees a physician 
should receive.8  Nachmanides, a medieval 
Jewish writer says that “a physician may accept 
fees for the loss of time and for the trouble” of 
leaving his home and traveling but he should not 
be remunerated for simply giving instructions.8  
There were contracts between Jewish physicians 
and Jewish communities in European cities 
during the 17th and 18th centuries.9  The 
physician was appointed for several years, was 
given a yearly salary or was to charge stipulated 
fees, was to attend to the poor without taking 
payment, and was to receive special payment for 
night calls and treating children.  The rich were 
expected to pay for their treatment but usually 
only a stipulated fee. 
In medieval Europe, some physicians were 
employed by royalty and attended to the health 
of the royal court and perhaps some of its 
subjects, others were paid by the church to treat 
the sick of the parish and the poor.  Some city-
states such as Venice employed physicians to 
give free treatment to the poor, treat the rich at 
reduced rates and advise the state on medico-
legal and public health matters.10 
There are many sources from America which 
record how physicians were paid and whether 
fees were regulated or not.  One example is the 
regulation of fees in Boston starting in 1780.11  It 
was the Boston Medical Society which 
developed the fee bill in order to stop physicians 
from undercutting each other.  The fees on the 
fee bills were minimums so physicians could 
charge more, but no less.  In addition, patients 
only wanted to pay for services if it included 
treatment such as a drug or a procedure.  The fee 
bill however stipulated that charges be made for 
all visits.  Because the physicians were 
controlling the fees, they made sure that they 
were always very well compensated, their 
general policy being to increase fees in good 
economic times but not to lower them in hard 
economic times.  Between 1795 and 1806 the 
cost of living changed very little but the fees 
increased by 50-60%. 
In Boston, we see an example were the 
physicians controlled their own remuneration 
and thus sometimes charged quite high amounts 
for their services.  In South Carolina in 1844, we 
have an example of quite the opposite.  The St. 
Peter’s parish, like the whole state, was very 
poor so the local officials decided to set a fee bill 
to curb the “exorbitant, oppressive” physician 
fees which “unjustly absorbs so large a portion 
of [the farmers] hard earned incomes.”12 
If we compare the fees in Boston and South 
Carolina, we can see the vast difference in fees 
when physicians or the community set them.  In 
Boston in 1806, a regular single visit was $1.50, 
normal obstetrical delivery was $12.00, treating 
gonorrhea was $10.00 and the fee for amputating 
a leg was set at $40.00.11  In South Carolina, 
almost three decades later in 1844, a regular 
single visit was no charge, normal obstetrical 
delivery was $3.00, treating gonorrhea was $2.00 
and the fee for amputating a leg was set at 
$5.00.12 
The advancing settlement of America 
westward necessitated innovative solutions for 
physician remuneration due to low populations 
and poor patients.  For example, a physician only 
agreed to move to Tucson, Arizona in 1871 after 
twenty-five families agreed to pay him $100 a 
year for his services.13  The frontier medical 
practice also required novel ways of payment 
such as poultry, cattle, tobacco, fruit, vegetables, 
wood and clothes. 
Barter was also a common payment method 
in Australia.  The very first physicians were 
military and naval surgeons and so would have 
been paid as salaried practitioners.  As free 
settlers came though, “civilian” physicians 
would need to be paid and payment with goods 
and services would have been acceptable 
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because the early Australian physician would 
have few places to spend his money.  By the 
middle of the nineteenth century there are 
examples of fee regulation in Australia.  The Port 
Philip Medical Association set fees for three 
different classes of patient with different fees for 
different classes.14  The 1st class patients (i.e. rich 
patients) had to pay two to five times as much as 
3rd class (i.e. poor patients) for the same 
treatment. 
In Canada, the first known surgeon came to 
Montreal in 1653 as a military surgeon earning 
147 livres a year from his military salary.15  He 
also treated 42 families for 5 livres annually each 
and trained an apprentice for 150 livres per year 
giving him an annual income of about 500 livres 
which was about 17 times that of the lowest 
salaried worker.  The first physician came to 
Quebec City early in the eighteenth century and 
earned about 2400 livres which was about 60 
times that of the lowest salaried worker.15  In 
1851, Dr. James Lanstaff’s medical income was 
only about $500, but climbed to $2000 in 1861 
and $3000 in 1880.  During the same period, a 
labourer would make about $300 per year.16  
Langstaff became a wealthy man, but only 
because he had income other than medical fees.  
In fact, several hundred families owed Langstaff 
money during his active practice and he accepted 
payment from some families in the form of food, 
produce, lumber, animals and labour.  Sir 
William Osler charged his rich patients very high 
fees and his poor patients nothing at all.6 
From the very earliest of recorded history in 
the code of Hammurabi to the present day, we 
can find records of physician remuneration.  It 
was an important matter of debate in medical 
texts as well as non-medical writings from 
Aristophanes’ and Sophocles’ plays as 
mentioned above to Moliere’s “Le Malade 
imaginare” and George Bernard Shaw’s “The 
Doctor’s Dilemma”.  For the subject to be found 
throughout recorded history – medical and non-
medical – the issue must have been important, as 
it is today.  Perhaps, some ideas to help us fix 
our current problems can be found in the past. 
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A Foundation of Western Ophthalmology in Medieval Islamic Medicine 
 
Daren Lin 
 
The conquests of Muhammad starting in the 7th century led to the spread of Islam and the teachings of the Qur’an, a 
theology believing that genuine health and happiness is the natural state of existence.  While medieval Europe rejected 
the medical knowledge of the pagan Greeks, the early Islamic world was eager to assimilate and expand the Hellenistic 
medical teachings, emerging as the collector and preserver of Western medicine.  For ophthalmology, an especially 
extensive literature developed.  The prevalence of eye diseases in the Islamic lands resulted in particular interest in 
their skilful diagnosis and treatment.  Using principles of clinical observation, many ocular diseases were described or 
classified for the first time.  Intricate surgical excision with an array of minute instruments was used in the treatment of 
several external diseases of the eye such as pannus and pterygium.  Suction removal of cataracts using a hollow needle 
was also described.  Their advances in the knowledge of optics, anatomy, and physiology of the eye became major 
contributions to modern ophthalmology.  Latin translations of the extensive Arabic literature on ophthalmology 
influenced late medieval Europe, and many of these contributions of early Islamic empire remain today.  Medieval 
Islam made these advancements because it eagerly encouraged knowledge and physician thinkers from all cultures. 
 
 
A Medium for Medieval Medicine 
Three civilizations emerged from the fall of 
Rome in 476: the Byzantine Empire, the Early 
Medieval West, and Islam.  The Islamic empire 
emerged as the sole preserver of the classical 
knowledge of ophthalmology and added 
contributions that are still significant today.  The 
Islamic empire was able to achieve its great 
contribution to ophthalmology because of unique 
cultural conditions within its borders during its 
establishment and its golden age. 
When Arabia was split into many different 
tribes in 622, Muhammad founded his ideal 
community in Medina, where religion and state 
became one.1  Muhammad gave specific 
instructions on various aspects of health, treating 
people himself, stressing that genuine health is 
the natural state of existence.2  With the 
prevalence of disease, medicine became a central 
part of medieval Islamic culture.3 
With Muhammad’s death in 632, Arabia was 
at peace for the first time1, united under a new 
and resourceful religion, which espoused sound 
health amongst its followers.  Inclusion of other 
societies within its growing borders allowed the 
young Islamic world to flourish, absorbing the 
culture and scientific knowledge of other 
civilizations. 
While conversion to Islam outside Arabic 
lands was gradual, linguistic conversion 
proceeded more rapidly.  After only a century, 
Arabic was the official and working language, 
often completely replacing older languages 
within the empire.  Islam not only inherited the 
earlier scientific and medical traditions, but also 
received contributions from its non-Arab, non-
Muslim peoples who adopted Arabic as a 
common language of scholarship4, facilitating 
unprecedented scientific and medical exchange 
and enabling significant expansion of past 
knowledge. 
Because copying the Qur'an was an act of 
piety, Islamic culture also had an engrossing 
tradition of book-making, including calligraphy, 
illustration, paper-making, and binding.  
Illustration practices were adopted from the 
Byzantine and Persian cultures, while Chinese 
paper making was improved upon.3  Islamic 
medical knowledge was recorded in textbooks 
and transmitted across its lands and to future 
generations. 
 
The Royal Library of Baghdad 
The knowledge of the earlier Greek medical 
teachings came to Islam through Nestorian 
Christians, driven out of Byzantine and settling 
in Persia.6  Their translations and teachings were 
valued by an emerging Islamic empire which 
needed to find ways of dealing with common 
medical problems: disease, pain, injuries, and 
Feature Article 
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successful child-bearing.7  Upheavals in the first 
millennium of Christianity caused the loss of 
many Greek medical works which are now only 
known from Arabic translations.5   
This heritage of medical theory and practice 
was assimilated and elaborated by an 
international community of scholars of many 
different cultures and languages including Arabic, 
Persian, Syriac, Hebrew, and Turkish.1,7  During 
the Abbasid Dynasty (750-1258), Islam’s Golden 
Age, translation of Greek, Hindu, Syriac, and 
Persian texts accelerated.  Caliphs of this age 
promoted knowledge and curiosity4 and the 
Royal Library in Baghdad became a centre 
where countless precious manuscripts from all 
corners of the empire were collected for 
translation.5 
Hunayn ibn Ishaq, a Syriac-speaking 
Christian working in Baghdad at this time, made 
Arabic translations of nearly all known Greek 
medical books.  He also wrote several medical 
and ophthalmologic treatises that later circulated 
in Latin in Europe.  His treatises were 
fundamental in establishing the basic conceptual 
framework of medicine in renaissance Europe.  
These translations maintained a continuity of 
ideas between Roman, Islamic and late Medieval 
European practices.7 
Islamic physicians like Hunayn produced a 
vast medical literature of their own, combining 
Greek doctrines and their own observations.5  By 
the end of the ninth century, Arabic medicine 
had fully integrated the Galenic humoral system, 
and further developed the Galenic tendency to 
systematize by writing medical treatises that 
organized the vast body of medical knowledge 
into one comprehensive and logical structure.  
Hunayn’s original work, Ten Treatises on the 
Eye, is an example of this new organisation and 
an exhaustive work on the eye.4  
As opposed to theoretical reflections on 
illness, a new trend developed that focused on 
expanding empirical knowledge and on practical 
procedures for treatment.  Abu Bakr al-Razi or 
Rhazes, criticized the inherited medical 
knowledge for inferences that did not always 
correlate with clinical observations.  He 
pioneered clinical medicine by conducting what 
amounted to controlled experimentation.  For 
instance, he used bloodletting in one group of 
patients while giving no treatment to another 
group.4  He also wrote case histories, 900 of 
which were included in his casebook, Kitab al-
Tajarib.  His casebook described 48 cases of eye 
conditions, often differing from his theoretical 
writings.  A third of the ophthalmologic 
complaints in his casebook, with their complex 
mixture of symptoms, do not appear in his 
famous theoretical book, Kitab al-Mansuri.  
Furthermore, several treatments used in the 
casebook deviated from the theoretical work 
because of adjustments to the particular needs of 
the patient.8 
Works of the late Islamic golden age reflect 
the mature development of all these trends as 
demonstrated by the Perfected Book on 
Ophthalmology written by Ibn an-Nafis (b. ca. 
1210).  The first part, on the theoretical 
principles, deals with anatomy, physiology, 
pathology, aetiology and symptomology.  The 
second, on the clinical treatment and surgery, is 
systemically organized and provides an account 
of the improvements made based on clinical 
observation.9 
Medieval Islam was responsible for 
translating and preserving many medical works 
into Arabic, allowing an international 
community of scholars to improve on inherited 
knowledge in two broad themes: the 
systematization of contemporary medical and 
ophthalmologic knowledge in manuals for easy 
transmission; and the development of clinical 
medicine through rigorous research and 
observation, challenging pre-existing theoretical 
frameworks.  These frameworks allowed the 
Arabic advancement of classical ophthalmology. 
 
A Specialty is Written 
Blindness was a major cause of disability 
throughout the Islamic lands.  As a result, 
Islamic physicians displayed particular concern 
and ability in the diagnosis and treatment of eye 
diseases3 and nearly every medical compendium 
had chapters on ophthalmology.  Rhazes’ work, 
Kitab al-Mansuri, included a large section on the 
specialty.10  It was one of the most widely read 
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medieval medical manuals in Europe and often 
reprinted with commentaries by prominent 
Renaissance physicians such as Vesalius.7 
There were a large number of 
monographs devoted solely to ophthalmology.3   
The early work of Hunayn’s ninth-century 
manual, Ten Treatises on the Eye, and Ibn an-
Nafis’ thirteenth-century manual, Perfected Book 
on Ophthalmology, are two examples.  Ali ibn 
Isa’s tenth-century Memorandum Book for 
Oculists was the classical Arabic textbook of 
ophthalmology and became the standard treatise 
of the eye for several centuries in Islam and 
Christendom.11  The text describes over a 
hundred different diseases of the eye organized 
by anatomical location and combined Greco-
Roman knowledge with novel observations.12 
The Greco-Roman attitude to ophthalmology 
was poor, with only five works on 
ophthalmology in the 800 years between 
Herophilus and Alexander, all of these lost and 
none by a specialist.  Moreover, the writings of 
Galen referred to ophthalmologists in a 
derogatory manner.  In contrast, during the 500 
years of the Islamic golden age, thirty textbooks 
on the eye were written, thirteen of them 
surviving and ten written by ophthalmologists.  
These doctors had thorough specialty training 
and were honoured by the public.13 
 
New Insights 
Anatomy 
The Islamic scholars based their anatomic 
knowledge upon Galen’s works and as a result 
made similar errors: the posterior chamber was 
too deep, the optic nerve had a canal and there 
was an extra extrinsic muscle.13  Nonetheless, 
two important contributions to modern 
ophthalmology were made.  First, Arabic 
medical literature contained the first illustrations 
of eye anatomy, with the earliest surviving 
drawing appearing in Hunayn’s Ten Treatises on 
the Eye.14  The optic chiasm and brain were 
illustrated in Ali ibn Isa’s Memorandum Book 
for Oculists.11 This was passed on to the 
European Renaissance, including Vesalius, 
whose figures resemble the Arabic (Figure 1).14 
Second, modern day terms for eye parts are 
derived from Arabic terms and not from Greek. 
For instance, the medieval Latin translation of 
Figure 1.  Hunayn’s figure of the eye, left, is the first known anatomical illustration, originally illustrated 
ca. 850 and shown here in translated form by Meyerhof (Wood, 1936).  Vesalius (1514-1565) was greatly 
influenced by Arabic anatomy of the eye in his figure, right (Sorsby, 1933). 
  
the Arabic word, qarniyah, became a part of the 
standard Leipzig anatomical nomenclature as 
cornea.  In contrast, Galen used the Greek word, 
kerotoeides, which is not used today to describe 
the cornea.13 
 
Optics 
Ibn al-Haytham, known as Alhazen, rejected 
Hellenistic theories of vision postulating that 
vision resulted from rays emitted from the eye 
(Euclid), or transmission of a form from the 
object to the eye (Aristotle).  Alhazen’s 
remarkable insight was that an image of the 
object is formed due to the emission or reflection 
of light from the object to the eye.4  He worked 
out his theory sufficiently to create the 
foundation for use of lenses to correct vision.  
However, this possibility was recognized only 
after the transmission of his discovery to Europe, 
where two centuries later Roger Bacon suggests 
the use of lenses for vision correction.14 
 
Cataract 
The first authentic document on the treatment of 
cataracts was by the Roman, Celsius, who 
described entering a sharp needle into the eye to 
downwardly displace the lens from the pupil, 
breaking it up into many fragments if needed.14  
This technique, known as couching, was 
commonly employed in the Arabic lands, with 
the major complications being infection and 
glaucoma.  Although the success rate was only 4 
in 10, it found wide acceptance because the 
alternative was blindness.3 Ammar, born in the 
late tenth century, invented the suction method 
for cataract extraction, by which a glass tube is 
introduced through a corneal incision for 
evacuation of the lens by suction (Figure 2).15  
Unlike other contributions from the Arabic lands, 
the suction technique was only popular in the 
eastern part of the empire, and thus failed to 
reach Christian Europe, where couching 
continued until the technique was separately 
described by Daviel in 1748.14 
 
External Diseases of the Eye 
Chalazions were described as collections of a 
gross humor that gathers in the lid.  If 
conservative topical treatments failed, it was 
incised with a round-headed lancet, scraped out 
with the spoon at the end of the sound, closed 
with a suture, and irrigated.11  Today’s treatment 
is similarly incision and curettage.16  Styes were 
described as an abscess at the root of an eyelash.  
Treatment was rubbing with very hot bread.11  
Modern treatment is likewise hot compress.16  
Original surgical techniques dealt with treating 
the sequelae of trachoma, a leading cause of 
blindness.  Trichiasis was treated through 
extraction of the inverted hairs and cauterization 
of the roots using a needle that was heated red-
hot.  Trachomatous pannus was recognized as 
the superficial vascularization of the conjunctiva 
and treated surgically by raising the pannus with 
a number of very small hooks and excising the 
raised film with very thin scissors or cataract 
needle (Figure 3).  Pterygium was described as 
the encroachment of the conjunctiva on the 
cornea and was removed using a similar 
technique as the removal of pannus.11 
 
The Reflected Light 
The Renaissance in Europe was the result of the 
normal development of science coming from the 
Islamic Orient, passing through the multilingual 
communities of Southern Italy and Spain, and 
finally reaching Western and Central Europe.9  
Constantinus Africanus, an Italian monk born in 
Carthage in 1018, translated numerous books 
into Latin.  The translations into Latin occurred 
at the same time as the Crusades. The crusades 
both aggravated relations between Christendom 
and Islam and provided opportunities for 
Europeans to learn different Arabic technologies 
and practices.7 
Systematic medical texts, such as Rhazes’ 
Kitab al-Mansuri and Ali ibn Isa’s Memorandum 
Book for Oculists, carried both classical and 
Arabic knowledge of ophthalmology and 
medicine to Christian Europe.  Used by 
European physicians for centuries, these works 
had permanent influences on the formation of 
Western ophthalmologic theories, practices and 
terminology.  Rhazes’ writings were part of the 
curriculum in Western medical schools until the 
nineteenth century.1  An analysis of De Oculis, a 
Latin textbook about eye diseases written by 
Peter Hispanus (Pope John XXI) in the thirteenth 
century, concluded that the text depended on 
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treatises from Hunayn, Rhazes, Galen and Plato 
alike.17 
Although Arabic medicine and 
ophthalmology were founded on the work of 
other cultures, and although several of its 
brightest minds were not Muslim but Nestorian 
Christian, the golden age of Islam was 
responsible for numerous advances in 
ophthalmology that remain with us today.  The 
common language of Arabic within Islamic lands 
allowed discussion of ideas and development of 
manuscripts by an international community of 
scholars.  Medical knowledge was improved by 
the systemization of information and testing 
theory with clinical observation.  Curiosity and 
knowledge, as well as acceptance of other 
cultures, allowed early Islam to rapidly develop 
scholarly knowledge in all fields, including 
ophthalmology. 
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AIDS and Guyana 
 
Victor Ng 
 
Since its first discovery in the early 1980s, the mystery of the Human Immunodeficiency Virus (HIV) has continued to 
elude health care workers.  While the standard of living has increased in developed nations with the advent of new 
medication, the treatment offered to patients in undeveloped countries is still primitive.  In Guyana, a country of about 
700,000 people, it is roughly estimated that 3% of the population has Acquire Immunodeficiency Syndrome (AIDS).  
However, many cases go unreported as a result of poor governmental statistics collection and lack of testing facilities.  
A large number of infections occur in the mining regions in the interior of Guyana where many of the miners are 
young men who engage in promiscuous engagements with local women.  Furthermore, the prevalence of malaria in the 
interior of Guyana has lead to HIV-malaria, leading to a greater number of both malaria and HIV cases. Throughout 
the last 10 years, many Non-Governmental Organizations (NGOs) have been established throughout Guyana to offer 
educational workshops on prevention and counselling services.  However, the lack of capital has been a major obstacle.  
While Guyana does receive developmental aid from developed countries, it is insufficient to substantially improve the 
AIDS epidemic under Guyana’s current health care delivery system. 
 
 
Guyana:  The AIDS Epidemic 
From the great plagues of Europe to the Small Pox 
Pandemics of the modern era, disease and pestilence has 
never been far away.  Throughout the ages, Medical 
practitioners have tried many different methods to combat 
illness and disease from animal magnetism to 
polypharmacy.  In the modern era, it is no different as 
modern medicine continues to seek out new ways to 
promote healing.  However, despite humanity’s best efforts, 
some diseases are still unconquerable, among these is 
AIDS. 
 Since its discovery in the early 1980s, the HIV virus 
has spread to every country of the world including Guyana 
in South America. Although Guyana is a relatively small 
country with a population of only about 700 000 people, it 
has the 2nd highest HIV prevalence rate in the Western 
Hemisphere after Haiti. An estimated 3% of the population 
currently suffers from AIDS, although the incidence rate 
may be higher as many cases go unreported. 
 
Guyana:  The Beginning 
The first ten AIDS cases were identified in Guyana in 
1987, all being homosexual males, followed by five 
females the next year.  In the early years of the epidemic, 
ignorance of the disease led doctors and nurses at the 
Georgetown Public Hospital to abandon patients because 
of fears that they would contract the disease themselves.  
Pan-American Health Organization (PAHO) Programme 
Assistant Dereck Springer described the situation: 
“Nobody was responsible in terms of creating a safe 
environment, persons were left unattended, not 
recommended for medical care, nurses were reluctant to 
provide nursing care, and families abandoned their sick 
relatives.  Even persons at home were isolated.” 
 
Guyana:  A Mining Nation 
Mining represent 25% of Guyana’s gross national product 
(GNP) in the mid 1990s.1 The mining industry has had a 
profound effect on the people of Guyana.  While most of 
the population lives along the coast, most of the mines are 
in the interior.  As a result, many men leave their homes 
and families to work in the interior for long periods.  This 
puts a serious strain on the families.  Furthermore, the once 
tranquil villages of the interior have been transformed into 
supply depots catering to the needs of thousands of 
migrant miners.  The government station of Kamarang is a 
small village in the interior.  Since the early 1970s, this 
calm administrative centre with a religious mission has 
been transformed into a “tawdy tinsel town” of grog shops, 
brothels and discos.1 Many young Amerindian women 
have become prostitutes, promoting the spread of sexually 
transmitted diseases such as HIV.  The HIV virus is not 
only spread among the Amerindian villages, but also to the 
rest of the country by men who return to their families 
after their work contract is done. 
 
Center for Disease Control Study on HIV prevalence in 
a Gold Mining Camp 
The high HIV prevalence rate in the interior of Guyana has 
been the subject of discussion of one study by Palmer et al.  
(2002) which focused on a mining camp 400km inland 
from the capital, Georgetown.2 The men at this camp 
worked 12 hours per day for 6-8 weeks before returning 
home for a 2 week break. 
 Of the 216 men between the ages of 18-35 at the 
labour camp, all but 4 men were tested for HIV.  The HIV 
testing was done on site by Determine (Dainabot, Tokyo, 
Japan) rapid Immunochromatographic test for the 
qualitative detection of HIV strains 1 and 2.  In previous 
fieldwork, this test was reported to yield 100% sensitivity 
and specificity.  In any case, a confirmation HIV test was 
also done by enzyme-linked immunosorbent assay 
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(ELISA) with western blot (Abbott, Abbott Park, Illinois) 
on all sera.  The study reported that 6.5% of the men tested 
positive for HIV and both the field test and confirmatory 
test were 100% in agreement of these findings.2  This high 
prevalence was troubling because it created a reservoir for 
the HIV virus.  This situation was exacerbated by the fact 
that the health care system in the interior communities was 
poorly equipped to deal the disease. 
 
Malaria – HIV Co-infection 
Since 1986, malaria prevalence has also risen in Guyana 
and has become a serious health problem.  There are over 
30 000 clinical cases of malaria every year in the interior.2 
P. Falciparum, the more dangerous species of the parasite 
has re-established itself in areas from which it had been 
previously eradicated.  It is thought that the extensive 
mining and natural resources exploration coupled with 
poor health care services in the interior has led to this 
resurgence.3  Furthermore, in some areas, P. Falciparum 
has developed a resistance to chloroquine and fansidar, 
two common anti-malarial medications.  This is especially 
dangerous since the victim can die within 24 hours of 
symptomatic high fever and chills.  Remote villages in the 
interior do not have easy access to health centres and it 
often takes hours just to get to the nearest health centre, 
which are often not well equipped with medications. 
High malaria prevalence in areas where HIV is present 
is especially alarming.  Immune T-cells and B-cells 
function as the body’s defence system against infectious 
diseases such as malaria.  However, these lines of defences 
are weakened during the first stages of HIV infection 
rendering the body vulnerable to infections such as malaria.  
Conversely, malaria could also exacerbate HIV infections 
because the immune system could be overwhelmed dealing 
with multiple infections. 
In a study done by French and Gilks (2000), it was 
shown that malaria infections were more frequent 
individuals with compromised immune systems.  The 
researchers looked at three different categories of 
individuals according to their CD4 T-cell counts.  The 
groups were as follows:  1) >500 2) 200-499 3) <200.  
French and Gilks (2000) found that 4.5% of those with 
CD4 T-cells >500 were infected with malaria compared 
with 7.3% with CD4 200-499 and 11.5% with CD4<200. 
Thus, an increase in malaria infection is observed in HIV 
infected adults, suggesting an important correlation 
between malaria and HIV.4 
During the early stages of the AIDS epidemic, it can 
be argued that non-governmental organizations played as 
great if not a greater role in battling the disease than 
governmental departments. Non-governmental 
organization sprang up in all regions of the country 
offering a variety of services from counselling to education. 
In the year 2000, many of the non-governmental 
organizations decided to combine their resources and 
began a national crusade against HIV/AIDS and sexually 
transmitted infections (STI).  As a result, the Guyana 
HIV/AIDS/STI Youth Project was born. This 5-year 
program is funded by the United States Agency for 
International Development (USAID) and will work to 
educate people about the disease, as well as collecting data 
to assess the knowledge Guyanese have about the disease 
and their perceptions of the disease. This project also 
works to interview focus groups such as sports clubs to 
understand their view of the disease.  Furthermore, the 
project also interviews prominent members of 
communities to understand the specific needs of 
communities as well as draw on their leadership capacity 
to motivate the community to wage the war against 
HIV/AIDS and sexually transmitted infections.   
The organizations that make up the Guyana 
HIV/AIDS/STI Youth Project are all reputable 
organizations with a history of their own.  Each of them is 
very active in their community in their field of work 
whether it is counselling, education or medical care.   
One of the more prominent NGO’s is Youth 
Challenge Guyana (YCG) which is a part of the Youth 
Challenge International alliance that includes partners in 
Canada, Australia, and Costa Rica.  Traditional, this 
organization has worked on infrastructure development 
and health promotion issues with a number of local and 
international volunteers.  Lately, Youth Challenge Guyana 
has transformed itself to move away from infrastructure 
projects and focuses on three streams:  governance, 
women’s issues and HIV/AIDS work.  The HIV/AIDS 
stream of work will be YCG’s contribution to the youth 
project.  International and local volunteers will travel into 
different regions of Guyana to collect statistical data on 
HIV/AIDS as well as provide educational workshops. 
Although the NGO’s have the good intentions of helping 
to ease the suffering of AIDS, the lack of resources has 
truly hampered the efforts.  In most countries, NGOs’ 
purpose is to support and complement the services offered 
by the government.  However, in the case of Guyana, the 
poor state of the country’s health care infrastructure has 
made many NGO’s primary care providers rather 
supportive care providers.  Although these organizations 
have a depth of experience in aid work, they simply do not 
have the manpower or financial resources to provide 
adequate care to everybody.  To the best of their abilities, 
the non-governmental organizations can only offer indirect 
methods such as counselling and workshops in the hope 
that people will learn to protect themselves from 
contracting HIV.  As the HIV incidence rate increases, the 
NGOs can only watch helplessly, hoping that the 
international community will contribute aid.  In the end, 
only proper medical services and pharmaceuticals can slow 
down this epidemic. 
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An Exploration of Anaesthesia through Antiquity 
 
Jeremy Keller 
 
“To avoid pain, in surgical operations, is a chimera…” 
-Velpeau (1839) 
 
 
The struggle to alleviate pain is not a new one.  
The modern day science of anesthesia provides 
this remarkable ability with great success.  The 
present era began in 1846 with the reported use 
of ether as an anesthetic during surgery.  The 
field blossomed quickly and the field of surgery 
grew exponentially.  However, the history of 
anesthesia does not begin here; an exploration 
through antiquity is required to gain a true 
understanding of the foundations of this 
impressive science. 
Throughout history and across civilizations, 
the use of herbal remedies as medicines is well 
documented.  Even though the anesthetic 
capabilities of some of these methods is 
debatable, it is worthwhile to explore the history 
of the science of anesthesia.  Herbal remedies as 
analgesics and sedatives have a rich history.  
Indeed, before ether, chloroform and nitrous 
oxide there was hemlock, mandrake and dwale.  
Physical attempts at anesthesia were also 
frequently employed, including a literal blow to 
the head.  Although they were often 
unsatisfactory these methods withstood the test 
of time in the pre-modern era.  Finally, several 
breakthroughs in anesthesia occurred as 
civilization marched onward towards the modern 
era.  Attempts at sedation took many forms in 
ancient times.  It is these antiquated methods of 
anesthesia that are the subject of investigation in 
this paper. 
The chimera is a mythical beast whose body 
is composed of parts of natural animals.  The 
French surgeon Velpeau describes a chimera of 
pain and surgery.  He argues that they are 
combined into one entity that is impossible to 
separate.  In the modern era of anesthesia pain is 
separated from surgery with great ease.  
However, prior to modern anesthesia humankind 
still partook in surgical interventions.  The 
problem of pain during surgery has victimized 
humans throughout the ages.  The history of 
anesthesia will provide an interesting and 
impressive account of how this problem was 
addressed. 
Before discussing the history of anesthesia it 
is necessary to explore the state of surgery in the 
pre-modern era.  Surgery in ancient times 
included amputation, caesarian section, treatment 
of hernias, hemorrhoids, tumours and tooth 
extraction1 as well as attempts to cure epilepsy, 
serious headaches, insanity, and depression 
fractures of the skull.2  It was not unusual for a 
surgeon to approach a patient with several strong 
men to literally hold the patient down.  A good 
surgeon is one who can perform quickly and one 
who has strong nerves to withstand the screams 
of the patient.  The concept of surgery without 
anesthesia is expected to cause some shock to 
those who practice modern medicine.  However, 
the testimony of patients screaming during an 
operation and the intense psychological distress 
caused to patients awaiting surgery establishes 
that the problem of pain was very real.2  It is 
therefore highly likely that for as long as patients 
were subjected to surgery people have searched 
for methods of anesthesia. 
Medicinal plants have been used throughout 
the ages to treat many diseases.3  Medicinal 
plants alone or in combination were often 
utilized as anesthetics.  Dioscorides, a Greek 
physician in the first century AD recorded 
hundreds of plant preparations for use in 
medicine.  Pliny the elder, a Roman of the same 
era as Dioscorides recorded the use of opium and 
henbane.4  These therapeutic plants were well 
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known in antiquity and there are many records of 
their use.1 
The first description of a preparation used for 
anesthesia is found in the 9th or 10th centuries AD 
where the spongia somnifera or the soporific 
sponge is first mentioned in the context of 
anesthesia.5  This concoction was made with the 
following ingredients: mandrake, opium, 
hemlock and henbane.  The plant extracts were 
dissolved in water and soaked in a sponge.  The 
sponge was then left to dry in the sun.  When 
needed the sponge was placed in warm water and 
then placed under the patient’s nostrils to be 
inhaled, putting him to sleep.  Once the surgery 
was complete the patient would inhale vinegar 
fumes and awaken.5 
Mandrake or Mandragora was a popular 
agent with many references throughout the ages.2  
Its particularly curious physical characteristic 
bifid root resembled the form of man, which 
undoubtedly added to the mystique surrounding 
the plant.6  The medicinal activity of the 
mandrake was well known to many ancient 
civilizations including the Egyptians, Greeks, 
Assyrians, Babylonians, Hindus and Chinese.  
Babylonians are believed to be the first users of 
mandrake in pain relief more than 2000 years 
B.C..2  The Greeks described its use mixed with 
wine and given prior to surgery to avoid pain.  
There is no doubt as to potency of the mandrake 
root and its use during surgical procedures of 
ancient times is well documented.1  Pliny went 
as far as claiming that anesthesia can be induced 
by smelling the juice.7  However, it was also 
identified as a narcotic and necessarily a poison 
when taken in large amounts.  Dosing was also a 
problem as the potency of the plant was variable 
based on season and geographic location.  This 
caused it to fall out of favour.8  
The opium poppy is the oldest, most familiar 
and most effective of all the ancient drugs.  
Opium's use in pain control can be traced back to 
the Roman Empire.1  However, its regular use 
for anesthesia is only observed in the Middle 
Ages.  Opium is a well-known potent narcotic 
and pain reliever.  Dosing was again a problem 
since in high doses the opium will cause central 
nervous system depression and death.1  As with 
mandrake the variable effects of the opium 
poppy made it difficult to consistently use as an 
anesthetic. 
Dwale was a liquid mixture that the patient 
was required to drink prior to surgery.  Recipes 
for dwale were found dating back to the 12th 
century AD.  Dwale was composed of bile of a 
boar, lettuce, vinegar, bryony root, hemlock, 
opium and henbane.  All of these were mixed 
together in wine and drunk by the patient to 
render him asleep before surgery.  To arouse the 
patient afterwards, vinegar was used just as it 
was in the case of the spongia somnifera.9  Bile, 
lettuce, vinegar and bryony root can be discarded 
as ineffectual ingredients in the realm of 
anesthesia and will not be discussed.  While 
opium has already been dealt with, henbane and 
hemlock are both important plants in the history 
of anesthesia. 
Henbane or Hyoscyamus and hemlock were 
not referred to nearly as much as mandrake or 
opium.  Henbane was a lesser-known sleep 
inducer.  It was generally used as a local 
anesthetic in treatment of toothache.1  However, 
it too has deadly consequences if ingested in 
high amounts and was considered a dangerous 
medication.  Hemlock was the poison ingested 
by Socrates that caused his death.  It was a well-
known drug and obviously quite dangerous.  It 
was also described in the 15th century as a 
method of inducing sleep before surgery.1  Both 
of these were strong poisons and were not 
frequently used. 
At this stage in the discussion it is important 
to note that potent analgesics, sleep inducers and 
anesthetics were known and used by people 
throughout antiquity.  Problems arose for several 
reasons including method of administration, lack 
of dosing control and most of all the ever-present 
danger of fatal overdose.  These methods all fell 
out of favour and patients still endured pain 
during surgery. 
The discussion must turn now to one of the 
oldest and most popular anesthetics, alcohol.  
Alcohol has always been a vital part of the 
struggle against pain.  It was likely the spur that 
caused people to attempt to alleviate pain 
through ingestion of medicines.2  Often, other 
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herbal remedies are mixed in with alcohol and 
administered for pain relief, a fact that certainly 
improved the potency of these ancient 
medicines.1  For example, the often used 
laudanum, which was very popular and was one 
of the only known consistent pain relievers of 
antiquity, was simply opium mixed with alcohol.  
Although alcohol alone is not sufficient to be 
deemed an anesthetic in the true sense it does 
have a valuable place in the history of medicine.2 
The investigation into anesthesia through 
antiquity shifts to a discussion of physical 
mechanisms.  Herbal remedies were discovered 
to be either ineffectual or too dangerous.  In an 
attempt to control pain patients were literally 
clubbed on the head prior to surgery.  In ancient 
Egypt men who dispensed this treatment became 
highly skilled in the technique.  The blow had to 
be strong enough to knock the patient out but not 
too strong as to kill him.  While this method was 
crude and unsatisfactory, it was used throughout 
history as it was better than providing nothing.2 
Local pressure proximal to the site of surgery 
was found to help control pain.  By using a 
tourniquet that placed pressure on both the 
vessels and the nerves, it was found that pain 
could be numbed.  This method was found to 
cause significant pain itself as well as tissue 
injury, which increased the risk of infection.2  
This method can be traced back to ancient Egypt, 
2500 BC, where evidence has been found in the 
form of pictures.  These pictures show pressure 
being placed on the brachial plexus during 
surgery on the hand1.  This was a very crude 
method of anesthesia that did not provide much 
benefit to the patient. 
The carotid artery translated from the Greek 
means artery of sleep.  It was found that by 
choking both arteries, a person could be rendered 
unconscious.  One could imagine that this was a 
truly ineffective method since the patient would 
regain consciousness soon after the pressure was 
removed.2 
The exploration thus far has discovered many 
options for anesthesia throughout antiquity but 
none of these are viable, reproducible or 
effective options.  The attention shall now be 
turned to more contemporary methods with 
significantly more promise. 
Joseph Priestly is credited with the invention 
of the first modern anesthetic, nitrous oxide or 
laughing gas, in 1773.  This gas is still used in 
the modern day as an anesthetic.10  Unfortunately, 
during Priestly’s era doctors were not 
courageous enough to make use of the new 
discovery for fear of its potential danger and 
despite the positive outcomes of his 
experiments.10  It took another pioneer in the 
form of Sir Humphry Davy to bring nitrous 
oxide into popular use.2  Davy showed that 
nitrous oxide was a safe and breathable gas.7  He 
further went on to show that nitrous oxide could 
render a person unconscious and went as far as to 
write that it was capable of removing physical 
pain, even during surgery.7  No surgeon made 
use of the newfound anesthetic and so nitrous 
oxide was destined for rediscovery at a later date. 
Henry Hill Hickman was another man who 
came close to a breakthrough discovery.  His 
idea of suspended animation involved 
introducing sufficient inhalant so that painless 
sleep could be induced.  His initial experiment in 
the 1820s involved depriving an animal subject 
of air and providing carbon dioxide alone, 
essentially anesthesia by asphyxiation.  He noted 
that without oxygen an animal would soon be 
unconscious and would remain so throughout the 
surgery.  As a further benefit the subject did not 
bleed as much and healed much faster.7  In 
retrospect this was not much different from the 
carotid artery compression discussed 
previously.2  This discovery truly provided an 
alternative to pain during surgery.  Hickman 
attempted to present his results with the animal 
subjects in the hopes of gaining recognition and 
eventually attempting the procedure on humans.  
However, his theory on suspended animation 
was ignored completely and this promising 
discovery died with him.2 
It is commonly accepted that 1846 was truly 
the birth of modern anesthesia with the use of 
ether in surgery.  However, ether was discovered 
in the 14th century by Raymond Lully, who 
synthesized it from sulfuric acid and alcohol.  He 
named it sweet vitriol.  The power of his 
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discovery eluded him and the discovery 
remained dormant until the 16th century when 
Valerius Cordus rediscovered it.10  Cordus 
recorded the method of synthesis and his 
contemporary, Paracelsus, documented its 
analgesic effects on chickens.  Paracelsus 
determined that it quieted all suffering and 
relieved all pain.2  At this point in history, 
approximately three hundred years before 
Morton’s landmark discovery the effects of ether 
were recorded for all to appreciate.  As with Day 
and Hickman, this discovery too was buried and 
ether was forced to wait for its famous 
unveiling.10 
Mechanisms of pain control found their way 
into the culture of their time.  Their existence 
was common knowledge and they provided plot 
mechanisms to both Marlowe and Shakespeare.8  
However, these plants did not provide adequate 
anesthesia.  The practice of surgery was 
continuing to flourish and the need for pain 
control was great. 
It is worthwhile here to discuss what is truly 
meant by anesthesia.  The exploration of the 
history of this science unveiled the possibility of 
providing some pain relief and methods of 
rendering a person unconscious but it cannot 
truly be declared that the ancients were in fact 
practicing anesthesia.  A general anesthetic not 
only puts a patient to sleep but also keeps him 
asleep throughout the operation.2  The medicinal 
herbs discussed in this paper had the capacity of 
causing some degree of unconsciousness yet 
these did not replace the physical means of 
clubbing and physically restraining a patient.  
One must ask the question, how effective could 
the spongia somnifera or dwale be if a patient 
can be roused by simply inhaling vinegar.  
Furthermore, a utilizable drug must be 
reproducible and consistent in its effects.  Since 
the potency of the plants was variable with the 
season and geographic area, it was impossible to 
establish a single effective and reliable method 
of providing anesthetic coverage during surgery.8 
The discovery of anesthesia by inhalation, 
nitrous oxide, carbon dioxide and ether, provided 
a great benefit and it is only at this stage in 
history that people truly began practicing 
anesthesia.  A gas can be administered until the 
patient is unconscious.  No longer were people 
tied to the variable potency of the ingredients or 
to the innate variability of the patient’s 
metabolism and overall health.  It is at this stage 
in history that the foundation for modern 
anesthesia is built. 
It has been over 150 years since the 
Velpeau’s chimera has been abolished.  The 
ability to remove pain from surgery is one of the 
great marvels of modern medicine.  By 
investigating the history leading up to this great 
discovery one may gain an appreciation of the 
great trouble that pain has caused humanity.  
Those whose experiments whether they were 
successes or failures deserve praise since they 
furthered humanities understanding of the 
science of anesthesiology and in doing so helped 
solve the problem of pain during surgery. 
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Anti Smoking Initiatives in Nazi Germany: Research and Public Policy 
 
Nathaniel Dostrovsky 
 
In 1939, German scientist Franz H. Muller published the world’s first epidemiological, case-control study showing a 
link between tobacco smoking and lung cancer.  Another more rigorous epidemiological study by Eberhard Schairer 
and Erich Schoniger in 1943 further supported this link. The Nazi regime was very supportive of anti-smoking 
initiatives.  In addition to funding research, the government posted propaganda, passed legislation and offered medical 
assistance in an effort to encourage Germans not to smoke.  This anti-smoking campaign was part of a public health 
initiative that included restrictions on alcohol and exposure to occupational contaminants as well as an emphasis on 
good nutrition. A number of reasons have been suggested for the government’s desire to improve health-related 
behaviour.  These include economic and strategic - medical care and lost productivity from sick workers was 
expensive, and Germany needed its soldiers to be healthy.   Another is idealogical - the Nazi government viewed 
alcohol, workplace pollutants, and especially tobacco as genetic poison to the pure German race.  After Germany’s 
defeat, the research linking smoking and lung cancer went virtually unnoticed by academics in the rest of the world, 
perhaps due to the connection between the anti-smoking campaign and Nazi ideology. 
 
 
Introduction 
The causal link between tobacco smoke and lung 
cancer is well established, and studies from the 
1950s by British and American scientists such as 
Sir Richard Doll, A.B. Hill, Cuyler Hammond 
and Ernest Wynder are generally credited with 
this discovery.1 Yet, the link was identified by 
German researchers a decade earlier, but their 
studies received little attention after World War 
II.  
The German research helped spawn anti-
smoking initiatives, a centre piece of a public 
health campaign that also targeted alcohol, 
nutrition, and occupational carcinogens. The 
rationale for improving public health included 
economic, military, and most importantly, 
ideological motives.  Nazi ideology, specifically 
racial hygiene, is a major reason why the 
research linking tobacco and lung cancer went 
virtually unnoticed after the war.  
 
Research Linking Tobacco Smoke and Lung 
Cancer in Nazi Germany 
Until the sharp increase in incidence in the early 
20th century, lung cancer was very rare.  German 
autopsy records show that it represented 1% of 
cancer deaths in 1878, 10% in 1918 and 14% by 
1927.1 An even larger increase in tobacco 
consumption occurred in the latter decades of the 
19th Century, with inventions such as safety 
matches and industrial-scale cigarette rolling 
machines.2  Despite the temporal correlation, 
doctors and researchers didn’t initially recognize 
the link, attributing the cause of the excess lung 
cancer to automobile exhaust, road tar, and the 
influenza pandemic of 1919. 
 Among the first to postulate a link between 
tobacco smoke and lung cancer was the German 
clinician Schonherr in 1928 who noted that many 
of his female lung cancer patients were exposed 
to “2nd-hand” smoke.3  Other doctors, such as 
Fritz Lickint in 1929, noted increased frequency 
of smoking in patients with lung cancer.   
 Scientists working during the Nazi regime 
built on this earlier research.  In 1939, Franz H. 
Muller published the world’s first 
epidemiological, case-control study showing a 
link between tobacco smoking and lung cancer.  
He compared the tobacco consumption of 86 
men with lung cancer to 86 healthy men 
(controls) of the same age.4 Patients with lung 
cancer were more likely to be heavy smokers 
than the control group and likewise the control 
group were more likely to be moderate or non-
smokers than the lung cancer group.  
This link was supported by a more 
rigorous study by Eberhard Schairer and Erich 
Schoniger in 1943.  Questionnaires, asking about 
amount and duration of smoking, were sent to 
relatives of 195 patients who had died of lung 
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cancer, relatives of 555 patients who died of 
other cancers (mostly stomach and colon), and to 
healthy controls.4  In their analysis, Schairer and 
Schoniger attempted to account for confounding 
variables such as occupational exposure to dust.  
They concluded that “there is a high probability 
in support of the contention that lung cancer 
develops much more frequently in heavy 
smokers and is much rarer among non-smokers 
than expected.”4  Later analysis showed their 
results to be statistically significant with 
p<0.0000001.3 
 These studies were financed by a Nazi 
regime very supportive of anti-smoking 
initiatives.  At a large conference about the 
effects of alcohol and tobacco in March 1939, 
Hans Reiter, head of the Reich Health office, 
“charged all the medical societies of Germany 
with the responsibility for determining 
scientifically the degree to which tobacco caused 
disease.”3 
The Nazi government’s support of research 
into the health effects of tobacco extended to the 
very top of their government.  Adolf Hitler 
donated 100 000 Reichmarks (RM) of his 
personal finances in 1941 to help fund the 
establishment of the ‘Scientific Institute for the 
Research into the Hazards of Tobacco’ in the 
city of Jena.5 This institute funded the study by 
Shairer and Shoniger, as well as other research 
into the health impacts of smoking including 
‘nervous disorders’, gastrointestinal function, 
and tobacco's effect on the body’s 
potassium:calcium ratio.  
 
Anti-Smoking Initiatives in Nazi Germany 
Such research provided scientific rationale for 
the government’s anti-smoking initiative which 
included propoganda, education, legislation and 
economic measures.  The government’s anti-
smoking advertisements often used role models, 
most notably Adolf Hitler, an ardent anti-
smoking activist.  One advertisement read: 
 
Brother national socialist, do you know 
that your Fuhrer is against smoking and 
thinks that every German is responsible 
to the whole people for all his deeds and 
omissions, and does not have the right to 
damage his body with drugs?3 
 
The education ministry banned smoking in 
schools and ordered education about the dangers 
of tobacco to be included in school curricula.6 
Anti-smoking propaganda was also disseminated 
through the Hitler Youth, League of German 
Girls, and Federation of German Women.  A 
popular slogan aimed at women was “Die 
deutsche Frau raucht nicht!” (“The German 
woman does not smoke!”).7  Restaurants and 
cafés were forbidden to sell cigarettes to women.  
Smoking among women was further restricted by 
denying tobacco-rationing coupons to women 
younger than 25. 
 Restrictions were also put on cigarette 
advertising – they couldn’t imply that smoking 
had any hygienic value or associate it with 
masculine or feminine imagery.3 Smoking was 
banned in many public places, including military 
barracks, government offices, workplaces and 
trains.  Specific groups of men were also 
prohibited from smoking including uniformed 
soldiers and anyone under 18.6  
 In addition to restricting smoking and its 
advertising, the Nazi government implemented 
medical programs to help people quit.  These 
included counselling, provision of nicotine gum, 
and use of silver nitrate mouthwash which made 
cigarettes distasteful.6 The government also 
researched ways of producing nicotine-free 
tobacco, and by 1940 it comprised 5% of the 
German tobacco harvest.6 
 The Nazi government also used economic 
means to limit tobacco consumption.  In June 
1940, the government ordered that cigarette 
rations for soldiers be limited to six a day6 and 
raised taxes on cigarettes to 80% in 1941.  
The Nazi government’s anti-smoking 
campaign was part of a broader public health 
initiative that emphasized preventative medicine.  
In an attempt to limit alcohol consumption, the 
Nazi government used similar strategies to their 
anti-smoking campaign.  Advertisements 
claimed that alcohol “was sapping the strength of 
the German people.”6 
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 Government authorities promoted a diet high 
in fruits and vegetables, while encouraging a 
reduction in fatty foods such as meat and 
whipped cream.8  A concerted effort was made to 
encourage bakeries to make whole wheat bread 
instead of white and laws were passed that 
limited the use of carcinogenic additives, such as 
dyes, in food.   
 Regulations were also put on occupational 
exposure to toxins such as limiting the use of 
asbestos in factories.7 
Just as the research into the dangers of 
tobacco-smoking in Nazi Germany was ahead of 
the rest of the world, so too were these public 
anti-smoking initiatives. The government’s 
multi-pronged combination of advertising, 
legislation, medical therapy and economic 
measures is similar to the strategy used in current 
anti-smoking programs. 
 
Rationale for the Public Health Initiative 
A number of reasons have been proposed for the 
government’s desire to improve health-related 
behaviour, including economic, strategic and 
ideologic.  Throughout the 1930s, lung cancer 
had risen to be the second most common cause 
of cancer death in German men.2 By 1944, it was 
the most common. This rapid increase had 
tremendous economic impact: it was a large 
expense for the German healthcare system and 
health insurance companies, and workers' 
morbidity and mortality affected the bottom line 
of companies.  In 1941, the Nazi government's 
accounting division estimated that smoking was 
costing the economy approximately RM 4 billion 
annually.6  To put this in perspective, Germany's 
entire military budget as it prepared for war in 
1938 was only RM 16 billion.  The government 
had a strong economic impetus to reduce tobacco 
consumption. Similarly, the rise in morbidity and 
mortality from lung cancer was a concern to the 
military, which needed soldiers to fight.  There 
was also concern that smoking tobacco would 
affect the German soldiers' stamina and military 
prowess.7 
 Another important reason for the German 
government’s public health campaign involves 
Nazi ideology, specifically racial hygiene.  This 
was a central tenet of Nazism, involving the 
maintenance of a 'pure' Aryan race. The racial 
hygienists attempted to accomplish this goal 
through three main avenues: 
 
Racial hygienists distinguished 'positive', 
'negative' and 'preventive' racial hygiene, 
encompassing encouragement of 
breeding among the 'fit' (eg. by marital 
loans and prizes for large families), 
limitation of breeding among the 'unfit' 
(especially by sterilization), and 
prevention of exposure to genotoxic 
hazards.2 
 
Racial hygiene helps explain the Nazi 
government’s public health policies that 
attempted to ban or decrease use of many 
potential mutagens including food dyes, asbestos, 
and especially tobacco smoke.  In 1939, the 
Reich Health office commissioned studies 
investigating the effects of smoking on 
chromosome damage.3  
 After 1941, most of Germany’s research into 
the health effects of smoking involved the 
Institute for Struggle Against Tobacco Hazards 
in Jena.  It was founded and directed by Dr. Karl 
Astel, Dean of the University of Jena, head of 
both the Office for Racial Affairs and the Office 
for Public Health and Social Affairs for the state 
of Thuringia, a high ranking SS officer, and a 
leading racial hygienist.5  His rationale for anti-
tobacco research is evident through his belief 
that “We cannot change our genes, but at least 
we can safeguard them from future damage.”2 
Astel was also involved in other aspects of the 
Nazi’s racial hygiene campaign including 
organizing the euthanasia programs that 
murdered over 200 000 mentally and physically 
disabled and was involved in organizing Hitler’s 
‘final solution’ to murder all Jews.2 
  
Why the Anti-Smoking Research Went 
Unnoticed After World War II 
After Germany’s defeat, the research showing a 
link between smoking and lung cancer went 
virtually unnoticed by most academics.  
Logistics would have contributed to this: 
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German scientific journals were not sent abroad 
during the war.2   
 Another more important reason was that the 
research was done in Nazi Germany.  Even 
though both Muller's and Shairer and Shoniger's 
studies were purely epidemiological, many 
associated all research from Nazi Germany with 
the atrocious human experiments carried out.  
The scientific community ignored much of the 
research, because, as biochemist James Watson 
explained, some thought "that good work simply 
could not have been done by Nazi scientists.”2 
Muller's 1939 paper wasn't completely 
ignored and was occasionally referenced in the 
1950s, even in the influential papers by British 
and American authors such as Doll and Wynder, 
whose studies are generally credited with 
demonstrating the link between smoking and 
lung cancer.6 Yet, Shairer and Shoniger's study, 
which was methodologically and statistically 
superior, was cited only three times in the 1960s, 
and only once in the 1970s.2 The study also went 
unnoticed in Germany, and failed to be 
mentioned in a German bibliography about the 
links between tobacco and cancer published in 
1953. 
This may have been because the study was 
conducted at the Institute for Struggle Against 
Tobacco Hazards, whose director had 
involvement in the Nazi sterilisation, euthanasia 
and murder of the Jews.  Some other scientists 
connected with the Institute engaged in horrific 
human studies.2  
Muller's study was completed before the 
conception of the Institute, and so lacks the same 
stigma.  It also lacks Nazi ideology.  For 
example, "race", a common theme in many 
medical studies from Nazi Germany, was not 
mentioned at all.6 Furthermore, Muller refers to 
work by Jewish authors in his study.  Perhaps 
this is why it received some minimal attention 
after the war, compared to almost none for the 
paper by Shairer and Shoniger. 
 
The Effect of the Nazi Government’s Anti-
Smoking Policies 
Despite the Nazi government's anti-smoking 
initiatives, German tobacco consumption 
continued to rise throughout the 1930s. One 
reason for this increase may have been that 
smoking was a form of passive resistance against 
the authoritarian Nazi government.3 In the latter 
stages of the war, tobacco consumption did drop 
considerably, but rationing and economic 
problems were likely the major factor. 
At a glance, it appears that the Nazi 
government’s anti-smoking initiatives were a 
failure. Yet, the rise in smoking throughout the 
1930s was due to growth in the German 
economy, and it is possible that the Nazi 
government's opposition kept this increase lower 
than it would have been otherwise.  Furthermore, 
in 1990, lung cancer mortality among German 
women was one fourth that of American 
women.6 As much of the anti-smoking policies 
were aimed at women, it is possible that the Nazi 
government’s public health initiative is partly 
responsible for this reduction.  
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From Marjorie to Leonard: Leaping the Clinical Hurdle of Insulin in 1922 
 
Aaron R. Mocon, Meds 2008 
 
In the study of no other non-infectious disease has there been closer collaboration  
between laboratory and clinical investigators than in that of diabetes.1 
 
Leprosy has long had a reputation for being one of the most feared of all human diseases. In Canada today the disease 
is a rarity and the few existing cases are considered little threat to public health; however, this was not always the case. 
In the mid- to- late nineteenth century an endemic leprosy was found to exist among the Acadian Population of New 
Brunswick, a discovery which caused much concern within the nation’s medical and legislative communities of the 
time. In this outbreak, which occurred prior to the discovery of the leprosy bacillus, the physicians involved with the 
situation were deeply divided as to the nature of the disease: was it hereditary or was it contagious? Their decision 
would prove fateful for the victims of the disease in this area. Furthermore, issues of race and class would become 
central in the discussion surrounding the appearance of leprosy in this population. 
 
 
When J.J.R. Macleod wrote this statement in the 
February 1922 edition of The Canadian Medical 
Association Journal (CMAJ), he was referring to 
the contributions of numerous groups of 
scientists and physicians over many years, 
including his own Toronto-based team, to the 
study and treatment of diabetes mellitus. 
Macleod, a professor of physiology at the 
University of Toronto and assistant dean of the 
Faculty of Medicine, was the primary 
investigator who supplied the laboratory space, 
advice and medical science community clout that 
ultimately allowed F.G. Banting, C.H. Best and 
J.B. Collip to isolate the pancreatic hormone 
insulin and to be the first to use it to successfully 
treat diabetes mellitus. Macleod’s commentary 
prefaced Banting, Best and Collip’s preliminary 
report published in the same issue of the journal 
entitled “Pancreatic Extracts in the Treatment of 
Diabetes Mellitus.” This was the team’s first 
publication, which, although preliminary, 
indicated that their pancreatic extract (later 
named insulin) was able to control the clinical 
manifestations of diabetes mellitus in humans 
and in their opinion left “no doubt…that 
[insulin] was a therapeutic measure of 
unquestionable value.”2 The impact of insulin 
can be regarded as one of the most dramatic 
events in the history of the treatment of disease 
and in 1923, the Nobel Prize was awarded for the 
discovery of insulin at Toronto. 
 In early November of 1920, Dr. Banting 
arrived in Toronto to meet Dr. Macleod after 
being directed there by Prof. Miller of the 
University of Western Ontario in London, 
Ontario. Upon reading volume XXXI, number 5 
of “Surgery, Gynecology and Obstetrics” (1920), 
Banting, a struggling physician in London, was 
struck by an idea of how to make a pancreatic 
extract that contained the mysterious substance 
or internal secretion, which was hypothesized to 
control the metabolism of carbohydrates in 
blood.3 He was sent to Macleod, a specialist in 
diabetes, with the hope that he would give advice 
and laboratory resources. After two turndowns, 
Banting’s persistence was able to convince 
Macleod to provide him with eight weeks of lab 
space, experimental dogs and a bright young 
physiologist named C.H. Best to partially 
compensate for Banting’s lack of medical 
science research skills. In May of 1921, Banting 
and Best began what would be a tedious and 
tumultuous conquest to ligate the pancreatic 
ducts of dogs, wait for their pancreases to 
degenerate and isolate isletin, a working term for 
what was later called insulin. Upon injection into 
depancreatized dogs, it was hoped that the 
extract would counteract the clinical features of 
diabetes. On July 30th, 1921 Banting and Best 
found that injecting their extract into a diabetic 
dog’s veins was able to transiently reduce the 
blood and urine sugar levels and relieve the 
Feature Article 
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dog’s diabetic comatose state ― their first 
promising results.3 
Since 1887, when Von Mehring and 
Minkowski discovered that depancreatizing an 
animal renders it diabetic, many efforts had been 
attempted to devise methods for extracting the 
principle ingredient of the gland that mediated its 
anti-diabetic effects. However, no method was 
sufficiently robust to produce large enough 
quantities needed to sustain a diabetic animal 
once treatment had started while at the same time 
being pure enough to eliminate unwanted 
toxicity reactions.4 In an issue of the CMAJ, an 
editorial by Macleod recognizes Knowlton and 
Starling, Kleiner, Murlin, E.L. Scott and 
Paulesco as the investigators that provided the 
most notable evidence of an internal secretion 
before the Toronto team had done. He notes, 
however, that their “results…have 
been…insufficiently constant and significant to 
justify more intensive research with the object of 
securing preparations of greater potency that 
could be used for the treatment of diabetes in 
man.”5 Banting wanted to produce the elusive 
sufficiently constant results and Macleod 
apparently believed that he might be able to 
succeed. 
Aware of the progress that Banting and Best 
had accomplished in dogs and perhaps 
foreseeing the potential of clinical implications, 
Macleod expanded the Toronto team, at the 
request of Banting, to include the biochemist and 
endocrinologist J.B. Collip in mid-December 
1921. At this point, Macleod had shifted the 
focus of his other research interests and 
instructed his whole staff to work to purify 
insulin (the Toronto team had now used the term 
insulin for their extract, coined years earlier by 
Sir A.E. Schafer).6 It was Collip’s principle task 
to work on Banting and Best’s newly discovered 
extract in order to refine its purity and increase 
its yield through the use of more sophisticated 
biochemical techniques. The priority was to 
produce enough pure insulin for use in human 
testing ― the hurdle that so many other 
researchers had failed to leap. 
It was merely six months later, on January 11, 
1922, a refined version of the extract used in the 
summer was injected into 14-year-old Leonard 
Thomson in Ward H of the Toronto General 
Hospital (TGH).2 Many significant events 
occurred within this time period. Most notably, 
the extract was able to prolong the life of a 
depancreatized dog named Marjorie (referred to 
in lab note books as dog #33) for 70 days 
beginning in the last week of November until it 
was sacrificed. These long-term results were a 
significant and unprecedented achievement and it 
was the formula for this extract that was chosen 
by Macleod to be used in Leonard Thomson, 
heralding the first clinical trial of insulin.7  
Interestingly though, the extract injected into 
Leonard Thomson, was of Banting and Best’s 
formula that they had been using on Marjorie 
since November, a month before Collip began 
working on the project. In fact, Collip’s extracts 
were only starting to be used on January 23, 
1922, which was 12 days after the first clinical 
trial of insulin in Leonard.8 Perhaps the mixed 
experimental results were sufficient to convince 
Macleod that Banting and Best’s extract was 
refined and safe enough to be injected into a 
human. Insulin’s first patient, Leonard Thomson 
was 14 years old when he was admitted to TGH 
on December 2nd, 1921 as “poorly nourished, 
pale, weigh[ing] 65 pounds, hair falling out, 
odour of acetone on [his] breath…abdomen large 
and tympanic…dull, talked rather slowly [and] 
quite willing to lie about all day.”2 He had been 
diagnosed with a case of severe juvenile diabetes 
with ketosis and according to Macleod, Banting, 
Best and the rest of the Toronto group, his 
“careful dietetic regulation [(the prevailing 
treatment for diabetes at the time)] failed to 
influence the course of the disease. [B]y January 
11th his clinical condition [was]…definitely 
worse.”2 Banting et al., made it evident in their 
1922 CMAJ publication from which these 
excepts are taken that it was Thomson’s 
unpromising and grave circumstance that 
prompted them to inject what was described as a 
“thick brown muck” into the boy’s buttocks – 
this muck, as described by Walter Campbell, the 
chief clinician at TGH at the time, was 15 cc. of 
beef pancreas extract made by Banting and 
Best.9 
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The effect of this first clinical test with 
Banting and Best’s extract was not spectacular. 
In the Banting et al. CMAJ paper, it is described 
with one sentence: 
 
The extracts given on January 11th were 
not as concentrated as those used at a 
later date, and, other than a slightly 
lowered sugar excretion and a 25% fall 
in the blood sugar level, no clinical 
benefit was evidenced.2 
 
More extracts were administered to patients 
at TGH beginning on January 23rd. It was these 
injections that justified insulin’s eventual fame 
as a wondrous therapeutic because they resulted 
in immediate improvement to the diabetic 
patient’s clinical and emotional condition. But 
the extracts that provided these positive results, 
which, were given subsequently to the one that 
Thomson received, were made from Collip’s 
formula and not Banting and Best’s. On January 
19th, 1922 Collip recalled, “I discovered a way 
to get the active principle free from all the 
‘muck’ with which it appeared to be inseparably 
bound.”9 With additional insulin therapy, 
approximately 85 units per day for 13 years, 
Leonard Thomson was able to live a “more or 
less normal life” until he died on April 20, 1935 
of complications due to pneumonia.4 Collip had 
accomplished the duty to which he was 
specifically assigned. He had prepared a more 
pure extract by refining Banting and Best’s 
method and, in doing so, as Macleod had 
requested, made available an extract that was 
more suitable to be injected into a human for 
clinical testing. The result was that for the first 
time in recorded history, an extract of pancreas 
had been unambiguously successful in having a 
distinct antidiabetic effect on a human. Now, 
millions of people worldwide who suffer and 
would surely die from diabetes mellitus are 
offered life and the hope of fulfilling their goals 
and achieving happiness. 
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Laennec and Auscultation 
 
Milli Gupta 
 
René-Théophile-Hyacinthe Laënnec invented the stethoscope in 1816 while trying to examine a young female thought 
to have a heart problem, improving the diagnosis of disease and establishing objectivity in clinical medicine.  This 
invention came while physicians were struggling to correlate post-mortem pathology with clinical symptoms. Until 
1816, symptomatology was the only means to diagnosis.  The stethoscope not only connected post-mortem findings 
with clinical findings but also helped identify illnesses that were asymptomatic.  Laennec’s invention furthered the 
study of physiology, and he used it to study the lung and heart. This paper discusses both his life and his pivotal 
contribution to medicine. 
 
 
Biography 
René-Théophile-Hyacinthe Laennec was born on 
February 17, 1781 at Quimper, Brittany, the first 
born in a respectable family. After his mother’s 
death from tuberculosis in 1786, he and his 
brother were sent to live with relatives and 
eventually ended up with Guillaume-Francois 
Laennec, a physician at Nantes, a second father 
to them, and a positive influence in René’s life.2 
 
 
Figure 1: René-Théophile-Hyacinthe Laennec1 
 
Through his uncle, René received the finest 
education during the revolution, and got a job as 
a medical aide in the army at the age of 14. He 
learned clinical work, surgical dressing, 
dissections and patient care. By 1799, after 34 
months of service, René had decided on a career 
in medicine.  However, the revolution had closed 
the medical faculty in Nantes, bringing René to 
Paris for his medical education.3  
On coming to Paris, he enrolled in the École 
de Sante, a school which received a huge boost 
in surgical studies from Napoleon. He was able 
to sharpen his clinical skills and broaden his 
knowledge by studying with some of the best: 
Jean Nicolas Corvisart des Marets, later 
Napoleon’s personal physician, and Jean-Noel 
Halle, professor of hygiene and a mentor.3 It was 
Laennec’s work with Corvisart that would have 
implications on his study of the chest and 
invention of the stethoscope. 
Around this time, Laennec became interested 
in the new science of pathological anatomy.  He 
wanted to connect presenting symptoms with 
physiological and pathological processes.4  He is 
reputed to have written roughly 400 case reports 
during his first few years in Paris, including 
important information on peritonitis, amenorrhea 
and liver disease. 1 He eventually transferred to 
École Pratique de Dissection in 1802.  
In 1803, he received first prize in surgery and 
runner up in medicine from the Grandes Écoles 
of Paris. He was the first to win two awards in 
one year, an acknowledgement of his skill as a 
surgeon.  Hoping to make more money and use 
his own organization of pathological anatomy, 
Laennec started his own anatomy class at the age 
of 22. He was also working as a ghostwriter on 
Feature Article 
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many medical texts, but stopped when 
remuneration was scarce.5 
In July 1804 he successfully defended his 
thesis on Hippocrates and his support of 
pathological anatomy. This successful defense 
made him part of the Societe de l'Ecole, to whose 
journals he made many contributions. He was 
still active as editor, contributor and reviewer in 
the ‘Journal de medecine’, in which he had been 
publishing as a student.  
Laennec managed to accomplish much at a 
young age, and had hoped that his research, 
impressive publications and prizes would garner 
him a position - but this was not so. He had little 
political influence as a devout catholic and proud 
royalist at the time when Napoleon was taking 
over. It wouldn’t be until 1816 before that dream 
would be realized. 
Following his graduation he pursued work in 
many different specialties, such as parasitology, 
pathological anatomy, nosology (classification of 
disease) and philology (study of ancient texts 
and authors). He also wrote a two-part treatise on 
pathological anatomy that was never published. 
The classification system from this treatise is 
important because his future work relied on this 
framework.  He tried to distinguish between 
benign and malignant tissue growth without 
describing the process behind their production.3 
In 1810, he applied for the chair of 
Hippocratic medicine, but the chair was 
dissolved in 1811 and he focused on clinical 
medicine instead. He also found that most of his 
income came from the care of patients. However 
by then, he was showing signs of tuberculosis 
infection, believed to have been acquired through 
a needle-stick injury during an autopsy in 1803 
(he did not acknowledge his illness until the end). 
He also felt a change of work style would do him 
good. 
He carried on his practice in Paris for a few 
years and took care of such prominent figures as 
Napoleon’s uncle before accepting a position at 
the Necker Hospital in Paris in 1816. His most 
important contribution to medicine, inventing the 
stethoscope, would be made there. 
In 1819, Laënnec published the first edition 
of his book, entitled De l’Auscultation Médiate. 
Two years later it was reorganized, translated 
into English, and published by John Forbes 
under the title A Treatise on Disease of the 
Chest.2 These books described in exquisite detail 
many lung diseases, especially tuberculosis.  A 
second edition with many additions was printed 
in 1826. 
 
 
Figure 2: Laennec’s stethoscopes6 
 
A few months after the book’s release in 
1819, he returned to his native Brittany due to 
failing health. His health improved and his 
recognition grew. He became a professor of 
medicine at the College de France and was put in 
charge of Hopital Charite in 1822. In 1824, he 
was made Chevalier of the Legion of Honor of 
France and was married.  His health deteriorated 
in April 1826 and he returned to Brittany, to pass 
away in August.  His physician may have used 
Laennec’s own invention to diagnose him, but 
kept the diagnosis from him until the end.3  
 
Auscultation 
As Laennec and others moved toward correlating 
post-mortem findings with clinical disease1, 
physical examination became an exciting new 
area of clinical medicine.  Given that Laennec’s 
mother, uncle, brother and friend Bayle 
succumbed to tuberculosis, he did considerable 
investigations in chest medicine. During his 
early days with Corvisart, he learnt of percussion, 
which was being re-introduced into medical 
practice. Percussion was initially introduced by 
Leopold Auenbrugger in 1761, who applied the 
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technique to examine a wine barrel towards the 
thorax1, surmising that a normal thorax would 
resonate, but one filled with secretions would 
sound low-pitched.  
Corvisart used his physical exam findings of 
percussion to predict postmortem findings before 
the patient died. He then applied this to the heart 
and could detect an enlarged heart. He could also 
discern a thrill, which led him to believe “the 
palpitations of the heart are sometimes so intense 
that the sound of the heart can be heard beating 
against the chest wall”.5  
Direct auscultation (placing the ear on the 
chest wall) was another technique (Figure 3). 
This was known to Hippocrates and extensively 
used in ancient Greece.  However, it was hard to 
perform this act on obese or heavily endowed 
females as it was socially unacceptable and 
unhygienic, and sounds would often be muffled 
and hard to interpret. 
It was only a matter of time before the 
stethoscope would have been invented.  Many 
glorified tales exist of how Laennec came to 
create it, but the consensus is that in 1816, he 
saw a young female presenting with generalized 
symptoms of heart disease. He was 
uncomfortable with direct auscultation, so he 
rolled up a paper notebook, applied one end to 
the chest, and listened to the heart.  He felt that 
he could hear the heart more clearly than if he 
had used direct auscultation. He coined a famous 
double entendre “J’entends,” meaning “I hear 
and I understand” and named his instrument the 
stethoscope, from the Greek “to explore the 
chest”.5 He subsequently used his invention to 
identify many pathological lesions within the 
heart and the lungs. 
 
 
Figure 3: Laennec at the bedside 
performing direct auscultation6 
 
Laennec needed a very good ear and wide 
vocabulary to create a classification system for 
his findings. He described what he heard by 
creating a common vocabulary to correlate 
anatomy and pathophysiology for others to use 
and understand. To describe what he heard, 
Laennec relied on imagination and the common 
sounds in nature. Examples include animal 
voices and pitch, music, and urban life.4  
In identifying what findings he considered to 
be a sign of the disease in question, Laennec 
used the basic concepts underlying sensitivity 
and specificity.5  Findings with high specificity 
(being present with just one disease) were 
deemed “pathognomonique,” while findings that 
were of low sensitivity (present in only some 
cases of a disease) were deemed less reliable. As 
an example, pericarditis can occur without 
friction rub, therefore making it not sensitive.   
 
Pulmonary Signs 
Although it was cardiac disease that led to the 
invention of the stethoscope, Laennec’s legacy 
arises from his work on the lung.  Laennec set up 
the first categorization of these findings.  His 
classification style relied on defining disease by 
its post-mortem characteristics. For instance, in 
his time, tuberculosis was defined by presenting 
symptoms. Laennec defined tuberculosis by the 
presence of lung caverns (tubercles) on autopsy.4 
He used the stethoscope to identify these lesions 
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and to diagnose patients earlier, not waiting for 
late symptoms to give the official diagnosis. 
Through percussion and auscultation, 
Laennec identified the pathophysiology of the 
cavitary lesions.  He believed there was a change 
in tuberculous ‘matter’ from grey to yellow, 
which then liquefied (caseation) and expelled 
through the airways, leaving a cavity (often 
calcified) at autopsy.5 He was the first to use his 
stethoscope to identify tuberculosis in patients 
who had no signs or symptoms (latent 
tuberculosis), but had anatomic defects.  
Laennec initially believed in a direct, one-to-
one relationship between the sound heard and the 
pathology a patient presented with.  He 
considered pectoriloquy, a change in the 
patient’s voice heard with a stethoscope, to be 
indicative of tubercles.4 Even if the patient did 
not present with the symptoms, if pectoriloquy 
was heard, the patient undeniably had 
tuberculosis.5 However, he soon realized that all 
cavities may result in pectoriloquy, but not the 
converse. By 1817 he thought that bronchiectasis 
(dilation of the airways) and the second stage of 
pneumonia (hepatization) also resulted in a 
similar sound. To maintain his 
“pathognomonique,” rule, he changed the name 
of the sound in the latter two lesions to 
bronchophony.5 He was initially resistant to this, 
and so this revision only appeared in the 1826 
edition of his book. 
Similarly, he claimed egophony was a variant 
of pectoriloquy but sounded like the bleating of a 
goat, and believed this to be synonymous with 
acute pleural effusion, refusing to be challenged. 
Ironically, he admitted having troubles 
differentiating between the two.5 He also 
believed rales (bubbling or silent respiration) 
was pathognomonic for bronchitis (1816-17), 
metallic clinking for pneumothorax with small 
quantity of fluid, and decreased breath sounds 
for emphysema (1818). He acknowledged the 
various sounds of rales, but attributed this to 
differing sputum color, quantity and texture.5  
His invention also helped him put physiology 
into practice.5 The first time he heard “puerile 
respiration”, he thought it was a physiologic 
response to increased oxygen demand in adults, 
and a normal variant in children. He later 
realized it was also a sign for asthma, but there 
was no post-mortem lesion to associate with this. 
He relied on physiology to explain the clinical 
presentation of shortness of breath: constriction 
of the bronchiolar muscles was separate from 
costal and diaphragmatic movements, leading to 
decreased air entering the bronchioles and 
reduced oxygen delivery.  Patients had to 
increase their breathing rates to increase oxygen 
flow. In those without clinical signs of asthma, 
hyperventilation secondary to ‘white coat effect’ 
led to these findings. 
Conclusion 
The stethoscope made it possible to reveal 
physical changes before the patient died.  The 
discoveries by auscultation of the thorax led to a 
frenzied search for pathognomonic signs in other 
parts of the body.  The stethoscope allowed 
physicians to detect asymptomatic lesions and 
introduced objectivity to clinical medicine, but it 
shifted the focus of medicine away from the sick 
person.  
Although active in establishing objective 
signs of disease, Laennec believed that patient’s 
symptoms were just as important when it came 
to diagnosis.  Even when the stethoscope did not 
tell him anything, he continued to believe in the 
possibility of the disease, and paid his patient 
due respect.  The work that Laennec did was 
indisputably amazing and accurate for his times. 
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Lovesickness: The Most Common Form of Heart Disease 
 
Nancy Dzaja 
 
“My mouth doth water, and my breast doth swell,  
My tongue doth itch, my thoughts in labour be;”1 
 
As Astrophil pines for his Stella in Sir Philip Sidney's sonnet, he describes the physical symptoms of his infatuation 
which point to a rampant case of lovesickness. In addition to its common presence in works of literature, lovesickness 
has been described as an actual medical entity with a specific etiology, pathogenesis, and treatment. Amazingly, many 
of the described symptoms of lovesickness are consistent across time and place, including fever, agitation, loss of 
appetite, headache, rapid breathing, and palpitations. On the other hand, other aspects of the disease and its care differ 
tremendously depending on the cultural context. Lovesickness (also known as lover’s malady, mal de ojo, mal amor, 
amor heroes, inordinate love, or philocaptio) had a variety of proposed etiologies. In the Middle Ages it was often 
attributed to love philters and demons, while the ancient Nahua of Mexico thought it had to do with the evil eye. The 
disease had serious consequences: failure to treat an afflicted patient could result in losing one’s genitalia, death, or 
eternal damnation. Treatments were creative and varied widely, from herbal remedies to the prescription of sexual 
intercourse, to drinking water that had been boiled in the desired person’s underwear. Lovesickness is a disease that 
permeates medical literature since the time of Hippocrates, and may still have a place in modern medicine in the form 
of somatoform disorder, bipolar disorder, or erotomania. 
 
 
Introduction 
In a case description, the physician Erasistratus 
(4th century BC) is called to the bedside of Prince 
Antiochus, who is extremely ill. On examination, 
the prince is weak, emaciated, and near death, 
and no one understands why.  As Erasistratus 
feels Antiochus’ wrist, he realizes that the 
prince’s pulse quickens and he becomes flushed 
when his stepmother Stratonice enters the room. 
Erasistratus realizes that Antiochus is suffering 
from lovesickness, and tells King Seleucus, who 
gives his wife to his son.2 Similar stories are 
attributed to Hippocrates and Galen. Indeed, 
lovesickness is a disease that permeates medical 
literature and the ability to diagnose it was the 
sign of a great physician.2 Descriptions of the 
disease have changed extensively over hundreds 
of years and it may exist today in the guise of 
psychiatric disorders. 
 
Signs and Symptoms 
The signs and symptoms of lovesickness (also 
known as lover’s malady, mal de ojo, mal amor, 
amor heroes, inordinate love, or philocaptio) are 
often consistent regardless of time or culture. 
Lovesickness involves fixation on a person: the 
afflicted individual has obsessive thoughts about 
the object of their fixation.3 Insomnia, loss of 
appetite, hollowing of the eyes, anorexia, pallor, 
rapid pulse, and jaundice are consistently 
described.3,4,5,6 
Other symptoms are more specific to the 
time or place in which they were described. For 
example, the Islamic physician Rhazes (850-923 
AD) described a unique syndrome. In the early 
stages, the patient’s eyesight would become 
weak, the tongue would dry up and pustules 
would grow on it.5 A dusty substance, and marks 
like dog bites would appear on the patient’s back, 
calves, and face. If untreated, the person would 
eventually wander through cemeteries at night 
and howl like a wolf.  
One of the manifestations in medieval Spain 
was the “Frog/Diana syndrome,” caused by 
excessive desire of a person, and led to a person 
viewing something unpleasant and repulsive as 
beautiful and desirable.6 
Some medieval writings connect 
lovesickness and bipolar disease.  Depressive 
symptoms of weeping, insomnia, and loss of 
appetite were accompanied by manic symptoms 
in many.4 Rapid mood swings between 
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inappropriate laughter and depression were 
common.6 Ferrand described a situation where 
patients “have a look about them that suggests 
they see something pleasing, or else are hearing 
it, or longing for it…one moment they laugh, a 
moment later they turn sad and weep, now they 
jest, and a short time later are sorrowful, pensive, 
and solitary.”5 Toohey maintained that the 
depressive type was more of a cliché with the 
manic form more common, and patients often 
becoming violent.7 Similarly, Hippocrates 
described violent symptoms with melancholy 
madness, which may have been related to 
lovesickness.5 He described how some women 
are prone to this condition, which causes them to 
become insane, homicidal, and produces a desire 
to asphyxiate themselves. This is akin to the 
violent impulses that may occur in people during 
a psychotic manic episode. 
The Nahua of Mexico describe unique 
findings, including grabbing posts as substitutes 
for the desired person, the formation of blisters 
on the face, and a red eye with a yellowish 
mucus discharge.8 In extreme cases, the disease 
interrupted the circulation, causing blood to 
freeze in the heart. Lovesickness could also 
result in the disappearance of the genitals. 
Although the major symptoms of lovesickness 
are fairly consistent, the disease also had a lot of 
variability in its atypical presentations. 
 
Etiology and Pathogenesis 
Physicians of Hippocrates’ era believed that 
maintaining a balance of the four humors (blood, 
phlegm, choler, and melancholy) was essential to 
maintaining health.5,10 Disturbances of the 
melancholy humor led to psychological 
problems and somatic side effects, resulting in 
symptoms of lovesickness. The early Christian 
writers did not clearly distinguish between 
illnesses of the body and illnesses of the spirit,5 
believing that lovesickness was a disease of the 
senses that could also corrupt the soul. 
Medieval medical writings had a more 
clearly defined pathogenesis for the disease. The 
first stage occurs when the object of desire 
causes overheating of the “vital spirit.”4 The vital 
spirit inflames the middle ventricle of the brain, 
which was where the faculty of estimation (or 
the virtus aestimativa) is located, resulting in 
dryness in the faculty of imagination (virtus 
imaginative). Consequently, the image of the 
beloved becomes imprinted in the patient’s 
memory, causing obsession, decreased ability to 
reason, and abnormal behaviour.6 
Hereditary causes were considered possible 
during the Renaissance. The child of a parent 
who suffered from lovesickness was at greater 
risk unless this predisposition was countered by 
other factors including a good education, 
excellent discipline, or an orderly lifestyle.5 It 
was also believed that most people who 
developed the illness had a susceptibility to it: 
young children, the very old, eunuchs, and the 
impotent were considered essentially immune.5 
Lovesickness befell men and women equally 
in the ancient Nahua. The disease did not 
necessarily occur in the person who was 
experiencing the desire: it had to do with which 
person was the weakest.8 The stronger person 
had more heat power in their eyes, and could 
cause harm to others by looking directly at them. 
For example, a woman might see a man she liked 
and make him ill by looking directly into his 
eyes. For this reason, lovesickness was 
considered a form of mal ojo, or evil eye. 
 
Magical and Demonic Causes 
In the Middle Ages, use of magic in the matters 
of love was fairly popular. For example, some 
believed that hair from a hyena’s muzzle was a 
love charm when placed on a woman’s lips.11 
Similarly, it was thought that if a woman kept 
the Eucharistic host in her mouth while kissing 
her beloved, she could make him fall in love 
with her permanently. In the 13th and 14th 
centuries, academics began writing about “visual 
species;” objects that mediated between the 
physical world and the mind. Visual species 
could cause lovesickness by imprinting images 
into the imagination from a distance. It followed 
that incantations and magic could also generate 
species in the mind and cause changes that 
affected the body. Consequently, magic was a 
possible cause of lovesickness. Temptation by 
demons was could also cause the disease since it 
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was thought that the Devil had a partiality for 
inflicting sexually-related diseases on people.12 
By the 15th century, lovesickness became 
associated with the occult and the disease was 
listed as a widespread form of witchcraft in 
manuals for witch hunters.11 During the 
Renaissance, potions and philters were also 
considered to be possible causes of the disease.11 
 
Lovesickness in Women versus Men 
The sex of the patient was also a risk factor. In 
medieval times, lovesickness tended to be a male 
disease, especially since medical writings came 
from monasteries where the illness was 
negatively regarded.13 Eventually, lovesickness 
became regarded as a form of courtly love, 
where a man worships and idolizes a woman as 
perfect even while she scornfully rejects him. 
This form of love was considered ennobling and 
chaste. In the Renaissance the illness was 
interpreted as a shameful and debasing sexual, 
and not a mental disease, and so it became 
attributed to women.13  According to medical 
treatises, women enjoyed intercourse more than 
men, were more impulsive, and were not rational 
enough to resist their desires.5  Medical writers 
believed lovesickness could be caused by a 
distended clitoris, or by satyriasis (pain caused 
by a voracious desire for sexual intercourse).5 An 
illness known as uterine fury may also have been 
linked to lovesickness: in this disease, the 
woman has an inordinate interest in sex and 
experiences painless burning sensations in her 
genitals.5 Uterine fury was usually a disease of 
overly sensuous, greedy, and gluttonous women.  
 
Treatment 
Treatment options varied depending on the 
cultural values and medical beliefs of the time. 
Greek and Roman physicians often prescribed 
sexual intercourse for the illness.  Galen 
maintained that men should make love for the 
sake of staying healthy, even if they derived no 
pleasure from it.3 Similarly, the Iranian physician 
Avicenna recommended sexual intercourse, but 
only if law and religion allowed it.5 If this was 
not possible, physicians would attempt to distract 
their patients with baths, sleep, and exercise. 
They also hired old women to belittle the object 
of the patient’s affection. 
During the medieval period, many people 
perceived sexual activity in general as capable of 
corrupting the soul. Consequently, most 
therapies during this time revolved around 
distraction. Herbal remedies helped rid the body 
of destructive humors.6 Distracting the patient 
could be done in a number of ways, including 
sending the patient on a trip or inflicting pain.6 
Some believed that scaring the patient into good 
behaviour was the most effective cure: patients 
were told that sexual activity could lead to 
blindness, gout, accelerated aging, kidney failure, 
pulmonary disease, genital sores, baldness, 
infection, the conception of monstrous children, 
and even eternal damnation.6 Perhaps the most 
dramatic of treatments in this time period 
involved attempting to change the patient’s 
perception of his beloved from adoration to 
disgust. This was done in many creative ways, 
such as forcing the patient to stare at a cloth 
soaked in the woman’s urine or menstrual blood, 
or burning her stool in front of the patient.6  
Cures during the Renaissance tended to be 
more invasive, with blood letting being a popular 
choice.5 If a distended clitoris was the origin of 
the problem, then cutting it could bring about 
recovery.5 Pharmacological treatments included 
opium to treat the associated insomnia, and 
hemlock to reduce sexual desire. 
Because the Nahua of Mexico believed that 
the root of the illness was excessive heat from a 
person’s eye, most treatments involved the use of 
cold water.8 Some examples include drinking 
water from abandoned wells, drinking the saliva 
or urine from the desired person, or drinking 
water that had been boiled in the person’s 
underwear. Having the patient gaze directly into 
the eyes of the person to eventually satisfy their 
desire was another method. 
 
Lovesickness in Modern Medicine 
Lovesickness has been a common medical entity 
for hundreds of years, and yet it has no mention 
in modern medical texts. It is possible that the 
disease exists today under a different title.  Many 
symptoms of lovesickness are similar to 
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symptoms of modern psychiatric disorders, 
including obsession, rapid mood swings, loss of 
appetite, insomnia, and compulsions. In a recent 
study, Marazziti et al looked at serotonin levels 
in people who had recently fallen in love and 
patients with obsessive-compulsive disorder. 
They found that both groups had lower than 
normal levels of serotonin, suggesting shared 
psychological elements.14 Many of the symptoms 
of lovesickness have to do with alternating 
between depression and mania, so perhaps 
lovesickness in modern medicine is 
encompassed in bipolar disorder. One study used 
functional MRI scanning to show that very 
specific areas of the brain were activated in 
patients who were in love,15 and perhaps a 
pathological stimulus in these areas of the brain 
could lead to lovesickness. Tallis makes the 
point that some of the therapy used for 
lovesickness over a thousand years ago is similar 
to modern cognitive behavioural therapy, such as 
Avicenna’s encouragement of distracting the 
patient from his fixation using physical exercise, 
trips, and so on.16 Finally, lovesickness may be a 
somatoform disorder, where physical symptoms 
exist that are not part of another medical 
condition or mental disorder. These patients may 
have psychological conflicts that are translated 
into somatic problems. 
 
Conclusion 
Lovesickness was a common disease that 
persisted throughout centuries and may still 
endure today. The supposed etiological factors 
and treatments changed as cultural beliefs 
evolved and as the understanding of science 
developed. Many of the symptoms and signs 
remained constant regardless of what point in 
time or in what culture you examine them; this 
adds to the authenticity of the disease. Many 
aspects of the disease can be explained by 
elements of modern psychiatric disorders, which 
makes it likely that there are still many patients 
suffering from lovesickness even today. 
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Paracelsus the Innovator: A Challenge to Galenism from 
On the Miner’s Sickeness and Other Miners’ Diseases 
 
Emily R. Kelly 
 
Phillipus Aurelius Theophrastus Bombastus Von Hohenheim, called Paracelsus, occupies a curious place in the history 
of medical innovators: on the one hand celebrated for his emphasis on empirical observation, and on the other reviled 
as a hot-headed and arrogant mystic. His works show great devotion to the Light of Nature, a property of the world 
which caused it to reveal its God-given healing secrets to the discerning and knowledgeable physician. This emphasis 
on experience was radical in the days when scholastic study of the works of Hippocrates and Galen was the basis of 
medical practice. Paracelsus rejected the authority of Galen but lacked the tools of the scientific method to replace 
Galen’s teachings with empirical knowledge. Instead, Paracelsus devised a highly creative and interwoven mystical 
system of macrocosm and microcosm - God had devised the stars, spirits and the natural world in a pattern which was 
repeated in man’s sidereal, spiritual and physical bodies. The wise physician could study the natural world, waiting to 
reveal its healing clues.  This paper will evaluate Paracelsus the innovator based on one of his most influential and 
important writings, Von der Bergsucht und Anderen Bergkrankheiten, (On the Miners’ Sickness and Other Miners’ 
Diseases), written in 1534.  An in-depth look at Paracelsus’ theories of pathogenesis, cure, and prevention of miner’s 
diseases will show that Paracelsus was a positive innovator in the history of medicine in his role as a reformer of 
medical therapies, as proponent of preventive medicine, and as advocate of learning through experience. 
 
 
Introduction 
While some are remembered for important 
contributions to medicine, and others as icons of 
their time, Paracelsus is most remembered for a 
lively and infamous temper.  Phillipus Aurelius 
Theophrastus Von Hohenheim, called Paracelsus, 
was probably not a pleasant man. Paracelsus had 
a prolific output, and his follower Huser of Basel 
collected and edited these works (1589-91).  
Huser had difficulty separating Paracelsus’ life 
and works from colourful legend.1,2 Paracelsus 
was deeply concerned with healing the outcast 
and sick, and with reforming a stagnant and 
bastardized Galenic medicine, but was grandiose, 
self-assured, with poor political judgement and a 
wicked temper.2,3 
Sixteenth century medicine was the product 
of medieval scholasticism filtered through 
Eastern commentators.2 Galen, interpreted by 
Avicenna, was the medical authority of the day, 
while the Church ruled over diseases of 
supernatural origin.4  Medical knowledge was 
complete with Hippocrates and Galen, and 
although these early physicians had 
experimented, this was no longer done. Medieval 
observations were limited to those which 
reinforced pre-existing theories. Dissections 
were rare, crude, and viewed as immoral. 
Scholastic medical ideas were based on Galen’s 
theory of four humours: phlegm, blood, yellow 
bile and black bile representing the elemental 
influences of cold, dryness, warmth and moisture. 
Disease resulted from an imbalance in these 
humours, and was treated with a “cure by 
opposition” approach using complicated 
concoctions of herbs and unsavoury animal 
products, or bleeding and purging.1,2  Insanity 
was viewed as a supernatural affliction stemming 
from demonic activity.4,5 A rebel from the 
beginning, Paracelsus burst onto the scene with 
his own elemental system, the idea of like curing 
like6,7, an increased emphasis on simple herb and 
mineral remedies 6,7, and natural origins of 
insanity.5 
Theophrastus was born in Einsiedeln, 
Switzerland in 1493. His father, William of 
Hohenheim, was a local physician, from whom 
he presumably learned the basics of medicine. 
His name Paracelsus, a Latin creation perhaps 
meaning “equal of Celsus,” a classical physician, 
was taken on during his university days.2 His 
early education is mysterious: he may have 
obtained a medical degree at the University of 
Ferrara. He spent some years practicing in the 
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Fuggers mines at Hutenberg and Schwaz, 
possibly penning an early version of  Von der 
Bergsucht und Anderen Bergkrankheiten, (On 
the Miners’ Sickness and Other Miners’ 
Diseases). He worked as an army surgeon before 
arriving at Straussburg in 1526. The great 
turning point in his career came in 1527 when he 
was appointed as city-physician to Basel. He 
lectured at the university in vernacular German, 
an innovative insult to the scholastic sensibilities 
of the time, and gave lectures criticizing 
Galenism, demanding reform in medicine.  He 
publicly burned a copy of Avicenna’s Codex at a 
student gathering. After two years in Basel, he 
had so many enemies that he was forced to flee, 
spending years wandering and studying in 
various degrees of poverty. He wrote prolifically 
on syphilis, plague, and surgery, completing his 
fundamental books, Paragranium and Opus 
Paramirium, in 1531. He returned to the mines at 
Hall and Schwaz in 1532-1533, refining his 
knowledge of mining and chemistry. He died in 
relative comfort in Salzburg in 1541.2,6,7 
Paracelsus took ideas from ancient writers, 
neo-Platonists and alchemists, synthesizing them 
to create his own new metaphysics and 
cosmologies.1 He believed that when God 
created the universe’s astral, spiritual and 
physical realms, he echoed the human being’s 
astral, spiritual and physical bodies.1 Nature was 
a macrocosm, ordered into different groups and 
stages of being, reflecting a human’s different 
and ordered components.  The components were 
Paracelsus’ new elements: salt, the principle of 
stability; mercury, the principle of volatility; and 
sulphur, the principle of combustibility.  The 
stomach was the Archeus, a sort of alchemist that 
sorted out and arranged the salt, mercury and 
sulphur in the patient’s food and air.1,6,7 
A physician was gifted by God with the 
ability to read the Light of Nature1, a property 
which revealed secret patterns of Nature’s 
macrocosm which could be harnessed to heal 
disease. This is probably Paracelsus’ greatest 
scientific achievement: knowledge is to be 
sought through the observation of Nature. 
However, Paracelsus was a medieval man, not an 
empiricist. Without the tools of hypothesis and 
experiment, he was forced to substitute his own 
metaphysical theories for those that he had 
rejected. This is evident in his four pillars of the 
practice of medicine: Philosophy, the study of 
the Light of Nature, Astronomy, Alchemy, the 
earliest branch of chemistry, and Virtue, 
theological understanding and right practice.1  
 
 The Von der Bergsucht 
The Von der Bergsucht und Anderen 
Bergkrankheiten may have written as early as 
152510, though others favour 1534. It was 
published posthumously by Samuel Architectus 
in 1567, and was not widely read until a century 
later.10 It is based on years of up-close 
observation of the workers made by Paracelsus 
in local mines, who favoured experience over 
theoretical talk. As Paracelsus puts it: 
 
It is no longer meet to speak with the 
learned men and the philosophers, but 
with experienced men; for it is the 
manner and the innate custom of any 
experienced man not to confront another 
experienced man with talk…Experience 
is so constituted, that an understanding 
of its works makes itself known to 
everyone without much gab.11 
 
The Von der Bergsucht is divided into three 
books, each subdivided into four tractates. The 
first book deals with diseases of miners, the 
second with diseases of smelters and metal 
workers, and the third with disease caused by 
mercury, which Paracelsus considered unique 
enough to be treated separately. The four 
tractates introduce the disease and elements in 
question, and discuss pathogenesis, signs of the 
disease, and finally, the disease’s cure.  
 
The First Book 
Paracelsus, always humble, begins the first book, 
with an observation that no previous scholar has 
attempted such a classification.10 He then 
explains the basics of how sicknesses of the 
lungs are generated in the second tractate. Air is 
the food of the lungs, and is digested there.10 Air 
can be polluted through contact with the stars, 
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whose alchemical furnaces cause air to become 
separated into its separate elements which are 
harmful to human health.10 These elements are 
mercury, which causes disease by coagulating 
from smoke, sulphur, which can be roasted by 
fire onto the lungs, and salt, which precipitates 
into the lungs. Altogether, these imbalanced 
elements cannot be properly digested by the 
lungs and form tartarus10, a sort of mucus that 
induces disease. Paracelsus draws a distinction 
between the lung diseases that all people suffer, 
and those unique to miners. Those suffered by 
above-ground dwellers are caused by the 
poisoning of surface air by the celestial stars. 
Those suffered by miners, however, result from 
the digestion of subterranean air that is poisoned 
by subterranean stars. By this Paracelsus meant 
the minerals themselves, forming constellations 
under the earth in the same manner as proper 
stars do in the sky.10 Thus, astronomy, the 
second pillar of Paracelsus’ medicine, informs 
philosophy, his first pillar of medicine. 
The third tractate concerns the recognition of 
miners’ diseases. He stated that physicians are 
ordained by God to protect men from the 
dangerous but necessary work of mining.10 
Paracelsus understands himself as a divinely 
ordained servant. He recognized the importance 
of shortness of breath due to excessive cold, and 
acidity and hoarseness due to excessive 
sulphur.10 Paracelsus expounds the importance of 
observing disease to be able to accurately 
identify these signs.10 He then poses two ideas of 
enduring worth to the progress of medicine: a 
recognition of acute versus chronic forms of 
poisoning, which he attributes to ingestion of the 
body instead of the spirit of a mineral. Eating 
arsenic produces instant death, but a vapour 
coming off the mineral produces a slower disease 
with the symptoms similar to pulmonary fibrosis, 
neoplasia, or emphysema.10 The other idea is his 
formulation of what would become known as the 
homeopathic principle. As Paracelsus puts it: 
 
Now our physic (cure) is in mercury, 
sulphur and salt, and our poison is 
also in these three things, for they both 
exist together10…For instance: 
whatever causes jaundice, also cures 
jaundice. It is thus: good and evil are 
in the same thing, the jaundice arises 
from the evil, and when the good is 
separated from the evil, the arcanum 
(cure) against jaundice is there.10 
 
The final tractate concerns itself with cures 
for miners’ diseases. The first cures are 
preventative, beings recipes for prophylaxis 
against ore vapours.10 A diet rich in salt and 
deficient in spices is prescribed for the same 
reason.10 Once the disease has taken hold, 
Paracelsus divides his cures into natural cures 
and arcana cures. Natural cures include sweating 
and the use of cyclamen roots.10 Arcana cures 
take advantage of the astrological and elemental 
correspondences that caused the disease in order 
to cure the disease. The poisons are divided into 
arsenic, antimony and alkali sub-types, and each 
has its own mineral cure designed to produce 
sweating within the effected organs to wash off 
the polluting tartarus.10 
 
Discussion 
In treatment, Paracelsus rejects the Galenic 
model by rejecting the theory of bodily humours 
and by rejecting cure by opposition. Paracelsus’ 
pathogeneses are not internal humoural 
imbalances, but external poisons that have 
accumulated inside the body. This is much closer 
to our understanding of the modern pathogen. Of 
course, Paracelsus is reluctant to leave the older 
imbalance model behind entirely, as his 
dissertations imbalances of air, fire, water, and 
earth indicate. Paracelsus is also the first to 
suggest that the cause of disease may also be its 
cure - the homeopathic principle and the idea 
that one substance may contain both good and 
evil within it, which has played such an 
important part in the history of medicine. 
Paracelsus’ pharmacy is also of interest to 
history. He is an early, if certainly not the first, 
proponent of a return to simple herbal remedies. 
More importantly, he is the first to introduce 
mineral remedies effectively. These would 
become increasingly popular, entering England’s 
materia medica in the next century. 
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Paracelsus was also a strong advocate of 
what we might today call “lifestyle 
management”. He clearly understood that certain 
occupations carry their own specific risks, hence 
an entire book devoted to the diseases of miners 
and refiners. Of particular interest is his 
emphasis on the prevention of disease, 
something whose importance is sometimes 
forgotten in today’s medicine. Lifestyle control 
plays some part in this: Paracelsus recommends 
specific diets and sweatbaths for miners. 
Paracelsus shows a rudimentary understanding 
of primary and secondary prevention of disease 
by discussing those therapies that keep the 
patient from becoming weak and susceptible to 
mine vapours in the first place, and those that 
drive out infections before they take hold.  
Finally, there is Paracelsus’ emphasis on 
experience, and where his sermons reach their 
most bombastic heights. He was nothing less 
than fanatically passionate about rejecting book 
learning and going out to the patients and local 
healers to understand disease. In the Von der 
Bergsucht he says: 
 
This experience should defend itself and 
the results which should move every 
unbeliever to believe in physic should be 
examined. For the results are so clear, 
that they are not in need of any 
disputation… However, each one should 
retain his own experience; for who can 
or wants to fathom the end of 
medicine?10 
 
Paracelsus anticipates the secular and empirical 
trends that would soon sweep medicine as the 
Renaissance took hold. However, he cannot 
make the leap away from the medieval 
scholasticism in which he was raised; he does 
not have any guides or tools with which to do so. 
He cannot be properly understood as a de-
mystifier of medical knowledge.11 His own 
mystical systems are complex and frequently 
self-incompatible. For all his arrogant confidence 
in his own mystical ideas however, Paracelsus 
remained a stubborn proponent of experienced 
facts, and as the above quotation shows, he 
remained open to the idea that his own 
understanding might someday be surpassed by 
others’ experiences. 
 
Conclusion 
So was Paracelsus a positive innovator?  It 
depends on the measure.  The Von der Bergsucht 
is the first handbook of occupational disease, and 
one of the first therapeutic texts to endorse a 
homeopathic ideal.  Paracelsus’ descriptions of 
the physiognomy of mercury poisoning are quite 
accurate.  On a practical level, Paracelsus’ Von 
der Bergsucht is a mixed success. Some of his 
herbal and mineral cures may have worked, and 
some undoubtedly did not. His observation that a 
substance might be helpful or harmful depending 
on context is a valuable one. However, to focus 
entirely on the practical therapeutic value of 
Paracelsus’ cures is to miss out on his greatest 
contribution to the history of medicine.  This is a 
catalogue of diseases not heretofore recognized 
by medical authorities- the idea that the  
ancients might have missed a few things is 
radical and valuable. Furthermore, Paracelsus’ 
physiognomic data on the miners’ diseases more 
than any others (save perhaps his studies on 
syphilis) were based on real, objective 
observation.  Openness to new ideas and close 
observation and relationship with the patient, 
was an ideal of Hippocrates, and is something 
still highly prized in medicine today. It is also an 
innovation of which Paracelsus was one of the 
earliest proponents. For this reason, Von der 
Bergsucht und Anderen Bergkrankheiten, 
demonstrates the Paracelsus was indeed a 
positive innovator in the history of medicine. 
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Race, Contagion, and Discrimination: Endemic Leprosy 
in 19th Century New Brunswick 
 
Joanne Hamilton, Meds 2005 
 
Leprosy has long had a reputation for being one of the most feared of all human diseases. In Canada today the disease 
is a rarity and the few existing cases are considered little threat to public health; however, this was not always the case. 
In the mid- to- late nineteenth century an endemic leprosy was found to exist among the Acadian Population of New 
Brunswick, a discovery which caused much concern within the nation’s medical and legislative communities of the 
time. In this outbreak, which occurred prior to the discovery of the leprosy bacillus, the physicians involved with the 
situation were deeply divided as to the nature of the disease: was it hereditary or was it contagious? Their decision 
would prove fateful for the victims of the disease in this area. Furthermore, issues of race and class would become 
central in the discussion surrounding the appearance of leprosy in this population. 
 
 
Introduction 
In Canada today leprosy is a rare disease that is 
diagnosed exclusively those who acquired the 
infection outside of Canada’s borders.1 However, 
this was not always the case. In the nineteenth 
century endemic leprosy was found to exist in 
Maritime Canada, particularly among the 
Acadians of northeast New Brunswick. The 
appearance of leprosy on Canadian soil posed 
several challenges for the medical and legislative 
community of eastern Canada, and brought 
Canadian physicians into the debate regarding 
the nature of this particularly loathsome disease.  
Consequently, the medical community of eastern 
Canada made some significant steps toward 
understanding the transmission and pathogenesis 
of this disease. However, an examination of the 
era of endemic leprosy in New Brunswick also 
demonstrates the extent to which concepts of 
race and class influenced nineteenth century 
medical thinking.  
It is impossible to know exactly when the 
first cases of leprosy appeared in the Acadian 
population of New Brunswick or how it was 
introduced to this population. The first generally 
accepted case of leprosy in the Acadian 
population occurred in a woman named Ursule 
Benoit who began exhibiting symptoms of the 
disease around 1815. Other than her illness, 
which claimed her life in 1828, there was 
nothing particularly unusual about Mrs. Benoit.  
There were no reports of leprosy in her parents’ 
or her husband’s families prior her illness; 
however, after she became ill the disease 
appeared in two of her sisters and in her 
husband.2  By the 1840’s several small Acadian 
towns surrounding Chaleur Bay, New Brunswick, 
all had cases of leprosy among their townspeople. 
The cases were clustered within several families, 
and in most cases the afflicted families were in 
some way related to Ursule Benoit and her 
family.3 In 1844, the parish priest of Tracadie, 
one of the affected towns, began to suspect that 
the disease amongst his parishioners was leprosy, 
and notified the local health authorities and 
urged them to investigate the illness.4 In 1844 
the New Brunswick Legislature sent an 
investigative Commission to the region to 
confirm or disprove the existence of the leprosy. 
This Commission reported that they found 
eighteen confirmed cases of leprosy and several 
other highly suspicious cases.  The investigators 
unanimously agreed that the illness was 
contagious and advocated for the creation of a 
lazaretto to separate the sick from the healthy.3 
In response to the report, in April 1844 the New 
Brunswick Legislature passed legislation which 
authorized the construction of a lazaretto, and 
gave the Board of Health the authority to 
forcibly remove leprous individuals from their 
homes and transport them to the facility. 
From 1844 to 1849, leprous individuals from 
the Acadian communities around Chaleur Bay 
were sent to a lazaretto which was built on 
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Sheldrake Island, a small island in the mouth of 
the Miramichi River.3 Those confined there were 
expected to be self-sufficient for all of their basic 
needs such as cooking and cleaning.  With the 
poor living conditions, and deprived from the 
support of friends and family, most leprosy 
victims deteriorated within months of their 
arrival on the island.  During the Sheldrake 
Island years, the Acadian sufferers of leprosy 
were given no formal medical treatment.  In 
1849, thanks in large due to the lobbying efforts 
of the local Catholic Church, the Board of Health 
agreed to close the Sheldrake Island lazaretto and 
to transfer the surviving individuals to a lazaretto 
which would be built in Tracadie.  In its five year 
history thirty-seven people had lived on 
Sheldrake Island; five vanished after escaping 
the island, fifteen died, and another seventeen 
were transferred to the new facility in Tracadie.3 
The Tracadie Lazaretto, while certainly not 
without flaws, would over the next century prove 
to be a vast improvement over the Sheldrake 
Island lazaretto. However, in its early years there 
was little improvement in quality of life for those 
confined there. In 1850’s the population of the 
lazaretto grew and the mortality rate remained 
high. The situation was exacerbated by the lack 
of formal medical care inside the facility. In 
1861, again as a result of the efforts of local 
parish priest, a permanent physician was finally 
found for the lazaretto. From 1861 to 1864, Dr. 
James Nicholson served as resident physician at 
Tracadie before dying at an early age of 
tuberculosis. In 1865 Dr. Alfred Corbett Smith, a 
twenty-five year old graduate of Harvard 
Medical School, was hired to replace Dr. 
Nicholson; he would remain at the lazaretto until 
this death in 1909.  In 1868, ‘Les Hospitalieres 
de Saint-Joseph’ a Montreal-based order of 
cloistered nuns agreed to establish a religious 
community and nursing hospital at Tracadie.3 
The presence of the nursing sisters, who would 
stay with the various incarnations of the lazaretto 
until it finally closed in 1965, was pivotal in 
transforming the quality of patient care within 
this facility.2 With the arrival of first six 
‘Hospitalieres’ in 1868 the facility for the first 
time functioned as a hospital rather than a 
medically enforced detention centre. 
At the time of the leprosy outbreak in the 
Acadian population of New Brunswick the 
origins of the disease was a hotly debated topic 
in the medical circles of Europe and North 
America. With the discovery of leprosy in New 
Brunswick this debate became a local concern. 
In their 1844 report to the government of New 
Brunswick the medical commission led by Dr. 
Alexander Key stated that they unanimously 
agreed that leprosy was a contagious disease.3 
This conviction paved the way for the legislation 
that would create the Sheldrake Island lazaretto. 
In spite of this, one of the other authors of the 
report, Dr. A.H. Skene, seemed somewhat less 
certain of the contagious nature of the illness.  In 
a report which he submitted to the Montreal 
Medical Gazette just a few months later, he 
states that those who are vulnerable to the 
disease are so by virtue of “hereditary taint, and 
by contagion” and he goes on to demonstrate his 
conviction by providing genealogical tables 
linking the disease to the relatives of Ursule 
Benoit.5  In 1847, New Brunswick legislature 
appointed a committee of doctors to investigate 
the heredity-versus-contagion debate.  This 
committee led by Drs. Robert Bayard and 
William Wilson, conducted a thorough 
investigation of all of the known cases concluded 
that the illness was non-contagious and 
transmitted by hereditary means.6 To support 
their argument the authors pointed out the 
genealogy of the illness, and they also recounted 
the numerous reports of healthy spouses who had 
slept in the same bed as their leprous husband or 
wife for years without contracting the disease.6 
Nevertheless, they did qualify their conviction 
by stating that a small number, perhaps one 
percent of the population, with no known 
hereditary connection to the disease may be able 
to contact the illness through casual contact with 
a leprosy sufferer.6  The significance of this 
report, aside from the surprisingly accurate 
description of the immunological basis of 
leprosy, was that in their conclusions they 
foreshadowed the modern approach to leprosy 
management by almost a century. They 
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recommended that the lazaretto be abolished as, 
“It coerces the leper, and removes him from his 
family, without any regard to his feelings”.6 In 
the place of a lazaretto, they suggested that the 
leper should be given a small monetary 
appropriation and be allowed to be cared for at 
home. None of the recommendations of this 
seminal, albeit theoretically flawed, report were 
followed by the New Brunswick government. 
The legislature ultimately decided that the 
medical evidence was inconclusive, and 
therefore, they could not risk the health of the 
general public by closing the lazaretto.3 
As the heredity versus contagion debate 
continued within the medical community there 
was one aspect of the transmission of the illness 
that was quite generally agreed upon—that 
certain peoples, or races to use the term of the 
time, were more vulnerable to leprosy, either by 
virtue of some inherited factor or by means of 
the their lifestyle. Although it was acknowledged 
that leprosy had once plagued the European 
population it was felt that most European ‘races’ 
were no longer vulnerable to the leprosy by 
virtue of their civilized habits.7  Foreign places 
and their ‘inferior’ peoples, on the other hand 
were felt to be a reservoir of leprosy and other 
diseases that afflict those uncivilized in mind, 
body and soul.7  Race and class were frequently 
used by English speaking medical and 
governmental authorities and to a lesser degree 
by French Canadian religious authorities to 
explain the existence of a foreign or even 
‘tropical’ disease in the Acadian population. The 
Acadian people were considered to be racially 
different from the English-speaking of New 
Brunswick and even from the French-speaking 
population of Quebec. One Quebec-born priest 
wrote that his parishioners were “Acadian fools 
who live in disorder…being a racial mixture of 
Indian, Negro, French, Spanish and even Italian 
with all of the natural and intellectual defects of 
their origins.”3 
Dr. A.C. Smith, the longstanding physician 
of Tracadie Lazaretto, would become known as 
Canada’s foremost expert on the subject of 
leprosy.  Although he was known to be a man of 
considerable good-will, he was steadfast in his 
convictions that leprosy, while contagious to a 
degree, preferentially infected inferior classes 
and races, such as the Acadians.3 In 1891, 
reflecting on the New Brunswick experience, he 
wrote: “Leprosy never appears in the better class 
of our French population”.3 In the 1890’s, after 
investigating several cases of leprosy among 
Icelandic immigrants in Western Canada, he 
reassured authorities that leprosy would not be 
able to make headway among hard-working 
people such as these.3  Here the condemnation of 
the Acadians is implicitly obvious.  There are 
several reputable reports of the existence of 
endemic leprosy on Cape Breton Island in the 
late nineteenth century.  In 1889, Smith traveled 
to the island where he confirmed the existence of 
leprosy and brought one man to Tracadie; 
however, he did not propose the creation of a 
lazaretto in Cape Breton, nor did he formally 
publish his findings.3 Later, in 1904, Smith 
admitted that he had not disclosed his finding at 
the request of the Nova Scotia government after 
it was discovered that some of the descendants of 
the Cape Breton leprosy victims had achieved 
prominence within business and government.3 In 
addition to assuring a low profile to the Cape 
Breton cases, Dr. Smith also never made any 
racial or class generalizations regarding the 
presence of leprosy among these English 
speaking Scottish immigrants. To Dr. Smith the 
appearance of leprosy in those of superior racial 
stock was to be regarded as an unfortunate act of 
nature rather than as a condemnation of the 
intrinsic worth of the population. 
 
Conclusion 
The era of endemic leprosy in New Brunswick 
was significant to Canadian medical history on 
several levels. In terms of the elucidation of the 
nature of leprosy Dr. A.H. Skene proposed a 
theory that incorporated both features that we 
now understand to be prerequisites for the 
development of leprosy, an infectious particle 
and a susceptible host, in his paper published a 
full thirty years before Hansen first observed the 
leprosy bacillus.  Drs. W. Wilson and R. Bayard 
advocated a humane treatment strategy for the 
treatment of leprosy sufferers which included the 
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abolishment of leprosaria; a strategy which 
would not be utilized for another century after 
their proposal. Finally, the history of leprosy 
among the Acadians of New Brunswick is 
significant as it illustrates the racialized thinking 
which was so accepted in the Western medical 
paradigm of the nineteenth century, with 
‘inferior’ peoples acquiring ‘inferior’ diseases. 
While acting well within the acceptable 
standards of their time, the medical community 
openly contributed to the discrimination of the 
Acadians suffering from leprosy, who were felt 
to have acquired leprosy by virtue of their racial 
inferiority. Looking at this case with modern 
eyes, the discriminatory attitude of our Canadian 
physician forefathers is startling. However, this 
was not an isolated or particularly unusual case 
as throughout history and even up to our modern 
times there are many examples illustrating the 
role of the medical community in contributing to 
the oppression of an already vulnerable 
population. 
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The Birth of Caesarean Section 
 
Milli Gupta 
 
Caesarean section has been performed for many centuries and is considered to be one of the oldest operations in the 
history of medicine. References to cesarean section date back to ancient Hindu, Egyptian, Roman and Grecian folklore. 
For example, in Greek mythology, Apollo removed Asclepius, originator of religious medicine, from his dying 
mother's abdomen. Even the socio-economic structure of Jewish society accommodated such surgery. According to the 
Mishnah (140 B.C.), twins born by this method could not receive the right for primogeniture (obtain office or inherit 
property). Up until (and including) the 15th century, cases documented suggest that caesarean sections were performed 
only when the mother was dying or dead, in an attempt to save the unborn child or bury it separately (as was the 
religious custom). It was not meant to save the mother’s life. It was not until the 19th century that steps to improve the 
chances of survival of the mother were successfully made. This included the usage of anesthesia (allowed surgeons to 
take the time to operate with precision), surgical asepsis (carbolic acid introduced by Joseph Lister) better equipment 
(low obstetrical forceps reduced number of craniotomies performed and vaginal tears) and uterine sutures (used to 
treat the vaginal tears/fistulas resulting from traumatic childbirth). Following these changes, surgeons were able to 
focus on improving incisions made to the uterus. Advocated by British obstetrician Munro Kerr, between 1880 and 
1925, transverse incisions of the lower aspect of the uterus were found to reduce infections and uterine ruptures in 
pregnancy, increasing survival rates. This still remains as the most common method today. This is in contrast to the 
vertical incisions made classically.   
 
 
Origins of the name: Caesarean operation to 
caesarean section 
Caesarean section involves the delivery of the 
baby through an abdominal cut. Initially, 
“caesarean section” was referred to as “caesarean 
operation”. There is rampant debate over how 
the name “caesarean operation” came to be. 
Many theorize that the name came from Julius 
Caesar, who supposedly was born by this 
method.1 This, however, is unlikely because it is 
known that Caesar’s mother, Aurelia, was still 
alive when he invaded Britain, and it is unlikely 
that she could have survived such a surgery 
given the crude technique and amount of 
knowledge of the female anatomy and 
physiology known at that time.2   Also, it is 
believed that at the time of his existence, the 
surgery was mostly done on dead or dying 
women. A possibility as to why his name is 
associated is that during his reign he ordered the 
use of this procedure to procure the child from a 
dying mother.3   
Romans described caesarean birth until the 
last century B.C as “a caeso matris utero”, 
which means, “to cut an infant of its mother’s 
womb”.4  Another possible source is from the 
King of Rome, Numa Pompilius, who codified 
Roman Law in 715 B.C.5 Lex Regia, which later 
became known as Lex Caesarea (under the rule 
of the Caesars) made it mandatory to remove the 
child from its dying mother, even if there was no 
chance of its own survival. This was done in part 
to ensure separate burial for both mother and 
child.1  Also, the state was interested in raising 
its population size, and did not wish to loose any 
person unnecessarily.3   
Pliny (28-70 AD) in Book VII of ‘Natural 
History’ suggested that the term might come 
from the Latin verb ‘caedare’ which means ‘to 
cut’, implying delivery by cutting.2  Children 
born by this method were called ‘caesones’, 
which is another possible origin.4   
As for the change from caesarean operation to 
section, the first person to use the now common 
phrase was Jacques Guillimeau, who in 1598 
used ‘section’ in his book of midwifery.3 
 
Historical references  
The oldest authentic record of a living child is 
that of Gorgias, a famous orator of Sicily, 508 
B.C.5 References to caesarean section appear in 
ancient Egyptian, Hindu, Grecian and Roman 
folklore. Religious laws of Egypt in 3000 BC 
and of India in 1500 BC required abdominal 
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delivery of the child from its dead mother.6  
Greek and Roman mythology have tales of this 
surgery, and it is believed that Asclepius, the god 
of medicine, was removed by a cut from his 
dying mother’s (Coronis’) womb by Apollo 
(Figure 1).7  Bacchus, the god of wine, was also 
delivered this way, with Jupiter taking on the 
role of Apollo.1 
 
 
Figure 1: The extraction of Asclepius from the abdomen of his mother, Coronis, by his father, 
Apollo. Woodcut from the 1549 edition of Alessandro Beneditti's De Re Medica.3 
 
 
Ancient Chinese texts portray this as being done 
on living women.3  The story of King Sol’s wife, 
as recounted by Machnezie (1927) also 
suggested that she delivered a son by this method 
and survived.1 These references to women 
surviving is odd considering that many of the 
operations (done in the earlier part of its history) 
were carried out after the woman had died, or it 
was late in the pregnancy/labor and done when 
the health of the child was at risk.6  Perhaps this 
operation was successfully done on living 
subjects a lot earlier than is actually 
documented.2  
Caesarean section was an integral part of life 
and accommodations were made within religious, 
literary and societal texts. The Jewish book of 
Law, the Talmud (400AD) states that women do 
not need to observe the usual days of purification 
following this type of delivery. In Mishnah 
(Jewish text from 140 BC), twins born by this 
method had restrictions placed on their 
birthright: 
 
“… in the case of twins, neither the first 
child which shall be brought into the 
world by the cut in the abdomen, nor the 
second, can receive the right of 
primogeniture, either as regards the 
office of priest or succession to 
property”6 
 
Many great works of literature also refer to this 
operation. In Shakespeare’s ‘Macbeth’ for 
example, Macbeth is horrified to realize that 
Macduff was ‘from his mother’s womb untimely 
ripped’, therefore making him susceptible to 
death by Macduff’s hands (Macbeth could not be 
killed by “one of woman born”. Since Macduff 
was not ‘born’ in the sense of the word, he could 
kill Macbeth). Shakespeare also refers to 
caesarean sections in “Cymbeline”.5  
 
Religious influence 
Islam before 1500 was against the procedure and 
stated that any child born by this method was an 
offspring of the devil and therefore should be 
killed immediately.2  Now of course such is not 
the case.  
On the other hand, Christianity was positive 
towards this operation, being more concerned 
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with saving souls.1 Specifically, in the Middle 
Ages, the Roman Catholic Church encouraged 
the use of caesarean section to save the child and 
wanted to offer their souls a chance of salvation 
through baptism.1 The mother, on the other hand, 
was not a concern since the church prohibited 
usage of abortion, fetal dismemberment and 
craniotomy to save the mother.6  Other church 
councils did not decree anything positive for the 
mother either, but allowed for operating on a 
dead pregnant woman to save the child and allow 
baptism. In 1280, the church councils of Cologne 
made it mandatory to do this surgery. The 
Republic of Venice in 1608 actually laid down 
severe penalties for any doctor that failed to 
make an attempt to save a child in this way.6  
The need to baptize and therefore save the soul 
of the child was so prevalent and important, 
especially in France, that Peu in his “Practiques 
des Accouchements” states that: 
 
“… immediate opening of the abdomen 
as soon as the mother is assuredly dead 
and within the space of time taken to say 
one “Ave maria”, and as soon as the 
child is visible, pouring water over it 
and adding to the usual words of 
baptism, “si tu as vie” 8 
 
Similarly, in the United States, during the 
Franciscan mission period (1769-1833), it 
became the responsibility of the missionary 
priest to do the operation on dying women. They 
were actually taught pertinent maternal anatomy, 
the actual procedure and given instruments to aid 
in their task.4 
 
Earliest documented cases 
Even though references in ancient texts indicate 
this surgery was performed on live subjects, it 
was during the 1500’s that debates issued over 
the possibility of doing this on live women. 
Francois Roussett in 1582, was the first 
physician to endorse the operation on living 
women.5  In fact, he was the one to record Jacob 
Nufer’s story (below), and use it as proof that 
such surgery should be considered for live 
women.2  Except for the Trautmann case (below), 
even though the authors were not the ones that 
performed those surgeries, many were penned 
down and used for debating purposes.5  
Trautmann performed the first generally 
accepted and authenticated case in the presence 
of two midwives in Wittenberg, Germany in 
1610. The patient died 25 days after the 
procedure and the uterine wall was found to have 
already healed.2 
Jacob Nufer, in 1500, performed the first 
documented, successful operation on a living 
woman.1 He was not a doctor, but rather a Swiss 
sow-gelder. The story goes that the wife was 
pregnant for the first time, and was having severe 
labor pains. The skills of the 13 midwives 
involved were not leading to the subsequent 
delivery of the child. There did not seem to be 
much hope and so the husband wanted to 
perform caesarean section. She was willing, 
unfortunately, the municipal authorities were not 
willing to allow it. Only after the second request 
did the mayor consent, and then Jacob “…laid 
his wife on a table, incised the abdominal wall 
(with a razor), then the uterus and after which he 
quickly extracted the child. Several sutures were 
placed in the abdominal wall”.5  The wound 
healed and she lived to bear several children, 
even twins, vaginally, with no complications. 
This documentation suggests that this is the first 
successful vaginal delivery after a caesarean 
birth. The cesarean baby lived to be 77.3  
However, some historians do not accept the 
validity of this case because it was not reported 
until 1582, 82 years after the procedure was done. 
This delay suggests publication of this case was 
based on hearsay.1 Adding to that, had this been 
really done, it is expected that such news would 
have spread far and wide long before 82 years.2  
Some caesarean sections happened to occur 
under interesting and unique circumstances. For 
example, pregnant women were gored by the 
horns of animals such as bulls or cows, resulting 
in the birth of the child. Earliest case 
documented was in 1647 Holland, where the 
wife of a farmer in Zaandam was tossed by a bull 
in the ninth month of pregnancy and: 
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“… sustained an incision into the 
abdominal wall, which stretched from 
one ischium to the other, and through 
the pubic bone in the shape of a crescent. 
She had another wound through skin and 
peritoneum into the uterus, twelve finger 
breadths in length, from which the child 
issued.” 
 
The woman died 36 hours later, and the child 
escaped unscathed.9 
 
Refinements in the medical profession and 
caesarean sections 
Improvements in many aspects that helped to 
enhance the medical profession had an impact on 
the mortality and precision of caesarean sections. 
According to Boley5, three major reasons can be 
attributed to the death of these women: using the 
surgery only when the woman was close to dying, 
high rates of infection (lack of sanitation) and 
lack of uterine sutures. Many improvements with 
instruments (high vs. low forceps) and 
procedures employed (including other than 
caesarean sections) to remove the baby all 
further enhanced and strengthened arguments for 
using caesarean sections, and eventually lead to 
the current style of surgery. 
 
Anesthesia 
In 1846, at Massachusetts General Hospital, 
dentist William T.G. Morton used diethyl ether 
to desensitize the face to remove a tumor. 
However, there was opposition to its use in 
obstetrics because of biblical injunction that 
women should suffer while giving birth in 
compensation for Eve's sin.3 This argument was 
weakened when Queen Victoria, the head of the 
Church of England, had chloroform administered 
for the births of two of her children (Leopold in 
1853 and Beatrice in 1857). Subsequently, 
anesthesia in childbirth became accepted and 
practical in cases of cesarean section.3 
The use of anesthetics gave surgeons the time 
to operate with precision, clean the peritoneal 
cavity properly, record the details of their 
procedures, and learn from their experiences. 
Women were spared from feeling the cuts made, 
and were less susceptible to shock, which was 
becoming a leading cause of post-operative 
mortality and morbidity.3 
 
Procedures other than caesarean sections 
Using anesthesia shifted the argument for 
caesarean section versus relying on craniotomy. 
Craniotomy had been practiced for hundreds, 
perhaps even thousands, of years.3  It has been 
performed on both live and dead fetuses. This 
procedure involved the destruction of the fetal 
skull (by instruments such as the crotchet) and 
the extraction of the entire fetus vaginally. 
Figure 2 shows how this was done. Unlike 
caesarean section, it entailed lower risks to the 
mother.3 Another reason craniotomy was popular 
was because it was believed that the fetus felt no 
pain during this procedure.2 Closer to 1855 Sir 
James Y. Simpson showed otherwise and this 
seemed to have an effect on the number of such 
procedures done.2 
 
 
Figure 2: Craniotomy 
 
Another method to deliver the baby involved 
forceps (figure 3). Initially, high forceps were 
used, which reduced the number of deaths that 
would have occurred via craniotomy. However, 
it ended up creating severe tears (fistulas) in the  
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Figure 3: Forceps used in the 
1700s, French in origin 
 
vaginal wall and perineum of the mother, 
affecting maternal morbidity and mortality.3 The 
fetus could also be injured if the forceps used to 
pull the baby were pressed too tightly. Harold 
Williams (1879) of Boston researched the 
number of cases and mortality with these 
forceps, and he concluded they were more lethal 
than caesarean sections.2  An improvement with 
this method was the use of low forceps, which 
did not cause as many vaginal tears.3  These 
forceps are still used today. 
Neither craniotomy nor obstetrical forceps 
were of any help when severe pelvic distortion or 
contraction existed, and that is when caesarean 
sections were especially useful.3 One of the first 
men to suggest factors when caesarean sections 
should and should not be used was William 
Smellie (1752). He was a British physician who 
suggested that women should not be operated on 
when they were weak and in poor condition. If 
they were in such a situation then it was best that 
the operation was delayed until she died, after 
which it should be immediately performed to 
save the child. He suggested that it should only 
be done in: 
 
“… laborious and preternatural labors, 
on account of the narrowness or 
distortion of the pelvis into which it is 
sometimes impossible to introduce the 
hand; or from large excresences and 
glandular swellings that fill up the 
vagina and cannot be removed…or 
adhesions in that part and at the os uteri 
that cannot be separated, …in such 
emergencies, if the woman is strong and 
of good habit of body, caesarean 
operation is certainly advisable and 
ought to be performed; because the 
mother and child have no other chance 
to be saved, and it is better to have 
recourse to an operation which has 
sometimes succeeded than leave them 
both to inevitable death…”6 
 
Uterine sutures 
In the 16th century, obstetricians opposed 
performing surgery on live patients because 
maternal mortality was incredibly high.5 As well, 
during most of the 19th century (1787 to 1876), 
no successful caesarean operation had been 
performed in Paris.3 This was attributed to the 
wrong belief that the natural rhythmic 
contraction and relaxation of the uterus 
prevented the use of sutures. Therefore, after the 
baby was removed, incisions in the uterus were 
left open. Due to this, women died from 
hemorrhage and infection. As well, in those 
days, sutures had to be removed, and it was 
impossible to remove them from the uterine wall 
after the abdomen had been closed.5 The first 
man to close a uterine incision with sutures was 
Lebas, a French surgeon in 1769. However, the 
usage of sutures did not become popular until the 
Sanger method (below) resulted in reduced 
mortality rates. 
 
Antiseptic 
It is interesting to note that the early documented 
cases with successful births took place under 
unusual circumstances, and far away from 
hospitals (Bull horn goring and Jacob Nufer). 
Most of the surgeries in remote areas lacked 
medical staff and facilities. As well, because they 
lacked a medical community, time was not 
wasted on professional consultations. Instead it 
was being used to take action earlier. This meant 
that surgery was being performed earlier, when 
the fetus was not under much distress and the 
mother was not close to dying. Treating both 
parties at an earlier time increased their survival 
rates.3 Since operations got performed on kitchen 
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tables, beds and any other facilities but the 
hospitals, infection rates were low (sanitation 
was not practiced in hospitals) and survival rates 
were higher.  
Hospitals during those times were notorious 
for being ‘infection beds’, especially because the 
surgeons came in wearing street clothes and did 
not clean their hands in between patients. As a 
matter of fact, it was estimated that if a woman 
performed surgery on herself or was gored by a 
bull, she had a 50% chance of survival, 
compared with 10% survival rate if she were 
being taken care of by a New York surgeon!10 In 
the mid-1860s, the British surgeon Joseph Lister 
introduced an antiseptic method using carbolic 
acid.3 Introducing this method however helped 
reduce the number of deaths due to infection 
(seen as being the most common cause for 
women mortality), and allowed physicians to 
focus on their technique and style of operating.3 
 
Time of intervention 
As cesarean section became safer, obstetricians 
increasingly argued against delaying surgery. 
Rather than waiting for hours of unsuccessful 
labor, physicians like Franz von Winckel in 
Germany, Thomas Radford in England and 
Robert Harris in the United States opted for early 
intervention.3 Higher rate of survival were likely 
with early intervention. Such arguments 
eventually led to greater numbers of operations 
occurring earlier, and the data collected showed 
lower mortality.3 
 
Porro Operation 
The Porro operation, or the ‘radical caesarean 
section’, is defined as a surgery where the uterus 
is completely removed (hysterectomy). This left 
the woman unable to have any more children, 
which in itself had profound effects on emotional 
well being of the woman. Dr Joseph Cavallini 
had suggested this surgery as early as 1768, but 
attempts to perform this surgery then had 
been unsuccessful.2  In 1876, Eduardo Porro 
successfully performed this surgery. With the 
widespread usage of this surgery, presence of 
antiseptic protocols, and intervening earlier, 
mortality rates showed a marked decrease.2  
 
Sanger operation 
In 1882, Max Sanger used uterine sutures (silver 
and silk wire) to sew up the cuts made in the 
peritoneum. This was just as successful in 
reducing mortality rates as the Porro operation, 
and it did not involve removal of the uterus. 
Development of the silver wire stitches to treat 
vaginal tears (fistulas that resulted from 
traumatic delivery) was done by 19th century 
American gynecologist J. Marion Sims.3 Sanger 
operation was just as effective as the Porro 
method, and thus a lot of physicians moved to 
using this, for the woman’s benefit.  
 
Where to incise? 
As confidence in the outcome of their procedures 
increased, doctors turned their attention to where 
to incise the uterus. Various styles (longitudinal, 
oblique, etc.) were debated for a century (1770-
1880). Between 1880-1925, obstetricians 
experimented with transverse incisions in the 
lower segment of the uterus. The first person to 
suggest this type of incision was Robert Wallace 
Johnson (1786) in his book “A New Systems of 
Midwifery”.1 He suggested this because of low 
bleeding that occurred with such a cut. Kehrer in 
1881 successfully performed this type of 
incision.6  
Munro Kerr, a British obstetrician, highly 
advocated the Kehrer method during the 1920’s.2 
He believed that such an incision had low 
bleeding, low infection rate and low uterine 
rupture from subsequent pregnancies (because 
the scar would make the region stronger).6  
A further modification -- vaginal cesarean 
section -- helped avoid peritonitis in patients 
who were already suffering from certain 
infections.3  However, with the discovery of 
penicillin in 1928 by Alexander Fleming, this 
method was eventually eliminated from 
practice.3 
Most incisions today either involve 
transverse incision of lower segment (Kerr 
technique) or classical/vertical incision, which is 
a cut made through the abdomen and front wall 
of uterus. The latter has high blood loss and 
increased incidence of infection.6. However, if it 
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is an emergency C-section, a pre-term fetus, or a 
tumor that obscures the lower segment, then 
vertical incision is used.6 
 
Conclusion 
Caesarean section has enjoyed a very long 
history and has been continuously refined by 
society. At one time such a procedure was only 
used on deathbeds. But now it is heavily being 
considered as elective or first line when it comes 
to delivery of a child (especially in South 
American countries like Brazil). Before where 
the child’s health and well being was put first, 
now the mother’s health and cosmetic outlook is 
considered just as seriously. The art and style of 
caesarean section has developed despite many 
problems, and has grown with civilization as 
human nature has throughout these centuries. 
 
References 
 
1. Young JH. Caesarean Section: The History and 
Development of the Operation From Earliest Times. 
London, HK Lewis & Co Ltd, 1944.  
2. Gabert HA, & Bey M. History and development of 
Cesarean Operation. Obstetrics and Gynecology 
clinics in North America 1988; 15:591-605.  
3. National Library of Medicine. Caesarean Section – a 
brief history.  1993.  Accessed March 25th, 2004 from 
http://www.nlm.nih.gov/exhibition/cesarean/cesarean_
2.html to …/cesearean_6.html 
4. Rosen MG, Alper MH, Cefalo RC, et al. Consensus 
Development Conference on Caesarean Childbirth. 
Bethesda, Maryland: National Institute of Child 
Health and Human Development, National Institute of 
Health; 1980. 
5. Boley JP. The History of Caesarean Section. CMAJ 
1991; 145(4): 319-322 
6. Hillan EM. Caesarean Section: historical background. 
Scottish Medical Journal 1991; 36(5):150-154. 
7. Brian VA. The deepest cut of all. Nursing Mirror 
1976; 143:68-69. 
8. Radcliffe W. Milestones in Midwifery.  Bristol, John 
Wright and Sons Ltd; 1967. 
9. Harris RP. Cattle-horn lacerations of the abdomen and 
uterus in pregnant women. American Journal of 
Obstetrics and Gynecology 1887; 11:673-685. 
10. Harris RP. Remarks on the Cesarean Operation. 
American Journal of Obstetrics and Gynecology 1879; 
11:620-626.   
11. Young JH. Caesarean Section: The history and 
development of the operation from earliest times.  
London, United Kingdom: HK Lewis & Co Ltd; 1944. 
 
All pictures obtained for this paper were accessed from the 
Collection of the National Library of Medicine's History of 
Medicine Division on March 25, 2004 
(http://www.nlm.nih.gov/exhibition/cesarean/cesarean_1.h
tml). 
 
 
   UWOMJ 78(1)2008 P86 
 
 
 
The Birth of Defibrillation: A Slow March Towards Treating Sudden Death 
 
Stephen M. Chihrin 
 
Recent years have seen the rapid fine-tuning of external cardiac defibrillation for the treatment of cardiac arrest.  
However, this rapid advancement conceals the slow march of physiologists over several centuries to address this life 
threatening state.  Frequently, accounts of defibrillation research begin with the turn of the 20th century.  However, the 
birth of the field was rooted millennia earlier, and became the object of scientific investigation a full 150 years before 
Einthoven received the Nobel Prize for his work developing the electrocardiograph. Early accounts of resuscitation 
demonstrated an understanding of the necessity of respiration for life, as well as the correlation of respiratory and 
cardiac function.  The eminent danger posed by ventricular fibrillation was noted by the Egyptians as early as 3500 BC, 
when it was observed that “When the heart trembles, has little power and sinks, the disease is advancing and death is 
near.” However, it was the discovery of electricity that proved critical to research into heart function, and ultimately, 
defibrillation.  In the mid 18th century, Luigi Galvani made the classic observation that an electrical impulse could 
cause a frog’s leg to twitch “as though it were seized with tetanus at the very moment when the sparks were 
discharged.”  The excitement generated from Galvani’s experiments led to the almost instantaneous application of 
electricity to the treatment of cardiac arrest.  However, it would take a number of innovative physicians, in roles 
spanning from basic researchers to public educators, to bring defibrillation from a baseless practice attempted out of 
desperation, to a scientifically validated, reliable, and widely available procedure.  It is the intent of this report to 
highlight a number of these innovative individuals, and to detail the research that provides a foundation for the rapid 
advancements in cardiac care seen today. 
 
 
Introduction 
Recent years have seen the rapid fine-tuning of 
external cardiac defibrillation for the treatment 
of cardiac arrest.  The recent announcement of 
the Phillips HeartStart Home Defibrillator as one 
of Fortune Magazine’s “25 Best Products of 
2004”1 can be seen not only as a testament to 
medicine’s growing response to one of society’s 
greatest health risks, but also as the culmination 
of several centuries of discovery in cardiac 
electrophysiology. 
While our ability to respond effectively to 
sudden death has greatly improved in recent 
years, it comes as no surprise that the desire to 
do so is as old as antiquity itself.  Reviving 
someone apparently dead was no doubt a 
dramatic tale in any time, and countless instances 
of it are found in mythology and ancient texts.  
One of the earliest and most widespread written 
depictions of resuscitation can be found in the 
Bible, where Elisha was detailed on more than 
one occasion to raise the dead:  
 
“And when Elisha was come into the 
house, behold, the child was dead .... 
And he went up, and lay upon the child, 
and put his mouth upon his mouth, and 
his eyes upon his eyes, and his hands 
upon his hands: and stretched himself 
upon the child; and the flesh of the child 
waxed warm .... And the child sneezed 
seven times, and the child opened his 
eyes.” (2 Kings 4:32-35). 
 
While techniques to aid in true cardiac arrest did 
not emerge until the 18th century, knowledge of 
ventricular fibrillation – the most common cause 
of sudden cardiac death – existed more than 
3500 years ago.  At that time, it was written in 
the Ebers Papyrus that “When the heart trembles, 
has little power and sinks, the disease is 
advancing and death is near…”.2 The link 
between trembling (fibrillation), little power 
(poor circulation), and death, was again 
described by Vesalius as “worm-like” motions of 
the heart.  Vesalius added to this description in 
1543, by also noting the correlation between 
respiration and cardiac function: 
 
“…Indeed, with a slight breath in the 
case of this living animal the lung will 
swell to the full extent of the thoracic 
Feature Article 
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cavity, and the heart become strong and 
exhibits a wondrous variety of motions…. 
And as I … take care that the lung is 
inflated at intervals, the motion of the 
heart and arteries does not stop…”. 3 
 
Electricity 
It was the discovery of electricity that proved 
critical to research into heart function, and 
ultimately, defibrillation.  In the mid 18th century, 
Luigi Galvani began experimenting with 
electricity, and made the classic observation in 
that an electrical impulse could cause a frog’s leg 
to twitch “as though it were seized with tetanus 
at the very moment when the sparks were 
discharged”.4  This account of “animal 
electricity” quickly caught the interest of 
seemingly every scientist in Europe.  And while 
it undoubtedly put great survival pressure on the 
common frog, the discovery ultimately spawned 
the field of electrophysiology. 
 
Early Discoveries 
The excitement generated from Galvani’s 
experiments, and the countless experiments that 
followed, led to the almost instantaneous 
application of electricity to the treatment of 
cardiac arrest.  While it wouldn’t be until Prevost 
and Battelli’s work in the turn of the 20th century 
that true defibrillation would be depicted 
scientifically,5 the first case report describing 
successful resuscitation using electrical shock 
was made in 1774, when a young woman fell out 
a second-storey window and was believed by all 
accounts to be dead.6  After approximately 
twenty minutes, a doctor was summoned, who 
after exhausting all conventional techniques, 
attempted to apply electricity “to various parts of 
the body in vain; but upon transmitting a few 
shocks through the thorax, he perceived a small 
pulsation’ in a few minutes the child began to 
breathe with great difficulty, and after some time 
she vomited.”  This account, and many others, 
were recorded in the register of Royal Humane 
Society of London, an organization established 
the very same year to promote resuscitation as a 
means of saving otherwise healthy people – 
victims most often of falls, drowning, mining 
accidents, and lightning.6 
While doctors across Europe began using 
electricity as experimental treatment for sudden 
death, the first report of scientific investigation 
into this practice was not conducted until a year 
after the first recorded “save”.  In 1775, Dr. Peter 
Abilgaard published his observations on shock 
and countershock – a full 124 years before 
Provost and Battelli’s documentation of 
ventricular fibrillation and defibrillation.  
Abilgaard observed that electrical stimuli could, 
when applied anywhere across the body of a hen, 
in particular the head, render his animal 
specimen lifeless, and when applied again across 
the thorax, restarted the heart: 
 
“With a shock to the head, the animal 
was rendered lifeless, and arose with a 
second shock to the chest; however, after 
the experiment was repeated rather often, 
the hen was completely stunned, walked 
with some difficulty, and did not eat for 
a day and night; then later it was very 
well and even laid an egg.”7 
 
Surprisingly, given the importance of 
Abilgaard’s observations, few references were 
made to it in the literature of the time. 
 
A True Beginning 
While the study by Abilgaard and the numerous 
case reports from the Royal Humane Society 
suggested an early beginning to cardiac arrest 
research, it was not until the beginning of the 
19th century that work began in earnest.  The 
mechanism of cardiac arrest began to be 
elucidated by Ludwig and Hoffa, who in 1850 
were the first to physiologically describe 
fibrillation in animals, while also noting that 
electrical shocks can reliably induce the 
phenomenon.6  By 1851, chloroform had gained 
considerable popularity in operating theatres 
across the world, and numerous cases of sudden 
death left surgeons hesitant to use the 
anesthetic.8  Dr. Steiner was one of the first to 
investigate chloroform and ether induced cardiac 
arrest, and published accounts of successful 
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ventricular pacing in 10 dogs, 14 cats, 6 rabbits, 
and 1 donkey.  Unfortunately, his one attempt at 
resuscitating a human patient was unsuccessful.9 
Work on fibrillation continued by many 
physiologists in the later half of the 19th century, 
aided by advances in knowledge of cardiac 
function and in technology to observe it.  John 
McWilliam made several significant 
observations about ventricular fibrillation 
through a series of reports in 188710 and was one 
of the first to insist that that ventricular 
fibrillation must occur in humankind.  Until this 
point, and in fact for a number of years after, 
ventricular fibrillation had only been clearly 
observed in animals, leading many to believe it 
simply did not occur in mankind.6  McWilliam, 
however, demonstrated that ventricular 
fibrillation occurs with greater frequency and 
severity in larger mammal species, and suggested 
quite reasonably that the reason ventricular 
fibrillation had not been clearly identified 
humankind was simply that most cases of 
cardiac arrest occurred out of hospital, where 
response time exceeded fibrillation duration.10 
Around the same time, two other 
physiologists were studying fibrillation and 
made some significant discoveries.  The focus of 
Prevost and Battelli’s report was not unlike the 
conclusions made by McWilliam: the heart’s 
ventricles could be made to fibrillate with a 
small amount – as little as 40 Volts – of 
electricity delivered across the chest wall.5  What 
was not the focus of this report, but would 
become the focus of countless reports in the next 
hundred years was the casual observation – in a 
footnote – that a second, larger shock (between 
240 and 4800 Volts) could often defibrillate the 
heart.  While it is likely that Prevost and Battelli 
realized the importance of their observation for 
the animals they studied, they must not have 
been aware of McWilliams suggestion that 
ventricular fibrillation is likely a major cause of 
sudden cardiac arrest in mankind.11  Thus, with 
what could be the understatement of their 
professional careers, Prevost and Battelli helped 
electrophysiology conclude the 19th century with 
a solid background in ventricular fibrillation and 
defibrillation – in animals only – setting the 
stage for rapid advancement in the 20th century. 
 
Development of Defibrillation 
While cardiac arrest due to early application of 
anesthesia prompted research early in the 19th 
century, the advent of public electricity in the 
early 20th century prompted further development 
of the field of cardiac electrophysiology.  
Spurred by a growing number of employee 
accidents, in 1926 the Consolidated Electric 
Company of New York City funded a 
collaboration at John Hopkins between Orthello 
Langworthy and Donald Hooker, both physicians, 
and William Kouwenhoven, an electrical 
engineer.6  By 1933 the trio had published a 
summary of their initial research, expanding 
upon the findings made 30 years earlier made by 
Prevost and Battelli.  Specifically, the group 
noted that for defibrillation to be successful, the 
shock must be applied within a few minutes of 
arrest if no other intervention is made: 99% of 
cardiac arrests defibrillated after 30 seconds 
were successfully resuscitated, but after one, two 
and four minutes the success rates dropped to 90, 
27, and zero percent, respectively.8  They also 
noted that open- and closed-chest cardiac 
massage could extend this window, an 
observation that ultimately lead to the chest 
compressions used in CPR today. 
Around the same time that Kouwenhoven 
and colleagues were developing clinically usable 
defibrillation techniques, a man who would later 
be cited as one of the most influential individuals 
in cardiac resuscitation was completing his 
internship.  During his internship in Cleveland, 
Ohio, Claude Beck witnessed a number of 
cardiac arrests during surgery, and stood back 
with amazement as the surgeon would request 
that the local fire department be summoned to 
administer oxygen in an attempt at resuscitation, 
leaving him feeling, quite fairly, that “we were 
not doing our best for the patient”. 8  He went on 
to construct his own defibrillator and developed 
the first in-house cardiac resuscitation team – the 
precursor to the crash cart team.8  In 1947 Beck 
achieved the first clearly documented 
defibrillation, in a young boy undergoing surgery 
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for a congenital form of funnel chest.  Upon 
noticing ventricular fibrillation, Beck maintained 
manual heart massage for over 30 minutes before 
he had an electrocardiograph confirmation and 
then delivered a shock directly to the heart.  The 
first shock was unsuccessful, procaine was 
administered to improve the heart’s 
susceptibility to electricity, and upon a second 
shock normal sinus rhythm was restored. 
 
 
Figure 1: Electrocardiogram recorded by Dr. 
Claude Beck detailing the first documented 
successful defibrillation of a human.  The three 
tracings demonstrate:  a) ventricular fibrillation, 
b) ventricular fibrillation still present after first 
shock, c) supraventricular tachycardia following 
procaine administration and successful second 
shock.12 
 
Beck went on to fine-tune his device, and in the 
interest of promoting defibrillation, promising to 
“furnish this apparatus to anyone who would like 
to have it for the cost of the various parts”.8  In 
1950 Beck began to educate others in his 
protocol, establishing a course that trained 
surgeons, anesthetists, nurses, and dentists from 
around the world in his protocol, forming the 
basis of today’s CPR and ACLS courses.6,8  By 
1961, the advantages of closed chest cardiac and 
external defibrillation, first suggested by 
Kouwenhoven 30 years before, were proven 
clinically by Dr. Paul Zoll.8  Beck capitalized on 
the development of external defibrillation as an 
opportunity to expand his training to the lay 
public, establishing the Resuscitators of America 
program to train members of the public in CPR 
using the now ubiquitous CPR mannequins. 
Research continued from the early models 
designed by Kouwenhoven, Beck and Zoll, 
refining the amount and type of electricity, the 
method of delivery, as well as improvements in 
safety and automation.  The advances in cardiac 
treatment witnessed in just this last generation 
are substantial, and reveal a history of scientific 
research spanning over 300 years, and a history 
of curiosity in the heart’s operation spanning 
over 3000 years.  What will be the future of 
cardiac resuscitation?  The Phillips HeartStart 
Home Defibrillator is likely just the beginning.  
When Abilgaard conducted his initial research 
into “countershock” in 1775, science and society 
were not ready to appreciate the importance of 
his work in the context of improving patient care.  
Perhaps with time we too will find modern 
research deemed insignificant today shedding 
light on significant issues of tomorrow. 
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Triumph Over Pain: The Curiously Contentious History of Ether 
 
Daniel J. Kim 
 
Surgery in the early nineteenth century posed serious challenges to both the surgeon and the patient due to unbearable 
pain. However surgical textbooks of the day scarcely mentioned this pain; accompanying illustrations showed patients 
lying quietly, apparently unconcerned in the midst of gruesome and painful procedures. All this changed on October 
16, 1846. William T.G. Morton, a Boston area dentist, administered ether to a patient with a large vascular 
malformation in his neck. John Collins Warren, a senior surgeon at the Massachusetts General Hospital, painlessly 
excised the tumor in an operating theater filled with hospital staff. Morton’s demonstration revolutionized the way 
surgery was practiced, but the credit for the discovery of surgical anesthesia is certainly not his alone. Several 
individuals challenged Morton’s attempts to claim sole credit, including Horace Wells, Charles T. Jackson, and 
Crawford W. Long. Long, a physician from Georgia, was actually the first to perform an anesthetized operation using 
ether in March 1842, but failed to publish his results until several years after Morton’s demonstration. Morton learned 
of inhalation anesthesia at a failed demonstration by Wells, his former dental partner, who in turn noted the analgesic 
qualities of nitrous oxide at a public lecture in 1844. Jackson, a former mentor to Morton, supplied the critically 
important advice of using pure sulfuric ether, rather than impure commercial concoctions.  Hope of financial gain led 
to acrimonious legal battles erupted between Morton, Wells, and Jackson.  Ironically none received any financial 
reward, and all met untimely and tragic deaths. 
 
 
Introduction 
Surgery before the mid nineteenth century is 
difficult to comprehend today – patients suffered 
unbearable only relieved by a speedy 
conclusion.1  The necessity of anesthetic agents 
was not lost on surgeons, but there was a lack of 
systematic research. Opiates were administered 
gratuitously, alcohol intoxication, hypnotism, 
and sometimes even a blow to the chin was 
used.2 Unfortunately none worked reliably, and 
surgical textbooks of the day scarcely mentioned 
pain.  Illustrations showed patients lying quietly, 
apparently unconcerned in the midst of gruesome 
and painful procedures.1 All this changed on 
October 16, 1846 thanks to a resourceful but 
profiteering dentist. 
 
Discovery 
William T.G. Morton began his dental career at 
the Baltimore College of Dental Surgery.  
Without finishing his degree, he studied with 
Horace Wells, a Hartford dentist, in 1841. The 
two became partners during 1842 and 1843, but 
this proved unsuccessful and Morton set up his 
own practice in Boston. He attended several 
classes at Harvard Medical School in 1844 and 
studied briefly with Charles T. Jackson, an 
internationally famous physician, chemist, and 
geologist.  He quit his extracurricular academic 
interests to focus on his practice when it began to 
flourish.3 
Morton specialized in prosthetic dentistry, 
considering it essential to extract all tooth 
material from the jaw before fitting a prosthesis. 
Although skilled, his technique was laborious 
and painful, discouraging many potential clients. 
He realized that he was losing business, so he 
looked for a way to make extractions painless.4 
At this time, dentistry was a trade, not a 
profession, and many kept their special 
techniques secret. It is no surprise that Morton 
was so cautious in his search.5  He took interest 
in ether because Charles Jackson had suggested 
its local application might deaden the pain of 
extractions. Results were inconsistent, and his 
interest turned to ether vapor.  His experiments 
in the summer of 1846 were on household pets, 
then on himself and his assistants.  His results 
were unreliable, and Morton sought Jackson’s 
help.  Jackson suggested that Morton could 
improve his results if he used chemically 
purified sulfuric ether rather than less pure 
commercial products.3 After additional tests on 
himself and his assistants, Morton felt confident 
Feature Article 
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enough to administer ether to a patient. On the 
evening of September 30, 1846, Eben Frost came 
in with an intensely painful tooth and begged 
Morton to hypnotize him, a standard but 
ineffective pain reliever. Morton claimed that he 
could offer something far more effective, and 
Frost agreed to ether. After inhaling the ether 
through a handkerchief, Morton painlessly 
extracted the tooth and Frost had no recollection 
of the extraction.5 
After this success, Morton inquired about the 
possibility of patenting a new process using 
sulfuric ether. He received an uncertain response, 
but was assured that a definitive answer could be 
provided by consulting the law.3 Morton then 
approached John Collins Warren, head of the 
surgical staff at the Massachusetts General 
Hospital (MGH), about a public demonstration. 
Hoping for a patent and fearing piracy, he 
refused to disclose his exact preparation. Warren 
had ethical misgivings because the preparation’s 
identity and safety were unknown. Despite 
misgivings, Warren had an invitation sent to 
Morton written by one of the junior house 
officers, perhaps reflecting Warren’s skepticism 
and reservations.1 
Morton’s demonstration was scheduled for 
October 16, 1846.  The operating theater was full 
and skepticism was pervasive. Morton was late 
because of several last minute changes to the 
inhaler.5 Warren was impatient and decided to 
proceed. “As Dr. Morton has not arrived, I 
presume he is otherwise engaged,” he remarked 
to the audience implying that Morton was too 
fearful of failure to show up.6  Morton rushed in 
with his newly configured inhaler and applied 
the ether vapor to the patient, who was soon 
asleep. The theater watched in silent anticipation 
as Warren started his incision over a vascular 
tumor in the patient’s neck. To everyone’s 
surprise, the patient didn’t startle, scream, or 
give any indication of pain. As Warren ligated 
the deep vessels, the patient started moving his 
limbs and uttering nonsensical expressions. 
Warren doubted the success of the operation 
until he had full confirmation from the patient 
that he had had no pain. He then turned towards 
the amazed audience and famously remarked, 
“Gentlemen, this is no humbug”.3  
 
Origins 
The origins of inhalation anesthesia predate 
Morton’s interest. After nitrous oxide was shown 
to be relatively safe in the early 19th century, 
traveling chemistry professors lectured on gases 
and demonstrated their exhilarating effects. 
Nitrous oxide was quite popular because 
intoxicated individuals spoke foolishly and 
would sometimes laugh uncontrollably. It 
became fashionable to inhale nitrous oxide at 
lectures and social gatherings.3  In many social 
circles, ether replaced nitrous oxide because of 
the ease of obtaining, storing, and administering 
it. Ether frolics, where participants would 
become drunk from ether vapor, became popular, 
particularly among students.7 
Morton wasn’t the first to demonstrate ether 
as an anesthetic - Crawford Long, a well-trained 
physician practicing in the small town of 
Jefferson, Georgia, was. His offices were a 
clubroom for the town’s young intellectuals, and 
meetings often turned into ether frolics. Long 
enjoyed inhaling ether and often discovered new 
bruises on himself and his friends afterward. 
They had no recollection of pain or the causes of 
these bruises, and Long concluded that ether 
could eliminate pain. He put his observations 
into practice on March 30, 1842, when a boy 
named James Venable approached him 
requesting removal of two small neck masses. 
Long explained his observations to Venable, as 
he knew that Venable enjoyed inhaling ether.3 
After getting consent, Long painlessly removed 
one of the sebaceous cysts. Although thrilled 
with his achievement, he only gave ether for 
seven minor operations over the next four years 
and didn’t publish the report of his cases until 
1849.  Regardless of his lack of influence, Long 
had the innovation and courage to experiment 
with ether as a surgical anesthetic.5 
Horace Wells also had an important impact 
on the development of anesthesia. On December 
10, 1844, he and his wife attended a lecture in 
Hartford, Connecticut by Gardner Colton, a 
traveling professor. Colton demonstrated with 
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laughing gas, but Wells noticed that a participant 
suffered a severe gash to his knees without 
reacting to the pain. He reasoned that nitrous 
oxide might be able to alleviate the pain 
associated with dental procedures. After asking 
Colton to produce some nitrous oxide for him, 
Wells inhaled it and had one of his own wisdom 
teeth extracted.5 Upon waking he exclaimed, “I 
felt it no more than the prick of a pin.  This is the 
most wonderful discovery of our time”.2 In the 
following month, Wells performed about fifteen 
painless dental procedures with nitrous oxide and 
felt confident enough to demonstrate it publicly. 
John Warren invited Wells to demonstrate a 
dental extraction on a student in January 1845. 
Unfortunately, the gasbag was withdrawn too 
soon, the anesthesia was incomplete, and the 
student screamed in pain. This proved disastrous, 
and the surgeons took no further interest in Wells 
or his methods.  This demonstration had a strong 
and lasting impression on Morton, launching his 
clandestine quest for an effective and reliable 
anesthetic agent.5 
 
Fallout 
Morton’s success with ether continued after his 
original demonstration. The following day he 
aided in the removal of an adipose tumor from a 
woman’s arm.  The patent commissioning office 
confirmed that etherization could be patented. 
Unhappily, the patent commissioner was a friend 
of Thomas Jackson’s, and had been persuaded by 
Jackson to consider a joint discovery. Although 
Jackson was a distinguished academic, he had an 
unsavory tendency to take credit for other 
people’s inventions, especially when they had 
financial promise.  Jackson’s friend at the patent 
office persuaded Morton to include Jackson’s 
name, and the patent was issued on November 
12, 1846.3 
During this time, Morton had been prohibited 
from using ether at MGH because he had kept 
his preparation a secret, calling it Letheon, Greek 
for forgetfulness. John Warren and other senior 
surgeons at MGH were concerned about using a 
preparation whose composition and safety were 
unknown.  He finally revealed it to be nothing 
more than sulfuric ether on November 6. The 
next day Morton administered ether in two major 
operations both of which were complete 
successes, and the MGH surgeons were fully 
persuaded of the importance and effectiveness of 
this discovery. Morton enjoyed the endorsement 
of the MGH staff in his mission to collect fees 
and regulate the use of ether anesthesia.5 
As ether anesthesia became more accepted, 
Jackson wrote two letters to a friend in Paris 
claiming that he discovered ether anesthesia and 
introduced it into surgery, and that it had been 
thoroughly tested and accepted at MGH. These 
letters were presented to the Académie des 
Sciences, and the European scientific community 
accepted Jackson’s claims. Morton learned of 
Jackson’s letters and collected evidence to refute 
his claims, but Jackson’s connections in Europe 
had more influence. He continued to enjoy the 
support of his international friends from Paris 
and London.3 
Horace Wells also challenged Morton’s 
claims. After Wells’ failure with nitrous oxide at 
MGH, he returned to Hartford and became so 
seriously ill that his practice was ruined. In 
December 1846, his friends advised him to 
publish a statement in the Hartford Courant. He 
claimed that he should have rights to the 
discovery based on the fact that his nitrous oxide 
experiments used the same principles as 
Morton’s ether discovery.3 
Morton’s patent was soon ignored all over 
America and Europe, as surgeons used a sponge 
instead of Morton’s specialized inhaler.  The 
United States Army and Navy broke his patent 
with their widespread use of ether during the 
Mexican War in 1847.  Morton’s efforts to 
collect fees and regulate anesthesia failed and his 
dental business was ruined.3 In 1849, Morton 
petitioned Congress to recognize his claims and 
to compensate him. After three appeals, 
Congress finally agreed to reward Morton with a 
$100,000 award in 1852. Jackson’s and Wells’ 
supporters objected, and Crawford Long was 
persuaded to submit a claim in 1854. All the 
proposed bills were rejected due to the excessive 
number of claimants, and no one received any 
reward.5 
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Afterward 
Of the four figures involved in the ether 
controversy, only Crawford Long’s life wasn’t 
destroyed by the desire to gain prestige and 
monetary reward. After the Congressional 
debates of 1854, he gave up and continued his 
practice in Georgia until his death. As a hero of 
the South, his successful use of ether is 
commemorated by Doctor’s Day every March 
30.5 
Horace Wells’ attempts at recognition failed, 
and he left his family unsupported in Hartford, 
returning to New York City to resume 
experiments. He became addicted to chloroform 
and committed suicide after being incarcerated 
for throwing sulfuric acid on prostitutes. Twelve 
days later, the Paris Medical Society gave him 
the honor of being first to use vapors or gases to 
make surgery painless.5 
Charles Jackson became an uncontrollable 
megalomaniac.  When he came across Morton’s 
grave in 1873, Jackson developed a severe 
psychotic illness. He was placed in an institution 
for the insane outside of Boston and remained 
there until his death in 1880.  He was buried just 
a short distance from Morton at Mount Auburn.5 
 Morton became obsessed with financial 
reward and recognition for his contribution to 
anesthesia. However, none of his schemes were 
successful, and he was ruined by them. His 
creditors ignored him; he lost his home, and was 
censured by the American Medical Association. 
In the summer of 1868, Morton journeyed to 
New York City to refute a new publication by 
Thomas Jackson claiming credit for ether 
anesthesia, but Morton suffered heat stroke 
during a heat wave.5 
The discovery of ether anesthesia 
revolutionized surgery and dentists had the most 
important influence on this discovery.  Many 
surgeries that save or improve lives are now 
readily possible.  Although their motives may 
have been suspect, it was their drive, courage, 
and innovation that led to this important 
discovery.  Because of the bitterness and 
peculiarities of the ether controversy, it is fitting 
that no individual receives credit. The Boston 
Public Garden is home to the Ether Monument 
commemorating the discovery of ether 
anesthesia as a treatment rather than an 
individual.8 
 
References 
 
1. Moore FD. 1999. John Collins Warren and his act of 
conscience: a brief narrative of the trial and triumph of 
a great surgeon. Annals of Surgery. 229: 187-196. 
2. Keys TE. 1963. The History of Surgical Anesthesia. 
New York: Dover Publications Inc. 
3. Duncum BM. 1947. The Development of Inhalation 
Anesthesia. London: Oxford University Press. 
4. Snell EL. 1894. Dr. Morton’s Discovery of Anesthesia. 
The Century: A Popular Quarterly. 48: 584-592. 
5. Rutledge RH. 1996. America’s greatest medical 
discovery: 150 years later, who gets the credit? 
Journal of the American College of Surgeons. 183: 
625-636. 
6. Rice NP. 1858. Trials of a Public Benefactor. New 
York: Pudney and Russell. 
7. Bergman NA. 1992. Michael Faraday and his 
contribution to anesthesia. Anesthesiology. 77:812-816. 
8. Bigelow HJ. 1900. Address at the dedication of the 
ether monument. In: Surgical Anesthesia Addresses 
and Other Papers. Boston: Little Brown and Co. 101-
104. 
 
 
